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Every plant cell is enclosed by a cell wall that controls its volume and shape. It 
provides structural support, tissue elasticity, and protection against pathogenic organisms. 
The sophisticated network of biomolecules that form the plant cell wall consists of 
proteins, lignin, and primarily of polysaccharides. The polysaccharides are structurally 
highly diverse, which makes the analysis of individual functions and interactions 
challenging. Well-defined probes of oligo- or polysaccharides would greatly facilitate these 
analyses but they are difficult to obtain from natural sources. Chemical synthesis is a 
powerful alternative to prepare these probes. 
One of the main components of plant cell wall polysaccharides is the hemicellulose 
xylan. Xylans possess a common backbone consisting of -1,4-linked xylopyranoses 
which may be partially acetylated and substituted with arabinofuranosyl or (4-O-
methyl)glucuronosyl residues. In chapter 2.1 a collection of oligosaccharides related to 
plant arabino- and glucuronoxylans was synthesized by automated glycan assembly, 
which is a powerful tool for the synthesis of oligosaccharide libraries. By iterative addition 
of different monosaccharide building blocks (BB) to a linker-functionalized resin, xylan 
oligosaccharides of different length and complexity have been obtained. Among these 
were -1,2- and -1,3-substituted arabino- and glucuronoxylan oligosaccharides. To 
enable selective substitution of the xylan backbone with arabinose and glucuronic acid 
units the xylose BBs were equipped with 2-(methyl)naphthyl (Nap) and 2-
(azidomethyl)benzoyl (AZMB) groups that were used for the first time as protecting groups 
in automated glycan assembly. The glucuronoxylan oligosaccharides were obtained by 
using a glucose BB during oligosaccharide assembly that was afterwards converted in a 
two-step-oxidation procedure into the corresponding glucuronic acid. The synthetic 
oligosaccharides served as excellent tools for the characterization of binding epitopes of 
plant cell wall glycan-directed monoclonal antibodies and for determining the substrate 
specificities of cell wall-degrading enzymes. Monoclonal antibodies are used for high 
resolution imaging of plant cell walls, providing important information on the structure and 
function of cell wall polysaccharides. Using glycan microarray technology many binding 
epitopes were determined that were previously unknown with the help of the synthetic 
oligosaccharides. Cell wall-degrading enzymes are crucial for the deconstruction of 
lignocellulosic biomass, making the hydrolysis products available for various industrial 
applications. The substrate specificities of xylanases and arabinofuranosidases were 
determined by analyzing the digestion products after incubation of the synthetic 




In chapter 2.2 the synthesis of artificial arabinoxylan polysaccharides with defined 
substitution patterns is described. Polysaccharides from plant biomass are explored 
extensively as renewable resources for the production of materials and fuels. However, 
the heterogeneous nature of non-cellulosic polysaccharides such as arabinoxylan makes 
it difficult to correlate molecular structure with macroscopic properties. To study the impact 
of specific structural features of the polysaccharides on e.g. crystallinity or affinity to other 
cell wall components, collections of polysaccharides with defined repeating units are 
required. A collection of artificial arabinoxylan polysaccharides with systematically altered 
branching patterns was obtained by glycosynthase-catalyzed polymerization of glycosyl 
fluorides derived from arabinoxylan oligosaccharides that were procured either chemically, 
chemo-enzymatically, or from a commercial source. These artificial arabinoxylan 
polysaccharides, that are not accessible by other means, represent ideal probes for 
structure-property relationship studies. The crystallinity of the polysaccharides was 
qualitatively determined by powder X-ray diffraction, revealing that the specific substitution 
pattern has a higher impact on crystallinity of xylans than the degree of substitution. 
Experiments using quartz crystal microbalance with dissipation (QCMD) on a cellulosic 
surface indicated that polysaccharides carrying arabinose substituents, which are evenly 






Jede Pflanzenzelle ist von einer Zellwand umschlossen, die ihr Volumen und ihre 
Form bestimmt. Sie sorgt für strukturelle Stabilität, Elastizität des Gewebes und Schutz 
vor Krankheitserregern. Das hochentwickelte System aus Biomolekülen, das die 
Pflanzenzelle bildet, besteht aus Proteinen, Lignin und zum größten Teil aus 
Polysacchariden. Die Polysaccharide sind strukturell sehr vielfältig, was die Untersuchung 
ihrer individuellen Funktionen und Interaktionen erschwert. Strukturell klar definierte Oligo- 
und Polysaccharide würden diese Analysen stark vereinfachen, aber sie sind nur schwer 
aus natürlichen Quellen zu gewinnen. Die chemische Synthese ist daher eine 
vielversprechende Alternative, um diese herzustellen. 
Eine der Hauptkomponenten der pflanzlichen Polysaccharide in der Zellwand ist die 
Hemizellulose Xylan. Xylane besitzen ein Rückgrat, das aus -1,4-verknüpften 
Xylopyranosen besteht, welche partiell acetyliert und mit Arabinofuranose oder (4-O-
Methyl)glucuronsäure substituiert sein können. In Kapitel 2.1 wurde eine Bibliothek von 
Oligosacchariden, die strukturell mit pflanzlichen Arabino- und Glucuronoxylanen 
verwandt sind, mittels automatisierter Oligosaccharidsynthese hergestellt, welche eine 
leistungsstarke Technik für die Synthese von Oligosaccharid-Bibliotheken ist. Durch die 
iterative Verknüpfung von Monosaccharid-Bausteinen an ein Harz, das mit einem Linker 
funktionalisiert wurde, konnten Xylanoligosaccharide mit verschiedener Länge und 
Komplexität erhalten werden. Darunter waren -1,2- und -1,3-substituierte Arabino- und 
Glucuronoxylanoligosaccharide. Um die selektive Substitution des Xylan-Rückgrats mit 
Arabinose- und Glucuronsäure-Substituenten zu ermöglichen, wurden die Xylose-
Bausteine mit 2-(Methyl)naphthyl- (Nap) und 2-(Azidomethyl)benzoyl- (AZMB) Gruppen 
ausgestattet, die das erste Mal als Schutzgruppen in der automatisierten 
Oligosaccharidsynthese benutzt wurden. Die Glucuronoxylanoligosaccharide wurden 
durch die Verwendung eines Glucose-Bausteins in der Oligosaccharid-Synthese erhalten. 
Die Glucose-Einheit wurde dann in einem zweistufigen Prozess in die entsprechende 
Glucuronsäure überführt. Die synthetischen Oligosaccharide fanden Anwendung in der 
Charakterisierung von monoklonalen Antikörpern, die Zellwandpolysaccharide erkennen 
und bei der Bestimmung von Substratspezifitäten von Enzymen, die Pflanzenzellwände 
zersetzen. Monoklonale Antikörper werden in hochauflösenden bildgebenden Verfahren 
eingesetzt, um wichtige Informationen über die Struktur und Funktion von pflanzlichen 
Zellwandpolysacchariden zu erhalten. Durch die Verwendung der Glykan-Microarray-
Technologie wurden mit Hilfe der synthetischen Oligosaccharide zahlreiche 
Bindungsepitope von monoklonalen Antikörpern bestimmt, die bisher unbekannt waren. 
Zellwand-zersetzende Enzyme sind für den Abbau von lignozellulosischer Biomasse von 
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Bedeutung, der wichtige Hydrolyseprodukte für viele industrielle Anwendungen zugänglich 
macht. Die Substratspezifitäten von Xylanasen und Arabinofuranosidasen wurden 
bestimmt, indem nach der Inkubation der Oligosaccharide mit den jeweiligen Enzymen die 
Abbauprodukte analysiert wurden. 
In Kapitel 2.2 wird die Synthese von artifiziellen Arabinoyxlanpolysacchariden mit 
definiertem Substitutionsmuster beschrieben. Polysaccharide aus pflanzlicher Biomasse 
werden intensiv als erneuerbare Ressourcen für die Produktion von Materialien und 
Kraftstoffen genutzt. Die heterogene Beschaffenheit nicht-zellulosischer Polysaccharide 
wie Arabinoxylanen erschwert es jedoch, die molekulare Struktur mit makroskopischen 
Eigenschaften zu korrelieren. Um den Einfluss von speziellen strukturellen Merkmalen der 
Polysaccharide auf z.B. Kristallinität oder die Affinität zu anderen Zellwandkomponenten 
zu untersuchen, wird eine Bibliothek von Polysacchariden mit definierten 
Wiederholungseinheiten benötigt. Eine solche Bibliothek von artifiziellen Polysacchariden 
mit systematisch verändertem Substitutionsmuster wurde in dieser Arbeit durch 
Glykosynthase-katalysierte Polymerisation von Glykosylfluoriden erzeugt. Diese wurden 
aus Arabinoxylanoligosacchariden hergestellt, die wiederum entweder chemisch, chemo-
enzymatisch oder auf kommerziellem Weg erhalten wurden. Diese artifiziellen 
Arabinoxylanpolysaccharide, die nicht auf anderem Weg erhältlich sind, stellen ideale 
Werkzeuge für die Untersuchung von Struktur-Eigenschafts-Beziehungen dar. Die 
Kristallinität der Polysaccharide wurde qualitativ mittels Pulver-Röntgendiffraktometrie 
bestimmt, was ergab, dass das spezifische Substitutionsmuster einen größeren Einfluss 
auf die Kristallinität von Xylanen hat als der Substitutionsgrad. Experimente mittels 
Quarzkristall-Mikrowaage mit Dissipation (QCMD) auf einer zellulosischen Oberfläche 
weisen zudem darauf hin, dass Polysaccharide, die Arabinose-Substituenten in geraden 
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1.1 Plant Cell Wall 
1.1.1 Architecture 
The plant cell wall is a highly organized and sophisticated network of different 
polysaccharides, proteins and aromatic compounds.1,2 It encloses every cell of the plant 
and therefore controls its volume and shape. Furthermore, the cell wall provides structural 
support for the plant, tissue elasticity, and protection against pathogenic organisms.3 
Growing cells are surrounded by a thin, flexible, and expandable cell wall, which is called 
primary cell wall. Mature cells deposit additional layers of polysaccharides and lignin 
inside the old one, thereby forming a more rigid secondary cell wall that can differ in its 
composition significantly from the primary cell wall.2,4 The main component of cell walls 
are the polysaccharides, which can be categorized into the three classes cellulose, 
hemicellulose, and pectin (Figure 1).5,6 Apart from their structural role they are involved in 
signaling and the immune response to pathogens.7,8  
 
Figure 1. Schematic representation of the plant cell wall and its components.
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Plant cell wall glycans are the largest source of biomass on earth, making them an 
attractive target for industrial utilization, such as in the paper and pulp industry, or as a 
renewable resource for the production of second-generation biofuels and various 
materials.9,10 Moreover, a considerable amount of our diet contains plant cell wall 
polysaccharides in the form of dietary fibers in fruits, vegetables, and cereals. Their 





pressure, heart diseases, diabetes, and obesity.11,12 In the pharmaceutical industry 
immunostimulatory13-15 and anti-tumor14,16,17 effects of plant glycans are explored. 
1.1.2 Cellulose 
Cellulose is the most abundant macromolecule on earth, which makes up to 1.5 x 
1012 tons of the total annual biomass production.18 Already thousands of years ago 
cellulose fibers were used as material for clothing or in the Egyptian papyri. Today, this 
biopolymer is still used for the production of textile fibers, paper products and biofuels, but 
also in cosmetics, coatings, laminates, and optical films.18-20 
Cellulose is the main component of plant cell walls. This homopolymer consists of 
linear chains of -1,4-linked D-glucose dimers (Figure 2), whose adjacent glucose 
residues adapt an alternating spatial conformation, due to strong hydrogen bonds 
between the hydrogen atom of O3 and the ring oxygen atom of the next residue. Cellulose 
microfibrils are formed through further intermolecular hydrogen bonds connecting 20-40 
glucan chains. Each glucan molecule can reach a length of 8000-15000 monosaccharide 
units, depending on the plant source.2 These strong inter- and intramolecular hydrogen 
bonds make the microfibril a rigid and water-insoluble polymer which is mainly responsible 
for the structural support of the cell wall. 
 
Figure 2. Structural model of a cellulose microfibril. The repeating unit of a single glucose chain is 
cellobiose (shown in brackets). Intra- and intermolecular hydrogen bonds are indicated by blue, 
dotted lines. 
In plants, cellulose is synthesized in a multi-step process by a membrane-bound 
enzyme complex with six subunits, which are arranged in a rosette shape. Each of them 





single cellulose chain from UDP-glucose. The parallel chains produced by every subunit 
then self-assemble into a microfibril.21-23 
1.1.3 Hemicelluloses 
1.1.3.1 Occurrence, Structure and Biosynthesis 
The term hemicellulose originated from the early belief that the water-extractable 
polysaccharides in the plant cell wall were precursors for cellulose. Even though this is 
now known to be false, the term is still commonly used. Hemicelluloses are a 
heterogeneous class of low-weight polysaccharides with mostly -1,4-linked backbones 
(Figure 3). They are often referred to as matrix polysaccharides as they form a tight 
network with cellulose microfibrils to prevent their aggregation.24,25 
Depending on the plant species, the types of hemicellulosic polysaccharides that are 
present differ. In all seed plants, except for grasses, xyloglucans are the main 
hemicellulose (Figure 3a). They consist of repetitive units of a -1,4-linked D-glucose 
tetrasaccharide, of which three consecutive glucose residues are decorated with side 
chains. These always consist of xylosyl residues, which may be further extended by 
galactosyl and fucosyl residues.26 Mannans (Figure 3b) are found in variable amounts in 
all cell walls and their backbone can be substituted with additional galactose residues.27 
Mixed-linkage glucans (Figure 3c) possess a -1,4-linked D-glucose backbone, which is 
 
Figure 3. Main polysaccharide classes of hemicelluloses besides xylans: (a) xyloglucans, (b) 





occasionally disrupted by a single -1,3-linkage. They are exclusively present in the 
primary cell wall of grasses and play an important role in cell growth.28 Another class of 
hemicelluloses arexylans (not shown here), which consist of a -(1→4)-linked D-xylose 
backbone. They are mostly present in grasses and cereals and will be discussed in the 
next chapter. 
Industrial utilization of hemicelluloses has become increasingly interesting since up to 
50% of the biomass dry weight are hemicellulosic polysaccharides. They are mostly used 
as raw material for products with industrial significance, such as ethanol, xylitol, and 2,3-
butandiol29 or as novel materials.24 
Hemicellulosic polysaccharides are synthesized in the Golgi apparatus of the cell a 
variety of glycosyltransferases. The -1,4-linked backbones of xyloglucans,30 
mannans,31,32 and mixed-linkage glucans33 are synthesized by glycosyltransferases that 
belong to the cellulose synthase-like (CSL) gene family. The xylan backbone is 
synthesized by glycosyltransferases of other families and even though many of the 
involved enzymes have been identified, their exact role remains unclear.34 After backbone 
synthesis, the substituents are attached by further glycosyltransferases35 and the final 
polysaccharide is transported to the cell wall in vesicles. 
1.1.3.2 Xylans 
Xylans are the most abundant non-cellulosic polysaccharides in the plant 
kingdom.25,34 The xylan backbone consists of -(1→4)-linked D-xylopyranosides decorated 
with variable substitution patterns that result in an immense structural diversity across 
plant species (Figure 4). Arabinoxylans (AX) are an important xylan subclass in which the 
backbone is substituted with L-arabinofuranosyl residues in the C2- and/or C3-position 
(Figure 4).36 They are the most abundant type of xylans in cereals.37 In woody tissues, 
glucuronoxylans (GX) are the main class of xylans. Their backbone is substituted with D-
glucuronic acid or the 4-O-methylated D-glucuronic acid derivative exclusively in the C2-
position of the xylose residues. Glucurono(arabino)xylans (GAX), that are mostly found in 
grasses, carry both types of substituents.38 The backbone of GXs and GAXs may be 
partially acetylated and the arabinose in AXs and GAXs may be esterified with ferulic acid 
(FA), which forms dimers in the plant cell wall, linking two xylan polymers together.39,40  
The molecular structure of xylans is known to have a strong impact on the macro-
scopic properties. A decrease in arabinose-substitution is accompanied by a decrease in 
solubility due to increased interchain interactions which result in aggregation.41 
Crystallinity is similarly affected by substitution. In the crystalline state (and in solution) xy- 






Figure 4. Schematic representation of a GAX structure in CFG nomenclature
43
 (a) and as chemical 
structure (b). 
disrupt the interactions between xylan chains and therefore decrease crystallinity 
significantly. Furthermore, adsorption to cellulose usually increases with a lower degree of 
substitution leaving the backbone free to hydrogen-bond to the cellulose microfibril.41,44-46 
However, recently it was shown47,48 that in glucuronoxylans the discrete molecular 
structure of the substitution pattern affects binding to cellulose more significantly. Upon 
interaction, xylan adopts a flattened two-fold helical screw conformation49,50 in contrast to 
the three-fold helical screw conformation in solution.42 The former conformation can only 
be adopted by domains of the polymer that carry evenly spaced substituents.51,52 This 
shows that there is an important relationship between structure and function in xylans.  
The high abundance of xylans makes them an interesting natural source for various 
applications, e.g. in the food industry as a stabilizer and additive. Because of the 
beneficial health effects of dietary fibers xylans are utilized as ingredients in functional 
foods.11,17,53,54 Moreover, their non-food applications include the production of second 
generation biofuels from lignocellulosic biomass,55,56 oxygen barrier films for 
packaging,57,58 and as a strengthener in paper production.59  
1.1.4 Pectin 
The most heterogeneous and complex class of plant polysaccharides is pectin. Their 
ability to form a gel-like matrix in the cell wall is taken advantage of in their main industrial 





baked goods.60,61 In the plant cell wall, pectins are involved in cell-cell-adhesion and have 
numerous functions during cell expansion where they promote cell wall flexibility.4,62-65 
The chemical structure of pectins is rich in negatively charged carboxylic acids and 
can be divided into five domains, namely homogalacturonan (HG), xylogalacturonan 
(XGA), apiogalacturonan (AGA), rhamnogalacturonan II (RG-II), and rhamnogalacturonan 
I (RG-I). All five domains are believed to be covalently linked.63 The major constituent of 
all pectin is HG. Its backbone consists of -1,4-linked D-galacturonic acid residues66 to 
which D-xylopyranosyl (XGA) and D-apiofuranosyl residues (AGA) or complex side chains 
consisting of up to 12 different monosaccharides (RG-II) may be attached.63,67,68 RG-I is 
constructed from an [-1,4-D-GlcA--1,2-L-Rha] disaccharide repeating unit that is highly 
substituted with galactan, arabinan, and arabinogalactan oligosaccharide side chains.63,64  
The biosynthesis of pectin occurs presumably in the Golgi apparatus and, considering 
its structural diversity, it involves a plethora of glycosyltransferases of which only few have 
been identified to date.63,69,70 
1.1.5 Plant Cell Wall Analysis 
1.1.5.1 Monosaccharide Composition Analysis 
The fine structures and relative quantities of plant cell wall polysaccharides vary 
significantly not only between plant species, but also between tissues of the same plant. 
Therefore, a detailed knowledge about their composition is necessary to understand their 
functions in the cell wall. To analyze the occurrence and structure of plant glycans, the 
monosaccharide composition of the polysaccharides can be determined by 
chromatographic and spectroscopic methods. To do so, the polysaccharides are first 
isolated by extraction from plants. After acidic or enzymatic hydrolysis, the 
monosaccharides are released and analyzed qualitatively and quantitatively by gas 
chromatography (GC). For their identification, they are compared to authentic standards,71 
often in combination with mass spectrometry (MS). In order to achieve the requisite 
volatility, chemical modifications to the carbohydrates prior to analysis are necessary.72,73 
Often the “peracetylated alditol acetate” derivatization74 or protection of the hydroxyl 
groups with trimethylsilyl groups75 are performed (Scheme 1). A more recent method for 
composition analysis utilizes high-pH anion-exchange chromatography (HPAEC), which 
does not require derivatization of the monosaccharides.76 However, none of the above 
described methods provides information about the type of linkages between the 
monosaccharides. The most common method to analyze the linkages is methylation of the 





carry unprotected hydroxyl groups in positions that were previously bound in a glycosidic 
linkage. Analysis of GC retention times by using the peracetylated alditol acetate method 
and MS-fragmentation patterns allow the identification of the linkages.72 Their 
stereochemistry has to be determined by NMR spectroscopy of the polysaccharides as 
the anomeric configuration is lost during the derivatization.77 
 
Scheme 1. Hydrolysis of polysaccharides to monosaccharides and their derivatization for GC-MS 
analysis for quantitative determination of the monosaccharide composition. Left: peracetylated 
alditol acetate, right: trimethylsilylated monosaccharide. 
 
1.1.5.2 Cell Wall Glycan-Directed Monoclonal Antibodies 
The complexity and heterogeneity of plant cell wall glycans is still not well understood. 
However, it has become apparent that the plant cell wall is a highly sophisticated network, 
which is able react to environmental changes e.g. by compensatory deposition of one 
polymer for another or release of certain oligosaccharides to trigger an immune 
response.8,78 Previously, studies of the molecular structure of polysaccharides in the 
context of an intact cell wall were limited to lectins, which significantly lack diversity and 
specificity.79 The use of monoclonal antibodies that were raised against plant 
polysaccharides has greatly improved the number and versatility of probes for high 
resolution cell wall imaging in plant research (Figure 5). Antibodies are proteins with 
specific recognition capacities that bind to only one single epitope.80,81 Differences in the 
composition of the plant cell wall between cell types and even within the wall surrounding 
of an individual cell can be detected using monoclonal antibodies. Also, it was shown with 
antibodies that the occurrence of epitopes changes during plant growth.82-85 To date more 
than 200 monoclonal antibodies have been raised against most classes of plant cell wall 
polysaccharides by different laboratories. The monoclonal antibodies were screened for 






Figure 5. Micrograph showing the epidermis and outer cortical tissue of a tobacco stem section. 




(ELISA) or in high-throughput analyses by using the carbohydrate microarray 
technology.86 However, the specific binding epitopes of the antibodies are often not known 
in detail, which limits the applicability of the antibodies. For their characterization so far 
isolated polysaccharides have largely been used, which do not allow for the determination 
of the exact chemical entity bound by the monoclonal antibody.87,88 A detailed 
characterization requires access to pure and well-defined oligosaccharides, which can 
only be obtained comprehensively by labor-intensive chemical syntheses. 
1.1.6 Cell Wall-Degrading Enzymes 
The hydrolysis of complex carbohydrates by glycosyl hydrolases (GHs) is vital to the 
natural degradation of plant cell walls to ensure recycling of carbon and its release into the 
carbon cycle. Also, many industrial applications such as bread making, animal feed in-
dustry,89-91 paper manufacturing,90 biofuel production,9,55,92 and the production of high 
quality brews93 depend on the use of GHs. To improve all of these processes, a detailed 
understanding of the cell wall degradation at the molecular level is necessary.  
The most fundamental enzymatic activity for the hydrolysis of cell wall glycans is hy-
drolysis of the backbone and its side chains. Xylan-degrading enzymes for example in-
clude xylanases, -D-xylosidases, and arabinofuranosidases. These enzymes for instance 
hydrolyze arabinoxylans to arabinoxylan oligosaccharides, which are used as prebiotics in 
the food industry.11,12 The GHs have been classified into families (CAZY database)94 
based on the amino acid sequence in the catalytic domain. Xylanases have been 





the families GH10 and GH11.95 To efficiently degrade the polysaccharides into short 
oligosaccharides or its monosaccharide components numerous GHs act cooperatively. 
The substrate specificities of several GH families have been determined by analysis of the 
hydrolysis products after incubation with natural polysaccharides.96,97 To identify the 
individual oligosaccharides in complex hydrolysis mixtures, sophisticated analytical 
techniques are used.98,99 These experiments are aided by crystal structures of ligand-
enzyme complexes and mutational analysis of potential binding sites.100-104 
1.2 Synthesis of Carbohydrates 
The analysis of individual functions and interactions of plant cell wall polysaccharides 
is challenging due to their molecular heterogeneity and diversity. Synthetic 
oligosaccharides can reduce this complexity as they represent model compounds for the 
larger polysaccharides.5,6 A library of tailored oligosaccharides may be particularly useful 
in the characterization of substrate specificities of glycosyl hydrolases or the epitopes of 
cell wall glycan-directed antibodies.105-107 These oligosaccharides may also serve as 
glycosyl acceptors for the characterization of glycosyl transferases to elucidate 
biosynthetic pathways. Artificial polysaccharides with defined substitution patterns may be 
helpful for the correlation of structural aspects and macroscopic properties. 
Over the past 100 years many chemical and enzymatic methods have been 
developed for the efficient synthesis of oligo- and polysaccharides. These methods will be 
briefly discussed in the following chapter. 
1.2.1 The Chemical Glycosylation Reaction 
In carbohydrate synthesis, the most important reaction is the glycosylation reaction 
between an activated glycosyl donor and a nucleophile, the glycosyl acceptor.108,109 The 
first glycosylation reaction was discovered in the late 19th century by Michael110 who 
obtained a protected phenyl glucoside by nucleophilic attack of phenolate to peracetylated 
glucosyl chloride. Few years later, Fischer111 synthesized a methyl glucoside from glucose 
in methanol and HCl. A more controlled glycosylation reaction that uses glycosyl halides 
as donors was reported by Koenigs and Knorr.112 This method is still applied today. 
Numerous glycosyl donors including thioglycosides, imidates, and phosphates have been 
developed in the meantime. Even though many more protocols for the formation of 
glycosidic bonds have been described, the synthesis of carbohydrates remains more 
challenging than that of other biopolymers, since oligosaccharides are often highly 





stereoisomeric forms. Furthermore, the mechanism of the glycosylation reaction is still not 
fully understood. It is believed that the glycosyl donor forms an oxocarbenium ion upon 
activation with an electrophilic promotor, which leads to dissociation of the leaving group 
(Scheme 2).113 Most glycosylation reactions proceed through a contact ion pair rather than 
a “naked” oxocarbenium ion.114 The contact ion pair can be attacked by a free hydroxyl 
group of the glycosyl acceptor to form a new bond. The attack can take place either from 
the upper (red arrow) or the lower face (blue arrow), which gives the 1,2-trans (often -
anomer) or the 1,2-cis glycoside (often -anomer), respectively. Often a mixture of both 
isomers is obtained. The complexity of the glycosylation reaction is further increased by 
several alternative reaction pathways that may occur. The glycosyl donor can undergo 
side reactions, such as hydrolysis, elimination, rearrangements, or orthoester formation.115  
 
Scheme 2. Mechanism of the glycosylation reaction with and without a participating group in the 
C2-position of the glycosyl donor. 
The stereoselectivity of the reaction is influenced by many parameters and it is 
desirable to gain control over the outcome. In general, 1,2-trans products are more easily 
accessible in high selectivity due to the possibility to make use of the neighboring group 
participation effect (Scheme 2, lower pathway). When an ester group is installed as a 
participating protecting group in the neighboring C2 position, its acyl moiety can form an 
acyloxonium ion complex. This complex blocks the -face and leaves only the -face free 
for the subsequent attack of the glycosyl acceptor. Hence, the 1,2-trans product is formed 
with high selectivity. 
Without neighboring group participation, the stereoselectivity can be controlled 
through temperature and other reaction parameters. The -anomer is the 
thermodynamically favored product due to the anomeric effect, which stabilizes an axial 





reaction temperature, whereas the -product is formed in larger amounts at low 
temperatures. The reaction outcome can also be controlled via the choice of solvent, an 
effect which is known as the “solvent effect”. While the use of acetonitrile favors the 
formation of the -product, the use of diethylether, THF, and 1,4-dioxane predominantly 
give the -product.114,116-118 The protecting groups of the glycosyl donor may also assist in 
the selective formation of 1,2-cis glycosidic bonds when remote participating protecting 
groups are used.119 These are often ester protecting groups at the C6-position of the 
glycosyl donor that shield the -face either sterically or by electronic interactions and 
therefore favor the attack from the -face. Also, many other sophisticated protecting 
groups that influence the stereochemical outcome of the reaction through specific reaction 
mechanisms have been developed.119-123 
Despite the challenges associated with the formation of glycosidic bonds, many 
complex oligosaccharides have been successfully synthesized. Recently, even the 
synthesis of an arabinogalactan containing 92 monosaccharide units was reported.124 Also 
the synthesis of plant glycans has gained some attention, and among many others,5,6 a 
pectic homogalacturonan dodecasaccharide was synthesized.125 Still, the chemical 
synthesis of carbohydrates remains labor-intensive, particularly due to the many 
purification steps that are required. 
1.2.2 Automated Glycan Assembly 
Automated solid-phase synthesis provides fast access to a large number of 
structurally complex compounds. Solid-phase synthesis was introduced by Merrifield,126 
for which he received the Nobel prize in 1984.127 This technique allows for the use of 
excess reagents, enabling high conversion, and facilitates purification of the 
intermediates, as all reagents can be removed by simple filtration. Automated solid-phase 
synthesis of peptides128 and oligonucleotides129 has been well established for decades. 
Although solid supports have been used also in carbohydrate synthesis for over 40 
years,130 the first automated solid-phase oligosaccharide synthesis (automated glycan 
assembly) was only reported in 2001.131  
In solid-phase synthesis of oligosaccharides the first monosaccharide is attached to a 
linker-functionalized resin in a glycosylation reaction and one or more protecting groups 
are removed (Scheme 3). Through alternating cycles of coupling and deprotection steps 
the oligosaccharide chain grows until the desired length is reached. Then, the 
oligosaccharide is cleaved from the resin and global deprotection using methanolysis and 





building blocks (BBs) must be suitably protected with permanent protecting groups (PGs) 
that are not affected during the assembly of the oligosaccharide chain, and temporary 
PGs that can be selectively removed on the solid phase. Moieties such as benzyl ethers 
(Bn), benzoyl esters (Bz), silyl ethers, azides, and trichloroacetyl groups (TCA) have been 
used as permanent PGs, whereas fluorenylmethoxycarbonyl (Fmoc), levulinoyl (Lev), (2-
methyl)naphtyl (Nap),132 and 2-(azidomethyl)benzoyl (Azmb)133 have been routinely used 
as temporary PGs. For elongation of the backbone, Fmoc is most commonly used as it 
can be quantitatively removed using mild bases. 
 
Scheme 3. Schematic representation of the automated glycan assembly process. 
The first automated synthesizer was built based on a modified peptide synthesizer.131 
In 2012, a new synthesizer was reported that can be considered to be the “first fully 
automated oligosaccharide synthesizer”,134,135 which is currently used in an improved 
version of automated glycan assembly at the Max Planck Institute of Colloids and 
Interfaces (MPIKG, Figure 6). The synthesizer is placed in a fume hood and contains a 
reaction vessel (Figure 6 yellow box), in which the resin is placed. The temperature in the 
vessel is controlled by an external cooling/heating device which can adjust the 
temperature from -50 °C to +50 °C. Solvents such as DCM, DMF, and THF can be 
delivered to the vessel from bottles in a safety cabinet (Figure 6 blue box). The solvents 
are used to wash the resin thoroughly after each reaction step. In most reactions DCM is 
used as the solvent as the resin swells well in it, making the oligosaccharides better 
accessible to reagents and building blocks. Reagents are introduced into the vessel from 
bottles containing stock solutions in DCM or DMF. These can be BBs (Figure 6 yellow 
box), activation reagents (Figure 6 red box), and deprotection reagents (Figure 6 green 
box). The modular setup of the synthesizer allows for the use of all common glycosyl 
donors including thioglycosides,134 phosphates, and imidates.131 Bubbling of Argon 






Figure 6. Home built-synthesizer at the MPIKG. Blue box: solvent cabinet; orange box: cryostat; 
green box: deprotection solutions; red box: activation solutions; purple box: building blocks; yellow 
box: reaction vessel. 
When a reaction step is finished, the solution containing all excess reagents and soluble 
byproducts is drained through the filter by applying Argon pressure from the top. 
After the synthesis the oligosaccharide is cleaved from the resin. This cleavage 
process requires some particular attention. The linker that is attached to the resin has to 
meet several requirements. It needs to be stable under the activation and deprotection 
conditions used over a wide range of temperatures. It is also desirable that the linker 
provides the oligosaccharides after cleavage in a form that allows for further 
functionalization. This was initially accomplished by using an octenediol linker (Scheme 
4a), which after cleavage by using Grubb’s catalyst gives oligosaccharides functionalized 
with a pentenyl linker.131,136,137 Later, a carbamate-based linker that provides the 
oligosaccharide with an aminopentyl linker by methanolysis and hydrogenolysis was 
developed (Scheme 4b).134,138 However, the double bond in the octenediol linker excluded 
the usage of thioglycosides, and the carbamate-based linker was not stable towards 
strongly acidic conditions as are required for the coupling of phosphate donors. These 
restrictions have led to the development of a third linker that contains a p-nitrophenol 
moiety and can be cleaved using light at a certain wavelength (Scheme 4c).139 This linker 
is used in most modern automated glycan assembly syntheses as it can withstand the 
widest range of reaction conditions. After cleavage the oligosaccharides are released with 
a Cbz-protected aminopentyl linker at the reducing end. Subsequent hydrogenolysis 






Scheme 4. Commonly used linkers for automated glycan assembly and the conditions for their 
cleavage. 
The photocleavage is performed in a continuous-flow photoreactor. A suspension of 
the resin in DCM is pumped through tubing (Figure 7, green box) that is wrapped around a 
mercury lamp (305 nm) (Figure 7, red box). This setup circumvents the problems that are 
usually encountered with photochemistry in batch reactors, due to the exponential 
decrease of light intensity with increasing distance from the source, and allows for efficient  
 
Figure 7: Continuous flow reactor. Red: photolamp, blue: cooling device, yellow: solution containing 





irradiation of the resin with light. As the UV lamp produces heat it must be constantly 
cooled (Figure 7, blue box). At the outlet of the tubing the resin is filtered off and the 
solution containing the oligosaccharide is collected (Figure 7, yellow box). 
Automated glycan assembly has enabled the synthesis of many biologically relevant 
molecules,140,141 such as chondroitin sulfate glycosaminoglycans139 that play important 
roles in infectious diseases and the tumor-associated Globo-H antigen.142 The synthesis 
of oligosaccharides as potential vaccine candidates was also reported.143,144 The synthesis 
of both, 1,2-trans- and 1,2-cis-linkages in automated glycan assembly is possible, as 
demonstrated by the successful syntheses of oligosaccharides containing a -
mannose145,146 or even multiple cis-linkages.147 The limit of accessible glycan length is 
constantly extended, with the assembly of a 30-mer148 and a 50-mer mannoside reported 
recently.149 Current limitations of automated glycan assembly are that the 
oligosaccharides are only produced in small amounts and the instrumental setup is 
expensive. 
1.2.3 Enzymatic Synthesis 
Another approach for the preparation of carbohydrates is enzymatic synthesis. 
Enzymes have high substrate specificities and are highly stereoselective so that no 
protecting group manipulations are necessary. Two different classes of enzymes can be 
explored for the transfer of glycosyl donors to an acceptor: glycosyltransferases (GT) and 
glycosyl hydrolases (GH). GTs are responsible for the majority of glycosylations in nature 
and can transfer activated glycosyl moieties to a hydroxyl group of a saccharide chain. 
Lipids, aryl moieties, and heteroatoms of amino acids, such as nitrogen or sulfur, can also 
act as the acceptor to give glycoconjugates. The donor is typically a nucleotide 
diphosphate (NDP) sugar, e.g. uridine diphosphate (UDP)-xylose (Figure 8). However, 
since the required NDP sugars are highly expensive and the expression of many enzymes 
is still challenging, the synthetic utility of GTs for the synthesis of oligosaccharides on 
larger scale is somewhat limited. 
 





GHs act mainly as glycan-degrading enzymes in nature. In this case, water is the 
glycosyl acceptor and the glycosidic bond is hydrolyzed. However, the reaction is 
reversible, and GHs can also catalyze the formation of glycosidic bonds, which will be 
described in detail later in this chapter. There are two groups of GHs: retaining and 
inverting GHs. The active sites of both types of enzymes contain two carboxylic acid 
residues, usually aspartic acid and glutamic acid.151-153 Inverting GHs use a direct 
displacement mechanism (Scheme 5), in which the substrate and water must be present 
simultaneously. The carboxylic acids, which are ~10 Å apart, provide assistance in the 
form of a general acid-base-catalysis to facilitate the nucleophilic attack of water.154 The 
anomeric carbon in the transition state has substantial sp2-character and can be 
considered oxocarbenium-like.150 The resulting product has an anomeric configuration 
opposite to the one of the starting material. Hence, the reaction proceeds under inversion 
of configuration. 
 
Scheme 5. Direct displacement mechanism in inverting GHs.
150
 
Retaining GHs follow a double-displacement mechanism (Scheme 6). Here, the 
carboxylic acids are only ~5 Å apart. This enables one of the carboxylic acids to function 
as a nucleophile. The carboxylate attacks at the anomeric center and forms a covalent 
substrate-enzyme-intermediate. This reaction is facilitated by the other carboxylic acid that 
protonates the leaving group. The corresponding carboxylate anion acts as a catalytic 
base in the second step, by deprotonating water to facilitate its subsequent nucleophilic 
attack at the anomeric center.154 Both reactions proceed via oxocarbenium-like transition 
states. The product is obtained in the same configuration as the starting material with an 
overall retention of configuration.  
GHs can also catalyze the reverse reaction, the formation of a glycosidic bond, which 
was exploited in the “thermodynamic approach”. High concentrations of two sugars were 
treated with a GH to shift the equilibrium towards the condensation (glycosylation 






Scheme 6. Double-displacement mechanism in retaining GHs.
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activated sugar donor was used, which gives high steady state concentrations of the 
covalent-enzyme-intermediate that can then be trapped with a suitable glycosyl acceptor. 
However, yields are generally low, as the product is always also a substrate for 
hydrolysis.155,156 In order to efficiently utilize GHs to build up oligosaccharides, their 
hydrolytic activity had to be eliminated. This was accomplished first in 1998 by Withers et 
al.157 who genetically replaced the nucleophilic amino acid in the active site of -retaining 
GHs with an alanine. These mutants were termed glycosynthases150,157,158 (Scheme 7). In 
glycosynthase-catalyzed reactions an activated glycosyl donor such as a glycosyl fluoride 
with the opposite anomeric configuration of the natural substrate is attacked by the 
glycosyl acceptor, which is activated by acid catalysis of the non-mutated carboxylic acid 
in the active site. This SN2-type reaction inverts the configuration at the anomeric position. 
Therefore, the use of -fluorides results in the formation of -products when retaining 
 







glycosynthases are used. Now, the scope of this technology has been expanded to 
produce -configurated products as well.158 The use of leaving groups other than fluoride 
is limited because of the restricted space in the catalytic domain of the enzyme and only 
few alternatives such as the use of -glycosyl azides have been reported.159 
Self-condensation of the donor is possible when glycosynthases are used that are 
derived from endo-glycosidases.160-162 In this way, polysaccharides of different classes 
including xylans,163-165 xyloglucans166-169 and mixed-linked glucans169 with molar masses 
up to 60 kDa have been obtained. By introduction of substituents at the oligosaccharide 
monomer, the global substitution pattern of the polysaccharide can be tailored. This 
strategy was applied to the synthesis of functionalized cellulose from cellobiosyl ﬂuoride 
donors that carry amino-, bromo-, and even sulfur substitution at the 6′ position.170,171 
1.2.4 Chemical Synthesis of Xylan Oligosaccharides 
Chemical syntheses for many classes of complex plant oligosaccharides have been 
described.5,6 For xylans mostly syntheses of linear structures up to 
decaoligosaccharides172-175 have been reported. The first synthesis of linear xylans was 
described by Hirsch and Kováč in 1981 (Scheme 8).172,173 In their synthetic strategy a 
peracetylated xylosyl bromide donor was reacted with an acetyl protected xyloside 
acceptor in a mercury cyanide-promoted glycosylation reaction. A benzyl protecting group 
at the C4’-position of the resulting disaccharide was subsequently removed by 
hydrogenolysis. Iteration of the two steps, followed by a final methanolysis, provided a 
collection of tri- to pentaxylosides. However, the glycosylation reactions proceeded with 
poor stereoselectivity (/ 1:1.5) and low yields (<25%).  
 









By using a blockwise approach of suitably protected thioglycosides, Takeo et. al. 
(Scheme 9)175 achieved better coupling yields (~70%). They first synthesized tetra- to 
octaxylosides by using disaccharide BBs. The disaccharide BB at the reducing end was 
protected with a permanent benzyl ether at the anomeric center. The free hydroxyl group 
in the C4-position was reacted in an NIS/AgOTf-promoted glycosylation reaction with a 
thioglycoside disaccharide BB and a chloroacetyl protecting group in the C4-position of 
this BB was removed by treatment with thiourea. By repeating these steps, 
oligosaccharides up to an octasaccharide were obtained. These oligosaccharides were 
then reacted with peracetylated di- or trisaccharide thioglycoside donors to give a 
collection of oligosaccharides, containing tetra- to decaxylosides after global deprotection.  
 
Scheme 9. Block-synthesis of xylooligosaccharides up to decaxylosides by Takeo et al.
175
. 
Until recently the only syntheses of substituted xylans were reported for a D-
glucuronic acid-substituted tri-176 and pentasaccharide.177 As arabinoxylan oligo-
saccharides are of great economic interest due to their beneficial prebiotic effects11,54 and 
antioxidative activities,17 a collection of -1,3-arabinofuranose substituted xylan 
oligosaccharides has been recently synthesized by automated glycan assembly (Deborah 
Senf, MSc thesis, MPIKG, Scheme 10).132 Three monosaccharide BBs including two 
xylose and one arabinose  BB  were used for the automated glycan assembly.  The xylose  






Scheme 10. Automated glycan assembly of -1,3-arabinofuranose substituted xylan 
oligosaccharides from three monosaccharide BBs.
132
  
deprotected to enable chain elongation. Linear xylosides were produced by alternating 
coupling cycles with xylose BB 1a and Fmoc-deprotection cycles. Branching in the C3-





was protected at the C3-position with a (2-methyl)naphtyl (Nap) protecting group that can 
be selectively removed using DDQ.178-180 The resulting free hydroxyl group was then 
glycosylated with arabinose BB 2a. After cleavage from the resin and global deprotection 
the final oligosaccharides were obtained. 
1.3 Aims of this Thesis 
The general aim of this thesis was to contribute to plant biological research by 
providing synthetic glycans as tools for investigating the plant cell wall.  
The first aim was to characterize plant glycan-directed monoclonal antibodies, which 
are probes for high resolution imaging of cell wall polysaccharides and xylan-
deconstructing enzymes, which are key to the utilization of plant biomass (chapter 2.1). 
For this purpose, a collection of arabino- and glucuronoxylan oligosaccharides from the 
plant cell wall was required. Automated glycan assembly was envisioned to be a powerful 
technology to gain fast access to these oligosaccharides containing many repetitive 
structural motifs. While the assembly of the xylan backbone is straightforward, attachment 
of arabinofuranosyl- and glucuronosyl residues to the backbone requires the design of 
BBs with sophisticated protecting group patterns and an efficient synthetic strategy 
towards a stereoselective formation of cis-glucosidic bonds. 
The second aim of the thesis was to provide synthetic tools for studying the structure-
function-relationship of arabinoxylans that are important for the plant cell wall architecture. 
The structural inhomogeneity of many cell wall polysaccharides such as arabinoxylan 
makes the correlations of the molecular structure and macroscopic properties difficult. To 
study the impact of specific structural features on physico-chemical properties, such as 
crystallinity and the affinity to other cell wall components, collections of synthetic 
polysaccharides with defined repeating units were required. Therefore, a library of artificial 
arabinoxylan polysaccharides with defined substitution patterns was planned to be 
synthesized from oligosaccharide monomers by glycosynthase-mediated polymerization 
(chapter 2.2). The required oligosaccharide monomers can be obtained by chemical and 
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2.1.1 Automated Glycan Assembly of Arabinoxylan 
Oligosaccharides 
The efficient automated glycan assembly of selected oligosaccharide fragments of 
arabinoxylan requires differentially protected BBs that are readily synthesized and can be 
employed in a modular fashion. Four BBs were designed for construction of the xylan 
backbone (Scheme 11). BB 1a was used for linear chain elongation. It was equipped with 
a base-labile Fmoc-protecting group in the C4-position and, for permanent protection of 
the C2- and C3-positions, a benzoyl ester and a benzyl ether, respectively. In order to 
enable substitution of the backbone, temporary protecting groups were selected for the 
 
Scheme 11. Chemical structure of an arabinoxylan polysaccharide and the building blocks required 
for the assembly of representative oligosaccharide fragments. 
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hydroxyls at C2 and C3 that ensure similar reactivity of BBs 1b-d compared to BB 1a. 
Exchange of the benzyl for a (2-methyl)naphtyl (Nap) ether in 1b allows for installation of 
arabinose substituents in the C3-position. Nap ethers are readily cleaved under oxidative 
conditions178-180 and have been previously used for the synthesis of a small library of -
1,3-substituted arabinoxylan oligosaccharides (Deborah Senf, MSc thesis, MPIKG).132 For 
temporary protection of the C2-hydroxyl the use of a 2-(azidomethyl)benzoyl (Azmb) ester 
in BB 1c is particularly attractive. The Azmb-group provides both the required participating 
effect for selective -(1→4)-glycosylations and the potential for chemoselective removal 
using alkyl phosphines. Azmb had already proven to be a powerful protecting group in the 
solution-phase synthesis of different complex oligosaccharides181-183 and was recently 
added to the toolbox of temporary protecting groups for automated glycan assembly 
(Goswin deKruijff, MSc thesis, MPIKG).133 Combination of the Nap and Azmb protecting 
groups allows for the introduction of doubly substituted xylose units when using BB 1d. All 
xylose BBs were equipped with phosphate leaving groups that gave the best results in the 
synthesis of plant cell wall oligosaccharides previously.106,184 Arabinofuranose BBs 2a-c 
enable substitution of the backbone either with single arabinose units or elongated 
oligosaccharide side chains.  
The design of the protecting group pattern in BBs 1a-d allowed for their synthesis to 
diverge at a late stage (Scheme 12). Starting from 1,2-O-isopropylidene-D-xyloside 3 a 
simple three step transformation gave the 3-O-Bn and 3-O-Nap protected derivatives 4a 
and 4b in good yields.132,185 After acidic cleavage of the acetonide with concomitant 
equilibration of the furanose to the pyranose form, peracetylated 5a,b were obtained after 
 
Scheme 12. Synthesis of xylose building blocks 8a-d. Reagents and conditions: a) TrCl, DMAP, 
NEt3, DMF; b) R
1
Br, NaH, TBAI; c) TsOH, MeOH/Et2O, H2O (100:10:1), 4a: 72%, 4b: 62% (3 
steps); d) H2O/AcOH, reflux; e) Ac2O, DMAP; f) HSTol, BF3∙OEt2, 0 °C, 6a: 62%, 6b: 48% (3 
steps); g) NaOMe, MeOH, CH2Cl2; h) R
2
2O, 5-10 mol% Yb(OTf)3, dioxane, 7a: 71%, 7b: 61%, 7c: 
64%, 7d: 44% (2 steps); j) FmocCl, pyridine, CH2Cl2, 8a: 79%, 8b: 76%, 8c: 87%, 8d: 68%; k) 





treatment with acetic anhydride in pyridine. Subsequently, 5a and 5b were converted into 
the corresponding thioglycosides 6a and 6b and the acetyl groups were cleaved off by 
methanolysis. An ytterbium triflate catalyzed selective protection of the C2-position186 
using either Bz2O or Azmb2O gave the Bz esters 7a,b and Azmb esters 7c,d, respectively. 
The glycosyl donors 1a-d were finally obtained by protection of the free hydroxyls at C4 
with FmocCl (8a-d) and introduction of a phosphate ester as the anomeric leaving group. 
The arabinose BBs 2a and 2b were synthesized as reported previously.132 Arabinose BB 
2c187 was available in our group and kindly provided by Max Bartetzko. 
After their successful synthesis, BBs 1a-d were added to a Merrifield resin equipped 
with a photocleavable linker 9139 (Scheme 13) via alternating cycles of glycosylation and 
deprotection reactions. Glycosylations with phosphate BBs 1a-d were originally performed 
with two times 5 equiv of glycosyl donor and stoichiometric amounts of TMSOTf as an 
activator (module A).132 However, two cycles using 1.8 equiv of donor each were also 
found to be sufficient to obtain full conversion in the construction of the xylan backbone. 
Thioglycoside BBs 2a-c were also reacted using as little as two times 1.8 equiv BB upon 
activation with stoichiometric NIS and catalytic amounts of TfOH (module B). The 
temporary protecting groups were removed according to standard deprotection modules 
that are routinely used in automated glycan assembly. Fmoc was readily removed using 
triethylamine (module C), while deprotection of the hydroxyl group at 3-OH was 
accomplished best by treating the resin with a DDQ solution in DCE/MeOH/H2O (64:16:1) 
at 40 °C in seven incubation cycles of 20 min (module D).132 For deprotection of the Azmb 
ester, incubation of the resin with a solution of PBu3 in THF/H2O (5:1) at 45 °C in 6 cycles 
of 30 min each (module E) was performed. Key in this reaction was the use of the right 
amount of water to hydrolyze iminophosphoranes formed during the course of the 
reaction.133,183  
Having established reliable glycosylation and deprotection conditions for all BBs and 
protecting groups, a number of xylan oligosaccharides decorated with -1,2-linked 
arabinofuranoses (10-14) were prepared (Scheme 13). For the two tetrasaccharides 10 
and 11 the full xylan backbone was synthesized first using xylose BBs 1a and 1c, and 
then the arabinose substituent was added using BB 2a after selective deprotection of the 
Azmb group. For the longer xylan structures, however, the product yields in the synthesis 
of 2-substituted compounds decreased with the number of glycosylations performed after 
introduction of the Azmb-protected BB 1c. It was advantageous to remove the Azmb-
group at an earlier stage of the assembly and continue with elongation of the backbone 
after introduction of the substituent. Using this strategy, the two heptasaccharides 12 and 
13 were prepared. The latter, a branched oligosaccharide comprised only of 








Scheme 13. Automated glycan assembly of -1,2-substituted arabinoxylan oligosaccharides 10–
14. Reagents and conditions: a) 2 x 5 equiv, 2 x 3.7 equiv or 2 x 1.8 equiv of BB 1a or 1c, TMSOTf, 
DCM, -35 °C (5 min) → -15 °C (30 min) (Module A); b) 2 x 5 equiv or 2 x 1.8 equiv of BB 2a, NIS, 
TfOH, DCM/dioxane, -40 °C (5 min) → -20 °C (40 min) (Module B); c) 3 cycles of 20% NEt3 in 
DMF, 25 °C (5 min) (Module C); d) 6 cycles of PBu3, THF/H2O (5:1), 45 °C, 30 min (Module E); e) 
h (305 nm); f) NaOMe, DCM/MeOH, 12 h; g) H2, Pd/C, EtOAc/MeOH/H2O/HOAc, 12 h (yields are 
based on resin loading). The letter code below the structures represents the reaction sequence 






For the terminally substituted heptasaccharide 14, the backbone was assembled by 
introducing BB 1c as the last xylose unit. After deprotection of the Azmb-group, arabinose 
BB 2a was attached to the resulting free hydroxyl group. Due to the low yields obtained in 
the syntheses of large structures the synthesis of oligosaccharides carrying two -1,2-
linked arabinosyl substituents was not attempted. The fully deprotected oligosaccharides 
10-14 were obtained after light-induced cleavage from the resin and global deprotection 
consisting of methanolysis and subsequent hydrogenolysis in yields of 4-41%. 
Using a combination of the two orthogonal Nap and Azmb protecting groups in a 
single BB (1d) the synthesis of pentasaccharide 15 having two substituents linked to 
same xylose unit was achieved (Scheme 14). In order to attach these two 
arabinofuranose residues, first the Nap ether was deprotected and the resulting free 
hydroxyl was then glycosylated with 2a before deprotection of the Azmb ester allowed for 
another glycosylation with 2a. After light-induced cleavage from the resin and deprotection 
of the benzoyl protecting groups by methanolysis, hydrogenolysis was performed as with 
the previous compounds by using a solvent mixture of MeOH, EtOAc, H2O and AcOH. 
AcOH is used to avoid adsorption of the amino-group to the palladium catalyst. However, 
in this case the acidic conditions caused partial cleavage of one of the arabinose 
substituents, which resulted in a low isolated yield (4%) for pentasaccharide 15.  
Next, two -1,3-substituted arabinoxylan oligosaccharides containing disaccharide 
side chains were synthesized to expand the small library of oligoarabinoxylosides that was 
previously synthesized (Deborah Senf, MSc thesis, MPIKG).132 Both side chains are 
frequently found in grasses and often esterified with ferulic acid.189 Their automated 
glycan assembly was performed by following the well-established protocol developed 
previously (Deborah Senf, MSc thesis, MPIKG).132 For the synthesis of both 
oligosaccharides the xylose backbone was first fully assembled using BBs 1a and 1b. The 
synthesis of hexasaccharide 16, containing a-1,2-D-xylopyranosyl--1,3-L-
arabinofuranosyl disaccharide side chain required capping of the terminal xylose residue 
after backbone assembly using acetic anhydride and pyridine (module F). Only then, the 
Nap group was cleaved to enable glycosylation with arabinose BB 2b that contains an 
Fmoc protecting group for elongation of the side chain. Capping of the backbone was thus 
needed for the subsequent selective glycosylation of the arabinose with xylose BB 1a. 
Instead of octasaccharide 17 we originally intended the synthesis of a hexasaccharide 
containing only one arabinan side chain connected to the C3-position of the penultimate 
xylose residue. The synthesis of this hexasaccharide would have required capping of the 
terminal xylose residue in the backbone, similar to the synthesis of 16. Due to technical 
difficulties the capping module was not performed during the automated synthesis and the 




hydroxyl group at the C4-position remained unprotected. After deprotection of the Nap 
group and glycosylation reaction with arabinose BB 2c, the highly reactive arabinosyl 
donor has glycosylated both free hydroxyl groups simultaneously. The subsequent Fmoc 
deprotection and glycosylation with arabinose BB  
 
Scheme 14. Automated glycan assembly of -1,2--1,3-disubstituted and -1,3-substituted arabi-
noxylan oligosaccharides 15–17. Reagents and conditions: a) 2 x 5 equiv, 2 x 3.7 equiv or 2 x 1.8 
equiv of BB 1a, 1b or 1d, TMSOTf, DCM, -35 °C (5 min) → -15 °C (30 min) (Module A); b) 2 x 5 
equiv or 2 x 1.8 equiv of BB 2a, 2b or 2c, NIS, TfOH, DCM/dioxane, -40 °C (5 min) → -20 °C 
(40 min) (Module B); c) 3 cycles of 20% NEt3 in DMF, 25 °C (5 min) (Module C); d) 7 cycles of 
0.1 M DDQ in DCE/MeOH/H2O (64:16:1), 40 °C, 20 min (Module D); e) 6 cycles of PBu3, THF/H2O 
(5:1), 45 °C, 30 min (Module E); f) 3 cycles of Ac2O, pyridine, 25 °C, 30 min (Module F); g) h 
(305 nm); h) NaOMe, DCM/MeOH, 12 h; i) H2, Pd/C, EtOAc/MeOH/H2O/HOAc, 12 h (yields are 
based on resin loading). The letter code below the structures represents the reaction sequence 





2a were also performed twice resulting in the formation of the protected version of 
octasaccharide 17. The fully deprotected oligosaccharides 16 and 17 were obtained after 
light-induced cleavage from the resin and global deprotection consisting of methanolysis 
and subsequent hydrogenolysis in yields of 16 and 8%. 
2.1.2 Automated Glycan Assembly of Glucuronoxylan 
Oligosaccharides 
The automated glycan assembly of glucuronic acid substituted oligoxylosides 
required only two xylose BBs for the assembly of the backbone (Scheme 15) as 
substitution only occurs at the C2-position in natural glucuronoxylans. A glucose BB was 
utilized for the automated glycan assembly in combination with a post-assembly oxidation 
strategy because glucuronic acid BBs are disarmed donors and generally exhibit low 
reactivity.190 To favor the formation of an -glucosidic bond, as opposed to the -anomer, 
the C6-position was protected with an ester-group that enables remote participation.147 
Two types of glucose BBs were designed to introduce either glucuronic acid (19) or its 4-
O-methylated derivative (18a and 18b) as substituents of the xylose backbone. BB 18 was 
synthesized with both a Lev- and an Ac-protecting group in the C6-position in order to 
investigate their ability to favor the formation of the -glucosidic bond by remote 
participation.  
 
Scheme 15. Chemical structure of a glucuronoxylan polysaccharide and the building blocks re-
quired for the assembly of representative oligosaccharide fragments. 
The two 4-O-methylated BBs were synthesized starting from D-glucose which was 
transformed in five steps to acetal 20.191 Complete removal of the acetal by TFA gave 
dialcohol 21 that was selectively protected at the C6-position as a sterically demanding 




TBDMS ether. The free hydroxyl group in 22 was then deprotonated with NaH and 
reacted with MeI to introduce the 4-O-methyl group (23). The final BBs were obtained 
after removal of the silyl ether (24) and subsequent esterification of the C6-position. The 
Lev-group was introduced by DCC-promoted esterification of the free hydroxyl group with 
LevOH to give 18a. For 18b, the free hydroxyl group was protected using Ac2O in 
pyridine.  
 
Scheme 16. Synthesis of glucose BBs 18a and 18b. Reagents and conditions: a) TFA/H2O, DCM, 
quant., b) TBDMSCl, DMF, 96%, c) NaH, MeI, DMF, 93%, d) TBAF, THF, 95%, e) LevOH, DCC, 
18a: 60%; f) Ac2O, py, 18b: 98%. 
With the 4-O-methylated glucose BBs in hand, the glycosylation conditions for 
efficient automated glycan assembly were investigated (Figure 9a). For this purpose, 
model syntheses of disaccharides 25a and 25b consisting of one xylosyl and one glucosyl 
residue were chosen. The 2-O-Azmb protected xylose BB 1c was coupled to linker-
functionalized resin 9 (module A) and the C2-position was deprotected (module E). 
Subsequently, glycosylations with glucose BB 18a and 18b were performed. In order to 
promote the desired -selectivity relatively high temperatures, compared to the conditions 
used with other thioglycoside BBs, were chosen for the glycosylation reaction (module B: 
2 x 1.8 equiv of BB 1a or 1b, NIS, TfOH, DCM/dioxane, -20 °C (5 min) → -5 °C (40 min)). 
The formation of the 1,2-cis product was further promoted by the solvent effect exhibited 
by dioxane, which is commonly used instead of DCM in solid-phase glycosylations with 
thioglycosides in order to help the activator NIS to dissolve. After cleavage from the solid 
support, MALDI and NP-HPLC analysis confirmed the formation of the 1,2-cis-





9b). The stereochemistry of the main product was determined by 2D-NMR spectroscopy 
(Figure 9c) after HPLC purification. The Lev-protected BB 18a was less reactive in the 
glycosylation reaction and a significant amount of monosaccharide 26 was detected. The 
following syntheses were thus performed with 6-O-Ac-protected BB 18b. 
 
Figure 9. (a) Comparison of glucosyl donors 18a and 18b by automated glycan assembly of 
disaccharides 25a and 25b. Side product 26 is only obtained when BB 18a is used. Reagents and 
conditions: a) 2 x 1.8 equiv of BB 1c, TMSOTf, DCM, -35 °C (5 min) → -15 °C (30 min) (Module A); 
b) 2 x 1.8 equiv of BB 18a or 18b, NIS, TfOH, DCM/dioxane, -40 °C (5 min) → -20 °C (40 min) 
(Module B); c) 6 cycles of PBu3, THF/H2O (5:1), 45 °C, 30 min (Module E); d) h (305 nm). (b) 
Crude NP HPLC chromatograms of 25a and 25b (trace of evaporative light scattering detector 
(ELSD)). Both syntheses provided the product with good selectivity (/~7:1). (c) Anomeric 
region of HSQC-NMR spectrum of disaccharide 25b after HPLC purification. The two anomeric 
peaks belong to the -xylosyl and -glucosyl residues. 




After having successfully established efficient glycosylation conditions, 4-O-
methylated glucose-substituted xylan oligosaccharides 27 and 28 (Scheme 17) were 
synthesized by automated glycan assembly using BBs 1a, 1c, and glucose BB 18b.  
 
Scheme 17. Automated glycan assembly of glucose-substituted xylan oligosaccharides 27 and 28. 
Reagents and conditions: a) 2 x 1.8 equiv of BB 1a or 1c, TMSOTf, DCM, -35 °C (5 min) → -15 °C 
(30 min) (Module A); b) 2 x 1.8 equiv of BB 18b or 18, NIS, TfOH, DCM/dioxane, -40 °C (5 min) 
→ -20 °C (40 min) (Module B); c) 3 cycles of 20% NEt3 in DMF, 25 °C (5 min) (Module C); d) 6 
cycles of PBu3, THF/H2O (5:1), 45 °C, 30 min (Module E); e) h (305 nm); f) NaOMe, DCM/MeOH, 
12 h; g) H2, Pd/C, EtOAc/MeOH/H2O/HOAc, 12 h, (yields are based on resin loading). The letter 
code below the structures represents the reaction sequence applied in the respective synthesis. 
Analogous to the syntheses of -1,2-linked arabinoxylan oligosaccharides, the xylose 
backbone of tetrasaccharide 27 was fully assembled before a final glycosylation with 
glucose BB 18b was performed. For the synthesis of heptasaccharide 28, the assembly of 
the backbone was interrupted after the xylosyl residue to which xylose BB 1c was added 
and continued after introduction of the glucosyl substituent. This allowed the removal of 
the Azmb-group at an earlier stage of the assembly, preventing partial decomposition of 
this group during the further automated glycan assembly process. After photolytical 
cleavage from the resin, the fully protected versions of tetra- and heptasaccharides 27 
and 28 were obtained. HPLC analysis of the crude reaction mixtures confirmed high -





in the mixture of side products. After global deprotection, the fully deprotected 4-O-Me-
glucose-substituted xylan oligosaccharides 27 and 28 were obtained. In order to 
synthesize the desired glucuronoxylan oligosaccharides a suitable post-assembly 
oxidation procedure had to be developed. After automated glycan assembly of protected 
glucose-substituted xylan tetrasaccharide 29, its further transformation to the respective 
glucuronic acid was envisioned by selective oxidation of the primary hydroxyl group in the 
C6-position after methanolysis of all protective esters (Scheme 18 left). The primary 
oxidant (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) and the secondary oxidant 
bis(acetoxy)iodobenzene (BAIB) were added to the semi-protected tetrasaccharide 31 in a 
biphasic DCM/H2O (1:1, v/v) solvent system (Table 1, Entry 1).
192-194 The reaction was 
monitored by ESI-MS. Either no reaction was observed or when longer reaction times 
were used only decomposition of the starting material was observed. Therefore, also other 
protocols for TEMPO-mediated oxidations were tested. The addition of the phase-transfer-
catalyst Bu4NCl (Entry 2)
195 gave the same reaction outcome. Next, the solvents were 
changed to the monophasic mixture of ACN/H2O (1:1, v/v).
196 The use of ACN resulted in 
an increase of solubility of tetrasaccharide 31 compared to DCM. However, performing the 
oxidation reaction in ACN/H2O at room temperature (Entry 3) or at 0 °C (Entry 4) also led 
to decomposition of the starting material. It has been reported that increasing the pH of 
the reaction by the addition of NaHCO3 can accelerate the reaction (Entry 5).
197 Still, only 
decomposition of the starting material was observed. When a protocol using NaOCl as the 
secondary oxidant (Entry 6) in a bicarbonate-buffered ACN/H2O mixture was employed,
198 
no progression of the reaction was observed. Finally, the reaction was performed in the 
presence of KBr in the biphasic system DCM/H2O (Entry 7).
194 It was reported that KBr 
reacts with NaOCl to form HOBr in situ, which is a much more potent secondary 
oxidant.196 However, again only decomposition of the starting material was observed. 







1 BAIB DCM/H2O r.t. decomposition 
2 BAIB/Bu4NCl DCM/H2O r.t. decomposition 
3 BAIB ACN/H2O r.t. decomposition 
4 BAIB ACN/H2O 0 °C decomposition 
5 BAIB/NaHCO3 ACN/H2O r.t. decomposition 
6 NaOCl/NaHCO3 ACN/H2O r.t. no reaction 
7 NaOCl/KBr/NaHCO3 DCM/H2O r.t. decomposition 
 
 





Scheme 18. Automated glycan assembly of oligosaccharides 29 and 30 and different post-
assembly oxidation strategies towards glucuronoxylan oligosaccharides 32 and 34. Reagents and 
conditions: a) 2 x 1.8 equiv of BB 1a or 1c, TMSOTf, DCM, -35 °C (5 min) → -15 °C (30 min) 
(Module A); b) 2 x 1.8 equiv of BB 18b, NIS, TfOH, DCM/dioxane, -40 °C (5 min) → -20 °C (40 min) 
(Module B); c) 3 cycles of 20% NEt3 in DMF, 25 °C (5 min) (Module C); d) 6 cycles of PBu3, 
THF/H2O (5:1), 45 °C, 30 min (Module E); e) Bz2O, DMAP (Module G); f) h (305 nm), yields are 
based on resin loading; the letter codes below the structure represents the reaction sequence 
applied in the respective synthesis; g) NaOMe, MeOH/DCM, 16 h, h) TEMPO, BAIB; j) pTsOH, 
DCM/MeOH (9:1), 40 °C, 16 h; k) DMP, DCM, H2O, 2 d; l) NaOCl2, NaH2PO4, 2-methyl-2-butene, 
tBuOH/THF/H2O (2:1:1), 2 h 33: 55% over 3 steps; m) NaOMe, THF, 16h; n) H2, Pd/C, 






Based on these results a different oxidation strategy had to be applied. A two-step 
oxidation approach via the respective aldehyde was pursued that had previously been 
used for example in the synthesis of pectic homogalacturonan hexasaccharides.199 Unlike 
the previously described TEMPO-mediated oxidation reactions, this reaction is not 
selective towards primary alcohols. The oxidation had to be performed at the fully 
protected stage where only the hydroxyl group at the C6-position of the glucose residue is 
deprotected. Thus, fully protected tetrasaccharide 30 was prepared by automated glycan 
assembly (Scheme 18 right). The synthesis of tetrasaccharide 30 was performed in the 
same way as of tetrasaccharide 29. However, the hydroxyl group at the terminal C4-
position was capped with a benzoyl protecting group in a final esterification step. After 
photolytical cleavage, the acetyl group at the C6-position was selectively removed using 
pTsOH200 and the resulting free hydroxyl group was oxidized by performing the following 
two reactions. First, treatment with Dess-Martin periodinane (DMP) gave the respective 
aldehyde and then Pinnick oxidation with NaOCl2 provided the fully protected 4-O-
methylated glucuronic acid-substituted oligoxyloside 33 in 55% yield. Subsequent removal 
of the benzoyl esters by methanolysis and of the benzyl ethers by hydrogenolysis afforded 
the fully deprotected glucuronoxylan oligosaccharide 34.  
The synthesis of the analogous non-methylated glucuronoxylan oligosaccharide 38 
required the synthesis of glucose BB 36 (Scheme 19). As the previous comparison of 
glucose BBs 18a and 18b had shown that acetyl-substituted BB 18b gives better 
conversion in the glycosylation reaction, glucose BB 36 was only synthesized as the 
respective 6-O-Ac-substituted compound (Scheme 19a). The synthesis started from 
acetal 20, which had also served as the starting material for the synthesis of BB. Opening 
of the benzylidene acetal with BH3∙THF and TMSOTf gave alcohol 35 and the free 
hydroxyl at the C6-position was subsequently protected with an acetate-group to give 
glucose BB 36. Glucose BB 36 was used in the automated glycan assembly of the fully 
protected glucose-substituted xylan oligosaccharide 37 (Scheme 19b). After selective 
removal of the acetate group at the glucose residue using pTsOH, the above-described 
two-step oxidation was applied. The respective fully protected non-methylated glucuronic 
acid-substituted oligosaccharide was obtained in 28% yield. Subsequent removal of the 
benzoyl esters by methanolysis and of the benzyl ethers by hydrogenolysis afforded the 
glucuronoxylan oligosaccharide 38 in 49% yield. Due to the many post-assembly 
transformations required and the low yield achieved in the synthesis of glucose-
substituted xylan heptasaccharide 28, the synthesis of larger glucuronoxylan 
oligosaccharides was not attempted. 





Scheme 19. (a) Synthesis of glucose BB 36. Reagents and conditions: a) THF∙BH3, TMSOTf, 51%, 
b) Ac2O, py, 83%, (b) Synthesis of glucuronoxylan oligosaccharide 38. Reagents and conditions: a) 
2 x 1.8 equiv of BB 1a or 1c, TMSOTf, DCM, -35 °C (5 min) → -15 °C (30 min) (Module A); b) 2 x 
1.8 equiv of BB 36, NIS, TfOH, DCM/dioxane, -40 °C (5 min) → -20 °C (40 min) (Module B); c) 3 
cycles of 20% NEt3 in DMF, 25 °C (5 min) (Module C); d) 6 cycles of PBu3, THF/H2O (5:1), 45 °C, 
30 min (Module E); e) Bz2O, DMAP (Module G); f) h (305 nm), the yield is based on resin loading; 
the letter code below the structure represents the reaction sequence applied in the respective 
synthesis; g) pTsOH, DCM/MeOH (9:1), 40 °C, 16 h; h) DMP, DCM, H2O, 2 d; j) NaOCl2, NaH2PO4, 
2-methyl-2-butene, tBuOH/THF/H2O (2:1:1), 2 h, 28% over 3 steps; k) NaOMe, THF, 16h; l) H2, 





2.1.3 Characterization of Xylan-Directed Monoclonal Antibodies 
Monoclonal antibodies that recognize plant cell wall glycans provide important 
information on the structure and localization of cell wall polysaccharides. The prepared 
arabino- and glucuronoxylan oligosaccharides represent ideal probes to determine 
previously unknown epitopes of xylan-directed monoclonal antibodies. The 
oligosaccharides were printed together with the previously synthesized (Deborah Senf, 
MSc thesis, MPIKG)132 collection of four linear oligoxylans and eight -1,3-substituted 
oligoarabinoxylans as a glycan microarray and probed with 209 plant cell wall glycan-
directed monoclonal antibodies in collaboration with my colleague, Dr. Ruprecht. Binding 
of the monoclonal antibodies to the synthetic oligosaccharides was identified by 
incubation of the array with the primary monoclonal antibody, which is then bound by a 
fluorescently-labelled secondary antibody (Figure 10). The positions on the microarray 
slide that were recognized by a mAb were detected by using a microarray scanner.  
 
Figure 10. Schematic representation of a glycan microarray assay for characterizing the binding 
epitopes of cell wall glycan-directed monoclonal antibodies. 
We identified 30 monoclonal antibodies that bound to the synthetic xylan oligosaccha-
rides. Microarray scans of a selection of these antibodies are shown in Figure 11. 
Monoclonal antibody LM11 for example recognized the -1,4-linked xylose backbone with 
a high tolerance for backbone substitution. In some cases the binding epitopes were more 
precisely characterized. As expected all linear oligoxylans were detected by monoclonal 
antibody LM10 that was originally raised against a synthetic pentaxyloside-BSA 
conjugate. Previously, LM10 was thought to bind only to low- or unsubstituted xylans.201 
However, in our assay LM10 bound to all arabinose substituted xylan structures except for 
the oligosaccharides that carry an arabinose substituent at the non-reducing xylan residue 
(X, 11, 14, 17). For the three oligosaccharides X, 11 and 17, the absence of binding can 
be explained by the high degree of substitution next to the non-reducing xylose residue. 





Figure 11. Detection of arabino- and glucuronoxylan oligosaccharides by xylan-directed 
monoclonal antibodies. Representative microarray scans of selected examples are shown. Each 
compound was printed in four concentrations as indicated on the right. Light linkages and light 
monosaccharide symbols indicate positions for substitutions that are allowed but not required for 
binding. Red bars represent positions, which must not be substituted. 
To confirm that LM10 exclusively binds to the non-reducing end even when longer 
unsubstituted xylan stretches are present, the lowly substituted heptasaccharide 14, with 
only one arabinosyl substituent at the non-reducing end, was prepared. No binding to 
heptasaccharide 14 was detected.  
Other monoclonal antibodies recognized completely different epitopes. CCRC-M154 
bound exclusively to oligoxylans substituted with -1,3-linked arabinose (V-X) residues 





Glucuronoxylan oligosaccharide 38 was selectively recognized by CCRC-M150 and its 4-
O-methylated glucuronic acid derivative 34 by CCRC-M144, CCRC-M145, CCRC-M146, 
and CCRC-M155. It was furthermore confirmed that LM28 binds xylans that are 
substituted with either of the glucuronic acid derivatives.202 None of the monoclonal 
antibodies bound to glucose-substituted xylan 27, which indicates that the carboxylic acid 
moiety is essential for binding.  
The antibodies used in this study were previously grouped into four clades based on 
their binding properties towards natural xylan polysaccharides (Xylan group 1-4).88 In 
general, monoclonal antibodies from Xylan group 1 (e.g. CCRC-M138, CCRC-M153) were 
found to bind the -1,4-linked backbone of low-substituted xylans. Interestingly, different 
binding patterns towards the synthetic oligoarabinoxylosides were observed not only for 
antibodies from the same clade but also for antibodies raised against the same 
polysaccharide antigen. For example, while CCRC-M138 detected only the linear 
octaxyloside, CCRC-M153 also bound to arabinose substituted xylosides. Both antibodies 
were originally raised against the same natural oat xylan and bind the same group of 
natural xylans.  
None of the antibodies showed either strong or selective binding to penta- and 
hexasaccharides XI and 16 containing the -1,2-D-xylopyranosyl--1,3-L-arabinofuranosyl 
substituent. Similarly, the -1,3-L-arabinofuranosyl--1,3-L-arabinofuranosyl side chain 
was not recognized, making these antigens promising candidates for immunizations and 
production of monoclonal antibodies towards these otherwise undetectable epitopes. The 
results demonstrate that libraries of synthetic plant oligosaccharides can be used to 
determine the binding specificities of cell wall glycan-directed antibodies with high 
precision. With knowledge of the exact epitopes of these monoclonal antibodies, they can 
be now used as selective markers for xylans that carry specific substituents.  
2.1.4 Active Site-Mapping of Xylan-Degrading Enzymes 
Xylan-degrading enzymes are important tools for many industrial applications such as 
the production of biofuel.9,55,92 A detailed understanding of the enzymatic degradation of 
xylan at the molecular level is beneficial for its efficient utilization.55,203 The prepared 
collection of arabinoxylan oligosaccharides represents suitable substrates for the 
characterization of the substrate specificities of xylan-degrading enzymes. My colleague, 
Dr. Ruprecht, investigated a number of commercially available endo-xylanases and 
arabinofuranosidases, i.e. a GH family 10 xylanase from Cellvibrio japonicas 
(XYNACJ),204 a GH11 xylanase from rumen microorganism (XYRU6),205 and two GH43 




arabinofuranosidases from Bacteroides ovatus (ABFBO17 and ABFBO25) using the 
synthetic xylan oligosaccharides.204,206 Simple end-point measurements were performed 
by incubating the enzymes with the respective oligosaccharide for 3 h at 40 °C and then 
terminating the reaction by heat inactivation. The resulting fragments were analyzed by 
HPLC coupled to a mass spectrometer and an ELSD. Exemplary results for the GH10 
xylanase XYNACJ are shown in Figure 12a. As expected, linear octasaccharide IV was 
readily degraded by the xylanase, whereas the arabinose substituents in VI and 12 
directed the cleavage to the glycosidic bond. Depending on whether the arabinose was -
1,2- or -1,3-linked, the backbone was further hydrolyzed either one or two units before 
the substituent. Based on the identified fragments, the cutting sites for each of the 
oligosaccharides and for both types of endo-xylanases investigated were determined 
(Figure 12b). Summarizing these results, general requirements for arabinose substitutions 
that are tolerated by the GH10 xylanase were deduced (Figure 12c). These results are  
 
Figure 12. Investigation of the substrate specificities of GH10 and GH11 endo-xylanases using 
synthetic xylan oligosaccharides. (a) HPLC analyses of reactions of a GH10 xylanase with different 
substrates (indicated by boxes). Peaks are annotated with xylan fragments with aminopentyl linker or 
with free reducing end (with or without red bar). Note that the α- and the β-form of the fragments with 
free reducing end elute separately. (b) Cutting sites of GH10 and GH11 xylanases in all prepared 
arabinoxylan oligosaccharides. Thin arrows indicate minor activity at the respective site. (c) General 
requirements for arabinose substitutions relative to the cutting site of the GH10 xylanase derived 
from the results obtained in (b). The “X” denotes xylose residue positions that must not be 





consistent with previously published data on the active site of GH10 xylanases which is 
conserved between most, but not all, family members.95 Due to their larger xylan recog-
nition site and the limited size of the prepared oligosaccharides a similar generalization 
was not possible for the GH11 xylanases.  
Another important class of enzymes in the degradation of arabinoxylans are arabino-
furanosidases that can act on mono-207,208 or double-substituted209-211 xylose residues. To 
investigate the substrate specificities of these enzymes, experiments with two different GH 
43 arabinofuranosidases were performed (Figure 13). The results indicated a strong 
preference of ABFBO25 for cleavage of -1,2- compared to -1,3-linked arabinoses 
(Figure 13a) as confirmed by time-course experiments using compounds V, X, 10, and 11 
(Figure 13b). Compound 15 with two arabinose substitutions at the same xylose residue 
was exclusively not digested by ABFBO25, but represented the only substrate for 
ABFBO17 (Figure 13c). In agreement with previous studies,203,204,206 ABFBO17 selectively 
removed the -1,3-linked arabinose, leaving the -1,2-substituted arabinose compound 
 
Figure 13. Arabinofuranosidase activities on different arabinoxylan oligosaccharide substrates. (a) 
HPLC analysis of a reaction of a GH43 arabinofuranosidase from Bacteroides ovatus (ABFBO25) 
with xylotriose substituted with arabinose at the C3- (V) or the C2- (X) position after 60 min 
incubation time. The structure of the substrates is indicated by boxes. The glucose disaccharide was 
used as internal standard for quantification. (b) Time-course experiment using four different 
tetrasaccharides as substrates for ABFBO25. (c) Time-course experiment for ABFBO17, another 
GH43 arabinofuranosidase from Bacteroides ovatus, and ABFBO25 using a C2-, C3-disubstituted 
arabinoxylan oligosaccharide as substrate (indicated by a box). Note that only ABFBO17 specifically 
removes C3-substituted arabinose from C2-, C3-disubstituted xyloses. These results were obtained 
at an enzyme concentration of 0.1 U/mL. 




10 as the product. The exclusive selectivity of ABFBO17 and ABFBO25, which belong to 
the same GH family, for either mono- or disubstituted arabinoxylosides indicate distinct 
properties in the catalytic domain of these enzymes. 
2.1.5 Conclusion and Outlook 
In conclusion, a set of 12 xylan oligosaccharides with arabinofuranose and glucuronic 
acid substituents attached to the C2- and/or C3-position of the backbone xylose units was 
synthesized by automated glycan assembly. Elongation of the xylan backbone was 
accomplished by iterative additions of C4-fluorenylmethoxylcarbonyl (Fmoc) protected 
xylose building blocks to a linker-functionalized resin. Substituents were selective 
attached to the backbone using fully orthogonal 2-(methyl)naphthyl (Nap) and 2-
(azidomethyl)benzoyl (Azmb) protecting groups at the C2- and C3-hydroxyls of the xylose 
building blocks. The attachment of glucuronic acid substituents required the use of 
glucose BBs that were oxidized to the corresponding glucuronic acid after the full 
oligosaccharide has been assembled to overcome low reactivity of glucuronic acid donors. 
High 1,2-cis stereoselectivity in the glycosylation reactions was obtained by using an ester 
protecting group in the C6-position of glucose that exhibited remote participation. Different 
post-assembly oxidation strategies had to be examined. Firstly, a TEMPO-based strategy 
was tested, which did not lead to the desired product under several different reaction 
conditions. Next, a two-step oxidation procedure via the respective aldehyde as an 
intermediate was pursued that yielded the desired glucuronic acid oligosaccharides. 
The library of synthetic xylan oligosaccharides was printed as glycan microarray and 
probed with anti-xylan antibodies. The binding specificities of several antibodies were 
precisely determined, providing the required information for the specific detection of many 
complex molecular structures of xylan polysaccharides in the plant cell wall. The absence 
of binding towards the oligosaccharides containing disaccharide side chains makes these 
antigens promising candidates for immunizations and production of monoclonal 
antibodies, as these epitopes remain undetectable otherwise. This requires the production 
of larger amounts of the respective oligosaccharides, which can be achieved by multiple 
rounds of automated glycan assembly followed by combined global deprotection in 
solution. Future efforts will aim at the synthesis of esterified oligoxylosides, as xylans are 
often substituted with acetyl or ferulate esters. The current synthetic strategy does not 
allow for their synthesis as the ester groups would be cleaved during methanolysis of the 
benzoates and new BBs will have to be designed. 
The collection of arabinoxylan oligosaccharides was further utilized for determining 





oligosaccharides were incubated with different glycosyl hydrolases followed by HPLC-MS 
analysis of the digestion products. Simple end-point measurements revealed the substrate 
specificities of one GH10 xylanase and two arabinofuranosidases. More detailed 
information on the preferences of the enzymes for specific oligosaccharides was 
elucidated through time-course experiments. The developed HPLC-based assay using 
synthetic arabinoxylan oligosaccharides rather than natural polysaccharide substrates 
shortens analysis time to a single day and provides a powerful tool for screening xylan-
degrading enzymes. Future syntheses of even larger xylan oligosaccharides will enable 
the active site-mapping of xylanases belonging to the other GH families (5, 8, and 11). 
These xylanase families are less studied than the GH10 xylanases and insights into 
substrate binding properties are urgently needed.  




2.2 Artificial Polysaccharides with Well-Defined 
Branching Patterns2 
Cellulose and xylan are the major polysaccharides in lignocellulosic biomass and thus 
promising renewable resources for the production of materials and fuels.212 While 
cellulose is regularly utilized for these purposes, the exploration of xylan is lagging behind 
due to its structural complexity.25,34 Arabinoxylans, as a subclass of xylans, form long 
polymeric chains that are randomly substituted with arabinofuranosyl residues (Figure 
14a). The molecular composition of xylans has a strong impact on their macroscopic 
properties such as solubility41 and crystallinity as the substituents disrupt the interactions 
between individual xylan chains.213 Adsorption of xylan to cellulose is also strongly 
affected by its discrete substitution pattern as demonstrated recently by Dupree et al. for 
glucuronoxylans.41,44-48 
 
Figure 14. Schematic representation of (a) a natural xylan with random branching pattern and (b) 
artificial arabinoxylans with defined branching patterns. 
Detailed investigations into structure-property relationships of complex 
polysaccharides are hampered by their inhomogeneity as they are extracted from natural 
sources. Polysaccharides with defined branching patterns can only be obtained 
synthetically using a bottom-up approach. Enzymatic polymerizations using 
                                               
2
 This chapter has been modified in part from the following articles: Senf, D.; Ruprecht, C.; Matic, 





glycosynthases157 have proven useful for the synthesis of artificial polysaccharides of 
many different classes, such as xyloglucans and homopolymers of xylans.155,162-170 
However, substituted xylan polysaccharides have not been synthetically prepared. In this 
chapter, the synthesis of artificial arabinoxylan polysaccharides with defined branching 
patterns (Figure 14b) by glycosynthase-catalyzed polymerization of a number of different 
oligosaccharide fluorides is described. To catalyze the polymerization of the arabinoxylan 
oligosaccharide fluorides, the glycosynthase XynAE265G was chosen as it is able to 
produce xylan homopolymers containing more than 100 monosaccharide units.163  
2.2.1 Proof-of-Principle using Automated Glycan Assembly 
Arabinoxylan oligosaccharide fluorides can be easily obtained from the corresponding 
oligosaccharides with free reducing ends. Automated glycan assembly offers a fast 
synthetic route to these oligosaccharides (chapter 2.1). Recently, a new photo-labile linker 
(39, Figure 15 right) was developed,214 that is structurally analogous to the established 
linker 9139 that is routinely used to produce linker-functionalized glycans. This new linker 
releases oligosaccharides with free reducing ends after light-induced cleavage and 
deprotection. The benzyl moiety that is incorporated in the linker releases the anomeric 
hydroxyl group after a final hydrogenolysis.215-217  
 
Figure 15. Resin-bound photo-labile linkers for automated glycan assembly. Left: established linker 
9;
139
 right: modified traceless linker 39. 
For the automated glycan assembly of arabinoxylan oligosaccharides with free 
reducing ends, linear trisaccharide 40 served as an initial target structure to investigate 
the efficiency of the glycan assembly using the new linker (Scheme 20). Xylose BB 1a 
was iteratively added to a Merrifield resin equipped with linker 39 via alternating cycles of 
glycosylation and deprotection reactions. The fully protected trisaccharide was obtained 
after photolytical cleavage in high purity. Sequential deprotection of the permanent 
protecting groups by methanolysis and hydrogenolysis gave trisaccharide 40 
accompanied by a primary amine, which was formed as a side product during 
hydrogenolysis. Upon removal of the solvents, the open chain form of 40 reacted partially  





Scheme 20. Automated glycan assembly of trisaccharide 40 using traceless linker 39.  
with the primary amine of the cleaved-off linker to form a hemiaminal ether (Scheme 21). 
This mixture was converted to the desired product 40 under acidic conditions before it was 
subjected to final a HPLC purification.  
In order to proceed with the synthesis of -1,3-substituted arabinoxylan 
oligosaccharides, the stability of linker 39 during DDQ-mediated removal of the Nap-
protecting group of xylose BB 1b on the solid-phase had to be ensured. Thus, 
disaccharide 42 was synthesized by automated glycan assembly using BBs 1b and 2a 
(Scheme 22). After photo-induced cleavage of the oligosaccharide from the solid support, 
no side products were observed by HPLC confirming the stability of linker 39 during Nap-
deprotection.  
 
Scheme 21. Formation of hemiaminal ether 41 from trisaccharide 40 and a primary amine, which 







Scheme 22. Automated glycan assembly of arabinoxylan oligosaccharides with free reducing end 
(42-45). Reagents and conditions: a) 2 x 1.8 equiv of BB 1a or 1b, TMSOTf, DCM, -35 °C (5 min) 
→ -15 °C (30 min) (Module A); b) 2 x 1.8 equiv of BB 2a, NIS, TfOH, DCM/dioxane, -40 °C (5 min) 
→ -20 °C (40 min) (Module B); c) 3 cycles of 20% NEt3 in DMF, 25 °C (5 min) (Module C); d) 7 
cycles of 0.1 M DDQ in DCE/MeOH/H2O (64:16:1), 40 °C, 20 min (Module D); e) h (305 nm); f) 
NaOMe, DCM/MeOH, 16h; g) H2, Pd/C, EtOAc/MeOH/H2O/HOAc, 12 h. The yields are based on 
resin loading. The letter code below the structures represents the reaction sequence applied in the 
respective synthesis. 
Next, three target molecules (43-45) were selected for the automated glycan 
assembly of -1,3-substituted arabinoxylan oligosaccharides to evaluate their potential to 
serve as substrates in the glycosynthase-catalyzed polymerization. Tetrasaccharide 43, 
with an arabinose substituent attached to the non-reducing end xylose unit, was expected 
to be a good substrate in the polymerization reaction, as glycosynthase XynAE265G163 is 
derived from a xylanase belonging to the GH family 10, and GH10 xylanases only 
accommodate arabinose substitution in certain positions alongside the xylan backbone. 
Tetrasaccharide 44 with arabinose substitution at the penultimate xylose residue is less 
likely to be an acceptor. As a third substrate, hexasaccharide 45 will be prepared. 




For the automated glycan assembly of tetrasaccharides 43 and 44, the full xylan 
backbone was synthesized before the Nap ether was deprotected using DDQ to allow for 
the final glycosylation with arabinose BB 2a. For the synthesis of hexasaccharide 45, the 
assembly of the backbone was interrupted after the xylosyl residue to which xylose BB 1b 
was added. After subsequent deprotection of the Nap ether and attachment of the 
arabinose side chain, the backbone synthesis was completed. The fully deprotected 
arabinoxylan oligosaccharides 42-45 were obtained after global deprotection, acidic 
hydrolysis of the hemiaminal ether and final HPLC-purification.  
Transformation of the deprotected oligosaccharides into glycosyl fluorides was 
performed in a three-step procedure consisting of peracetylation, fluorination, and 
deacetylation. The synthesis is shown exemplary for trisaccharide 40 in Scheme 23a. The 
fluorination of the peracetylated trisaccharide was performed using HF/pyridine at low 
temperature,218-222 providing -fluoride 46 with high selectivity (/ ~ 10:1). The 
configuration of the anomeric center was confirmed by the characteristic geminal coupling 
constant (J = 53 Hz for -fluoride) between the anomeric H- and F-atoms in 1H and 19F 
NMR spectroscopy (Scheme 23b).223 Removal of the acetate groups by treatment with 
1 equiv NaOMe at 0 °C finally afforded deprotected trisaccharide fluoride 47. The 
fluorination of arabinose-substituted oligosaccharides 43, 44 and 45 was performed 
analogously. However, the strongly acidic conditions of the fluorination reaction provoked 
partial cleavage of the arabinofuranose in some cases, which explains the low yields 
obtained for 48 and 49 (Scheme 23c). The respective glycosyl fluoride of hexasaccharide 
45 could not be isolated after treatment with HF/pyridine, probably due to difficulties 
resulting from the very small scale of this reaction. 
With the desired glycosyl fluorides 47-49 in hand, enzymatic polymerizations were 
performed by overnight incubation of the respective glycosyl fluoride with glycosynthase 
XynAE265G (Scheme 24a). The formation of polysaccharides was investigated by 
MALDI-TOF. The peaks in the MALDI spectrum confirmed that the polysaccharides were 
formed from the starting oligosaccharides and that these polysaccharides represent 
oligomers of the oligosaccharide fluorides. In the polymerization reaction of trisaccharide 
donor 47 and tetrasaccharide donor 48 polysaccharides containing up to 33 and 32 
monosaccharide units, respectively, were formed (Scheme 24b). Conversely, 
tetrasaccharide 49 did not undergo polymerization. Substitution with arabinose in the 
position next the non-reducing end (+2 position) was not accommodated by the 
glycosynthase, which is in line with the substrate specificities of GH10 xylanases (see 






Scheme 23. (I)Transformation of deprotected trisaccharide 40 to the respective glycosyl fluoride 
47. Reagents and conditions: a) Ac2O, DMAP, py; b) HF/py, 5 h, -10 °C; c) NaOMe, MeOH, 0 °C. 
(II) - and -anomeric fluoride peaks in the 
19
F NMR spectrum of crude trisaccharide fluoride 46. 
(III) Tetrasaccharide fluorides 48 and 49 that were synthesized analogously to 47. 
example of an artificial arabinoxylan polysaccharide with a defined substitution pattern. 
These results show that enzymatic polymerization using the glycosynthase technology is 
a fast and convenient synthetic route towards regularly substituted polysaccharides. 
However, the scale of these polymerization reactions was limited to less than 1 mg due to 
the limited scale of the automated glycan assembly. 





Scheme 24. (a) Glycosynthase-catalyzed polymerization of glycosyl fluorides 47, 48 and 49. (b) 
MALDI-MS spectrum of polysaccharide 51, showing the formation of chain lengths up to n = 8 (32 
monosaccharides).  
2.2.2 Chemical Solution-Phase Synthesis of Arabinoxylan 
Oligosaccharides 
The polymerization of arabinoxylan oligosaccharides obtained from automated glycan 
assembly provided a proof-of-principle for the approach of synthesizing artificial 
arabinoxylan polysaccharides with well-defined substitution patterns by glycosynthase-
catalyzed polymerization of arabinoxylan oligosaccharides. However, the scale of these 
reactions was very small. Therefore, three oligosaccharides (43, 52 and 53) were 
produced in larger quantities by chemical synthesis to serve as monomers in the 
enzymatic polymerization reactions (Figure 16). For the synthesis of linear xylan 
polysaccharides, xylobiose 52 was chosen as a substrate instead of trisaccharide donor 
40 due to its simpler synthesis. The arabinose-substituted structures 53 and 43 carry -
1,3-linked arabinofuranosyl substituents at the non-reducing end xylose units to ensure 






Figure 16. (Arabino-)xylan oligosaccharides 43, 52 and 53 and the monosaccharide BBs for their 
solution-phase synthesis. 
For the chemical synthesis of oligosaccharides 43, 52 and 53, the same protecting group 
strategy was used as for the automated glycan assembly of the -1,3-substituted arabi-
noxylan oligosaccharides described in the previous chapter (Scheme 25). The synthesis 
started from thioglycoside BB 8a, which was reacted with BnOH and NIS/TfOH. After the 
C4-position was deprotected by using NEt3, chain elongation with thioglycoside 8a was 
performed to give fully protected disaccharide 55. Subsequently, global deprotection 
afforded fully deprotected disaccharide 52. For the synthesis of trisaccharide 53, 
glycosylation of the free hydroxyl group of xylose acceptor 54 was performed with Nap-
protected BB 8b to give disaccharide 56. Deprotection of the hydroxyl group at the C3-
position with DDQ was followed by a glycosylation reaction with arabinose BB 2a. After 
methanolysis and hydrogenolysis of 57, fully deprotected trisaccharide 53 was obtained. 
Finally, the synthesis of tetrasaccharide 43 was performed starting from fully protected 
disaccharide 55. After Fmoc-deprotection using NEt3, chain elongation at the C4-position 
was performed with Nap-protected BB 8b to afford trisaccharide 58. Subsequent removal 
of the Nap group in the C3-position using DDQ was followed by the attachment of the 
arabinose side chain by glycosylation of the free hydroxyl group with BB 2a, which gave 
fully protected tetrasaccharide 59. Methanolysis and hydrogenolysis afforded the fully 
deprotected tetrasaccharide 43. In this case, it was crucial to add triethylamine (0.1 equiv) 
directly after the hydrogenolysis in order to prevent acid-induced cleavage of the 
arabinose side chain during removal of the solvents. Traces of HCl are believed to be 
formed during hydrogenolysis from residual PdCl2 in the Pd-catalyst.
224,225 
 





Scheme 25. Chemical synthesis of di-, tri- and tetrasaccharides 43, 52 and 53. Reagents and 
conditions: a) NIS, TfOH, BnOH, -10 °C, 30 min; b) NEt3, DCM, 2 h, 93% over 2 steps; c) NIS, 
TfOH, DCM, BB 8a, -15 °C, 30 min, 96%; d) NaOMe, MeOH/DCM, 71%, e) H2, Pd/C, MeOH, 
EtOAc, H2O, 78%; f) NIS, TfOH, DCM, BB 8b, -15 °C, 30 min, 84%; g) DDQ, MeOH/DCM 79% h) 
NIS, TfOH, BB 2a, -30 °C, 30 min, 93%; j) NaOMe, MeOH/DCM, 73%, k) H2, Pd/C, MeOH, EtOAc, 
H2O, 99%; l) NEt3, DCM, 2 h, 90%; m) NIS, TfOH, DCM, BB 8b, -15 °C, 30 min; n) DDQ, 
MeOH/DCM 75% over 2 steps; o) NIS, TfOH, BB 2a, -30 °C, 30 min, 79%; p) NaOMe, 
MeOH/DCM, 65%; q) H2, Pd/C, MeOH, EtOAc, H2O, NEt3; the yield was calculated over 2 steps 






2.2.3 Chemo-Enzymatic Synthesis of Arabinoxylan 
Oligosaccharides 
Larger -1,3-arabinofuranosyl-substituted xylan oligosaccharides 60 and 61 were 
obtained by a chemo-enzymatic approach (Scheme 26), in which arabinoxylan 
trisaccharide donor 62 was ligated in a controlled manner to di- and trixyloside acceptors 
63 and 64 using glycosynthase XynAE265G.163 
 
Scheme 26. Retrosynthetic analysis of penta- and hexasaccharides 60 and 61, PG = protecting 
group. 
To prevent enzyme-catalyzed self-condensation of trisaccharide donor 62, it had to 
be equipped with a suitable protecting group (PG) at the C4-position of the non-reducing 
xylose residue. For this purpose, the tetrahydropyranosyl (THP)- and pivaloyl (Piv)-groups 
were evaluated. The THP-group had already successfully been used in the step-wise 
enzymatic synthesis of cellodextrins226 and xyloglucan oligosaccharides.227 It is cleavable 
under relatively mild acidic conditions in aqueous solution.228,229 However, THP-cleavage 
also occurs during the acidic conditions in the fluorination reaction to prepare the glycosyl 
fluoride and THP has thus to be reintroduced in an additional synthetic step. It was 
therefore desirable to find a different protecting group that is stable towards HF/pyridine. 
The Piv-group was envisioned to be a suitable alternative as it is stable to acidic, oxidative 
and reductive conditions, and can be removed with strong bases.230,231 However, if the 




Piv-group is accommodated by the glycosynthase during the enzymatic ligation and if the 
Piv-protected glycosyl fluoride can be selectively deacetylated in the last step remained 
elusive. In order to investigate the suitability of both protecting groups, model disaccharide 
fluorides 74a and 74b equipped with either the Piv- or THP-group at the C4’-position were 
synthesized (Scheme 28). The model disaccharides were synthesized from xylose donors 
65 and 66 as their synthesis requires fewer synthetic steps and they are also required for 
the synthesis of di- and trisaccharide acceptors 63 and 64. The synthesis of 65 and 66 
was performed starting from D-xylose according to a previously established reaction 
sequence in our group (Michael Wilsdorf, unpublished results, Scheme 27). Peracetylation 
of D-xylose using Ac2O in pyridine, followed by BF3∙OEt2-promoted thioglycosylation with 
TolSH232 and the removal of the acetate groups using NaOMe, gave fully deprotected 
thioglycoside 68. Subsequently, selective protection of the hydroxyl group in the C4-
position with Fmoc was accomplished by first refluxing thioglycoside 69 in presence of 
Bu2SnO in 1,4-dioxane
232 and then reacting the resulting tin acetal with FmocCl. Upon 
aqueous workup the tin acetal was cleaved, and Fmoc-protected compound 69 was 
obtained. Protection of the remaining hydroxyl groups with benzoyl chloride gave 
thioglycoside 65. In the last step the thiol leaving group was exchanged by a phosphate 
leaving group and glycosyl phosphate 66 was obtained. 
 
Scheme 27. Synthesis of xylose donors 65 and 66. Reagents and conditions: a) Ac2O, pyridine, 
DMAP; b) HSTol, BF3∙OEt2, 55%; c) NaOMe, MeOH/DCM, 65%; d) Bu2SnO, dioxane, reflux e) 
FmocCl, DCM, 72%; f) BzCl, pyridine, DMF, 64%; g) HOP(O)(OBu)2, NIS, TfOH, DCM, 0 °C, 84%. 
For the synthesis of disaccharides 74a and 74b (Scheme 28), thioglycoside 65 was 
deprotected using NEt3 and the resulting free hydroxyl group in 70 was reacted with 
phosphate donor 66 to give disaccharide 71. Introduction of the Piv-group was performed 
using PivCl and pyridine233 and introduction of the THP-group using DHP and catalytic 
amounts of pTsOH.226 Transformation of the resulting protected disaccharides 72a and 
72b into the respective fluorides 73a and 73b was accomplished using HF/pyridine and 
NIS, which is used to activate the thioether.234 In the case of glycosyl fluoride 73b the 






Scheme 28. Synthesis of 4’-O-protected disaccharides 74a and 74b for the investigation of 
suitable PGs in the chemo-enzymatic synthesis of penta- and hexasaccharides 60 and 61. 
Reagents and conditions: a) NEt3, DCM, 3 h, 80%; b) TMSOTf, DCM, 66, 66%; c) NEt3, DCM, 3 h, 
59% over 2 steps; d) PivCl, py, DCM, 0 °C to r.t., 82%; e) DHP, CSA, DCM, 80%; f) (I) NIS, HF, py, 
-10 °C, 5 h, 73a: 42%; (II) for 73b only: DHP, CSA, DCM, 82% over 2 steps; g) NaOMe, MeOH, 
0 °C, 74b: 89%. 
benzoyl groups were removed. Methanolysis using catalytic amounts of NaOMe at 0 °C 
afforded the 4’-O-THP-protected disaccharide fluoride 74b. The synthesis of 74a failed 
because the Piv ester was partially cleaved under these conditions. Using NEt3 in 
methanol at 0 °C for removal of the benzoyl esters231 did not improve the results. Thus, 
the Piv-group was not suitable for protection of the glycosyl fluorides and trisaccharide 
donor 62 was synthesized equipped with a THP-group at the C4’-position. 
The synthesis of protected glycosyl fluoride 62 was performed starting from 
trisaccharide 57 that had already been assembled from BBs 8a,b and 2a for the chemical 
solution-phase synthesis of trisaccharide 53 in the previous chapter (Scheme 29). The  
 
Scheme 29. Synthesis of 4’-O-THP-protected trisaccharide fluoride 62. Reagents and conditions: 
a) NEt3, DCM, 2 h, rt, 90%; b) DHP, p-TsOH, DCM, 4 h, rt; c) NaOMe, MeOH/DCM, 16 h, rt, 66% 
over 2 steps; d) H2, Pd/C, MeOH/EtOAc/NaxHxPO4 buffer, rt, 24 h; e) Ac2O, py, 4 h, rt; f) HF/py, 
DCM, -30 °C → -20 °C, 2 h, 60% over 3 steps; g) DHP, p-TsOH, DCM, 4 h, rt, 91%; h) NaOMe, 
MeOH, 0 °C, 96%. 




Fmoc-protecting group in the C4-position was exchanged by a THP-group in two 
steps,and subsequent methanolysis of the benzoyl esters and hydrogenolysis of the 
benzyl ethers provided 4’-O-THP-protected trisaccharide 75. Due to the acid-sensitivity of 
the THP-protecting group, it was necessary to perform the hydrogenolysis in a solvent 
mixture containing sodium phosphate buffer to prevent acid-promoted THP-
cleavage.224,225 Peracetylation of 75 was then followed by fluorination with HF/pyridine at 
low temperature to provide the corresponding glycosyl fluoride.218-222 Reaction 
temperature and time were carefully adjusted to ensure formation of the 
thermodynamically favored -fluoride without cleavage of the acid-labile arabinofuranose 
substituent. The THP-group did not stay intact under these reaction conditions and was 
subsequently reintroduced at the C4’-position using DHP and catalytic amounts of pTsOH. 
Removal of the acetate groups by treatment with catalytic amounts of NaOMe (1 equiv) at 
0 °C finally afforded THP-protected glycosyl fluoride 62. 
Next, acceptors 63 and 64 for the enzymatic ligation reaction were synthesized 
(Scheme 30). Glycosylation of the previously synthesized phosphate donor 66 with  
 
Scheme 30. Synthesis of di- and trisaccharide acceptors 63 and 64 and enzymatic ligations 
providing penta- and hexasaccharides 60 and 61. Reagents and conditions: a) TMSOTf, DCM, 
66%; b) NaOMe, MeOH/DCM, 2 h, 94%; c) 62, XynAE265G, rt, NaxHxPO4 buffer, 16 h; d) 1 M HCl, 
rt, 30 min, 78% over 2 steps; e) NEt3, DCM, 1 h, 72%; f) TMSOTf, DCM, BB 67, 72% g) NaOMe, 
MeOH/DCM, 16 h, 90%; h) 62, XynAE265G, rt, NaxHxPO4 buffer, 16 h; i) 1 M HCl, rt, 30 min, 76% 





thioglycoside 70 afforded disaccharide 76. Subsequent treatment of 76 with NaOMe to
 remove the ester protecting groups gave disaccharide acceptor 63. Overnight-incubation 
of glycosyl fluoride 62 and acceptor 63 with the glycosynthase XynAE265G followed by 
acid-promoted removal of the THP protecting group gave the desired pentasaccharide 60 
in good yield. Trisaccharide acceptor 64 was obtained after glycosylation of disaccharide 
76 with perbenzoylated phosphate donor 67 and removal of the benzoyl esters in the 
resulting trisaccharide 77 using NaOMe. Enzymatic ligation of glycosyl fluoride 62 and 
acceptor 64 with the glycosynthase XynAE265G was performed as with acceptor 63. The 
thioether moiety in 60 and 61 provided a good hydrophobic handle for purification and 
permitted their later conversion into the corresponding glycosyl fluorides. 
2.2.4 Synthesis of Glycosyl Fluorides and Enzymatic 
Polymerization 
In addition to the synthesized oligosaccharides 43, 52, 53 and 61-62, -1,2-
substituted and -1,2--1,3-disubstituted arabinoxylan tetra- and pentasaccharide (78 and 
79) were procured commercially in limited amounts to serve as monomers in the 
enzymatic polymerization reaction (Figure 17). All of these oligosaccharides were 
converted into the corresponding glycosyl fluorides. 
 
Figure 17. Commercially available-1,2-substituted and -1,2--1,3-disubstituted arabinoxylan 
oligosaccharides 78 and 79. 
Transformation into the glycosyl fluorides was accomplished by the previously 
described three step procedure consisting of peracetylation, fluorination, and 
deacetylation (Scheme 31).218-222 In the case of the peracetylated derivates of 52, 53 and 
78 fluorination was performed using HF/pyridine at low temperature. Activation of the 
peracetylated oligosaccharides derived from thioglycosides 60 and 61 required the 
admixture of NIS to activate the thioether leaving group.234 A milder procedure was 
applied to oligosaccharides 43 and 79, as the usage of HF/pyridine provoked cleavage of 
the arabinofuranose. In this procedure, the hydroxyl group at the anomeric center was 
selectively deprotected using hydrazine acetate first, and the resulting hydroxyl group 
converted then with N,N’-diethylaminosulfur trifluoride (DAST) into the corresponding -




fluoride. The -fluorides were finally equilibrated into the desired -fluoride-derivates of 43 
and 79 using a small amount of HF/pyridine.235  
 
Scheme 31. Synthesis of glycosyl fluorides 48 and 80–85. Reagents and conditions: a) Ac2O, py, 
A: 42%, B: 78%; C: 90% over 2 steps, D: 94%, E: 96%; b) only C and E: I) N2H4∙AcOH, DMF, 0 °C, 
5 h, II) DAST, DCM, 0 °C, 1 h, c) NIS (for F and G only), HF/py, DCM, -30 °C → -10 °C, 2-5 h, A: 
79%, B: 89%; C: 77% over 3 steps, D: 43%, E: 44% over 3 steps, F: 53% over 2 steps, G: 52% 
over 2 steps; h) NaOMe, MeOH, 0 °C, 80: quant., 81: quant.; 48: quant., 82: quant., 83: 96%, 84: 





With the desired arabinoxylan glycosyl fluorides in hand, enzymatic polymerizations 
were performed by overnight incubation of the respective glycosyl fluoride with 
XynAE265G, and arabinoxylan polysaccharides in amounts up to 55 mg (87) were 
obtained in one batch (Scheme 32). In some cases (86, 51, and 88), precipitates of water-
insoluble polysaccharides were formed during the reactions while in the other cases the 
reaction products remained fully soluble. When precipitated polysaccharides were formed, 
they were collected by centrifugation and the remaining solution was passed through a 
short C18 cartridge to isolate the soluble polysaccharide fraction. Water-soluble 
polysaccharides were directly subjected to C18 reversed-phase chromatography. MALDI 
mass spectrometry was used to confirm the formation of polymers of the starting 
oligosaccharides. The molecular mass distribution of the products was derived from high- 
 
Scheme 32. Synthesis of artificial arabinoxylan polysaccharides by enzymatic polymerization of 
arabinoxylan oligosaccharide fluorides. The molecular mass distribution of the resulting polysac-
charides was analyzed by HPSEC chromatography using a TSK gel 3000 column and an ELSD 
detector. Chromatograms with two ELSD traces were obtained when a water-insoluble polysaccha-
ride fraction (dashed line) and a water-soluble fraction (solid line) was obtained. These fractions 
were analyzed separately. 




performance size-exclusion chromatography (HPSEC) calibrated with pullulan standards 
(Scheme 32) since it cannot be deduced from mass spectrometry experiments due to the 
size dependent molecule desorption from the MALDI matrix.236,237 The molecular weight at 
the peak maximum (MP) of the different polysaccharide products was found to range from 
4.7 kDa for the water-soluble fraction of linear xylan 86 to 29.6 kDa for the water-insoluble 
fraction of arabinoxylan 88. These values correspond to 36 (n = 18) and 224 (n = 56) 
monosaccharides, respectively. The observed differences in the degree of polymerization 
(DP) of the artificial polysaccharides are most likely a result of the substrate specificity of 
the enzyme that transfers some of the arabinoxylan oligosaccharides more efficiently than 
others. There is an inherent limitation for the maximum achievable lengths of xylan 
polysaccharides that is determined by their solubility. Thus, the Mp of the linear xylan 
polysaccharide for example did not exceed 9.2 kDa. 
In addition to the linear xylan 86, water-insoluble polysaccharide fractions were 
obtained for arabinoxylans 51 and 88, which carry the arabinofuranosyl substituents at the 
2- and 3-position of every third xylose residue, respectively. In line with this, arabinoxylans 
51 and 88 showed significant crystallinity whereas 87, 90, and 91, having differently 
spaced substituents, were completely amorphous, as qualitatively determined by powder 
X-ray diffraction (Figure 18). The specific substitution pattern of arabinoxylans 51 and 88 
might favor a stable threefold helical screw conformation, with the substituents all pointing 
in the same direction.238 Such a conformation would enable interactions between the xylan 
backbones of individual molecules, explaining the low solubility and high crystallinity of 51 
and 88. This contradicts the commonly accepted notion that solubility and crystallinity of 
xylans directly correlate with the degree of substitution.41,44 
 





2.2.5 Adsorption of Arabinoxylan Polysaccharides to a Cellulosic 
Surface 
The ability of selected polysaccharides to bind to cellulose was investigated as 
Dupree et al. have found that only glucuronoxylans having evenly spaced substituents are 
able to bind to the cellulose microfibril due to the conformational change from a two-fold to 
a three-fold helical screw.47,51,239 The prepared collection of synthetic polysaccharides 
represents ideal substrates to investigate this effect for arabinose-substituted xylans. No 
or evenly spaced arabinose substituents at the xylose backbone should enable binding to 
cellulose, whereas unevenly spaced arabinose-substitution is expected to reduce the 
ability of the respective polysaccharide to bind. The experiments were performed using a 
quartz crystal microbalance with dissipation (QCMD) by Saina Kishani and Guillermo 
Toriz Gonzalez at the Chalmers University of Technology in Göteborg (Sweden). QCMD 
is a highly sensitive mass measuring system based on the principles of piezoelectricity. 
The quartz crystal is brought into oscillation and upon deposition of a substrate the 
frequency of the oscillation changes. The frequency is monitored and can be converted to 
units of adsorbed mass by using the Sauerbrey equation.240,241 The experiments were 
performed by slowly flowing a solution containing one of the polysaccharides over a spin-
coated cellulose model surface (Figure 19a). Rinsing before and after polysaccharide 
deposition was performed to remove loosely attached material. The mass of the adsorbed 
polysaccharides was measured over time. As substrates for these experiments the three 
polysaccharides 86, 87 and 51 were chosen for the investigation of their ability to bind to 
cellulose as relatively large amounts of sample were available. In order to reduce effects 
resulting from the overall length of the polysaccharides, the soluble fractions of 86, 87 and 
51 having similar MP values were compared.  
For all three polysaccharides, a layer of material was deposited when the cellulosic 
surface was exposed to the polysaccharide-containing solution (Figure 19b, 5-25 min). As 
expected, the deposited amount of linear xylan polysaccharide 86 was the largest, since it 
has no substituents and the xylan backbone can freely interact with the cellulosic surface. 
Evenly substituted arabinoxylan 87 was adsorbed in higher amounts than unevenly 
substituted arabinoxylan 51. This difference became even more apparent after the final 
rinsing step (at 25 min) was performed. The deposited layer of 51 is almost completely 
removed, while for 86 and 87 only a small decrease in the adsorbed mass was observed. 





Figure 19. Adsorption of synthetic polysaccharides 86, 87 and 51 to a surface spin-coated with 
cellulose. (a) Schematic representation of the experiment. A solution of the polysaccharide flows 
over the cellulosic surface. (b) Adsorbed mass of the polysaccharides on a cellulosic surface 
calculated by the Sauerbrey equation. 
These results indicate that also for arabinoxylans evenly spaced substituents enable 
stronger binding to cellulose, which could be explained by a conformational change from a 
three-fold to a two-fold helical screw. The availability of artificial polysaccharides with a 
defined substitution pattern, which are not accessible by other means, allowed us to 
directly investigate this effect outside of the plant cell wall. 
2.2.6 Conclusion and Outlook 
In conclusion, the glycosynthase technology was explored for the polymerization of 
synthetic arabinoxylan oligosaccharides into artificial polysaccharides with well-defined 
branching patterns. The oligosaccharides that served as substrates for the polymerization 
reactions were initially obtained in small amounts by automated glycan assembly using a 
photolabile, traceless linker as a proof-of-principle for the glycosynthase-catalyzed 
polymerization and to investigate the substrate specificity of the glycosynthase. 





enzymatic synthesis, and successfully used in enzymatic polymerization reactions. The 
obtained polysaccharides had molecular masses up to 80 kDa (606 monosaccharides), 
which are, to the best of our knowledge, the largest polysaccharides produced by 
glycosynthase technology to date. Due to the defined nature of the polysaccharide 
branching patterns, specific properties were observed for particular members of the 
prepared arabinoxylan collection rather than the simple linear correlation between 
crystallinity and degree of substitution reported previously.44 
The ability of three polysaccharides (86, 87 and 51), having either no, evenly spaced 
or unevenly spaced substituents, to adsorb to a spin coated cellulosic surface were 
compared using QCMD.41,44,50 The results indicate that evenly spaced arabinose 
substituents enable stronger binding of the xylan polysaccharides to cellulose than 
unevenly spaced substituents. Currently, this investigation is being extended to the 
remaining four polysaccharides. Also, further physico-chemical properties of the synthetic 
polysaccharides, such as their ability to absorb water, their immunomodulatory 
properties,242 as well as their potential to serve as substrates in assays to determine the 





 Experimental Part 3
3.1 General Information 
The automated syntheses were performed on a self-built synthesizer developed in the 
Max Planck Institute of Colloids and Interfaces. Xylan-degrading enzymes were obtained 
from Megazyme International Ireland. Linker-functionalized resin 9139 and 39214 were 
prepared as reported in the literature. The resin loading was determined as described 
previously.106 Xylose BBs 1a-c,132,133 arabinose BBs 2a, 2b132 and 2c,187 4-methylphenyl 
3-O-(2-methyl)naphtyl-1-thio-β-D-xylopyranoside,132 44-Methylphenyl 4,6-di-O-
benzylidene-1-thio--D-glucopyranoside,243 and 2-(azidomethyl)benzoic anhydride244,245 
were prepared as reported in the literature. Oligosaccharides 78 (A2XX) and 79 (A2,3XX) 
were obtained from Megazyme International Ireland. Solvents and reagents were used as 
supplied without any further purification. Anhydrous solvents were taken from a dry 
solvent system (JC-Meyer Solvent Systems). Column chromatography was carried out 
using Fluka Kieselgel 60 (230-400 mesh). NMR spectra were recorded on a Varian 400-
MR (400 MHz), a Varian 600-(600 MHz) or a Bruker AVIII 700 (700 MHz) spectrometer 
using solutions of the respective compound in CDCl3 or D2O. NMR chemical shifts () are 
reported in ppm and coupling constants (J) in Hz. Spectra recorded in CDCl3 and D2O 
used the solvent residual peak chemical shifts as internal standards (CDCl3: 7.26 ppm 
1H, 
77.0 ppm 13C; D2O: 4.80 ppm 
1H). Yields of the final deprotected oligosaccharides 
obtained by automated glycan assembly were determined after removal of residual acetic 
acid. Optical rotations were measured using a UniPol L1000 Polarimeter 
(Schmidt&Haensch) with concentrations expressed as g/100 mL. IR spectra were 
recorded on a Spectrum 100 FTIR spectrophotometer (Perkin-Elmer). High resolution 
mass spectra were obtained using a 6210 ESI-TOF mass spectrometer (Agilent). 
Analytical HPLC was performed on an Agilent 1200 series coupled to a quadrupole ESI 
LC/MS 6130 using a), a YMC-Diol-300 column (150 x 4.6 mm) with linear gradients from 
90% to 40% hexane in ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, flow rate 1 mL/min), a Phenomenex Luna C5 column 
(250 x 4.6 mm) with linear gradients from 80% to 0% water in ACN (50 min, flow rate 
1 mL/min), or a Thermo Scientific Hypercarb column (150 x 4.6 mm) with linear gradients 
from 97.5% to 0% water in ACN (45 min, flow rate 0.7 mL/min) Preparative HPLC was 
performed on an Agilent 1200 series using a preparative a YMC-Diol-300 column (150 x 
20 mm), a semi-preparative Phenomenex Luna C5 column (250 x 10 mm) or a semi-
preparative Thermo Scientific Hypercarb column (150 x 10 mm). Analytical HPSEC was 





flowrate. For filtration syringe filters (RC, 0.45 m) from Roth were used. Glycosynthase 
XynAE265G163 was provided by my colleague Dr. Ruprecht. X-ray powder diffraction 
patterns were recorded using a Nanostar with an X-ray beam (68 μm in diameter; λ 
=1.542 Å). All samples were placed in sealed capillary at a relative humidity of 53% and if 
possible at 90%. The calibration of sample to detector was performed using quartz as 
standard with the software DPDAK and all patterns were corrected for empty beam 
background. 
3.2 Synthesizer Modules and Conditions 
Linker-functionalized resin 9 or 39 (12.5-33.8 μmol or 44.2 μmol of hydroxyl groups) 
were placed in the reaction vessel of the automated oligosaccharide synthesizer and 
swollen for at least 30 min in DCM. Before every synthesis the resin was washed with 
DMF, THF and DCM. Subsequently the glycosylation (Module A and B) and deprotection 
(Module D and E) steps were performed. Mixing of the components was accomplished by 
bubbling Argon through the reaction mixture.  
Module A: Glycosylation with Glycosyl Phosphates. The resin (12.5-44.2 μmol of 
hydroxyl groups) was swollen in DCM (2 mL) and the temperature of the reaction vessel 
was adjusted to -30 °C. Prior to the glycosylation reaction the resin was washed with 
TMSOTf in DCM and then DCM only. For the glycosylation reaction the DCM was drained 
and a solution of phosphate BB (1.8 equiv in 1 mL DCM) was delivered to the reaction 
vessel at -35 °C. The reaction was started by the addition of TMSOTf in DCM (1.8 equiv in 
1 mL DCM). The glycosylation was performed for 5 min at -35 °C and then for 30 minutes 
at -15 °C. Subsequently the solution was drained and the resin washed three times with 
DCM. The whole procedure was repeated once to increase conversion of the acceptor 
sites. Afterwards the resin was washed three times with DCM at 25 °C.  
Module B: Glycosylation with Thioglycosides. The resin (12.5-44.2 μmol of hy-
droxyl groups) was swollen in DCM (2 mL) and the temperature of the reaction vessel was 
adjusted to -30 °C. Prior to the glycosylation reaction the resin was washed with TMSOTf 
in DCM and then DCM only. For the glycosylation reaction the DCM was drained and a 
solution of thioglycoside BB (1.8-5 equiv in 1 mL DCM) was delivered to the reaction 
vessel. After the set temperature was reached, the reaction was started by the addition of 
NIS (4.44 equiv or 8.88 equiv) and TfOH (0.44 equiv or 0.88 equiv) in DCM/dioxane (2:1). 
The glycosylation was performed for 5 min at -40 °C or -20 °C and then for 40 min 
at -20 °C or -5 °C. Subsequently the solution was drained and the resin was washed with 
DCM. The whole procedure was repeated once to ensure full conversion of all acceptor 






Module C: Fmoc Deprotection. The resin was washed with DMF, swollen in 2 mL 
DMF and the temperature of the reaction vessel was adjusted to 25 °C. Prior to the 
deprotection reaction the DMF was drained and the resin was washed with DMF three 
times. For Fmoc deprotection 2 mL of a solution of 20% Et3N in DMF was delivered to the 
reaction vessel. After 5 min the solution was drained and the whole procedure was re-
peated another two times. After Fmoc deprotection was complete the resin was washed 
with DMF, THF and DCM. 
Module D: Nap Deprotection. The resin was washed with DCM three times and the 
temperature of the reaction vessel was adjusted to 40 °C. For Nap deprotection the DCM 
was drained and 1.5 mL of a 0.1 M DDQ solution in DCE/MeOH/H2O (64:16:1) was deliv-
ered to the reaction vessel. After 20 min the reaction solution was drained and the whole 
procedure was repeated another six times. After Nap deprotection was complete the resin 
was washed with DMF, THF and DCM. 
Module E: Azmb Deprotection. The resin was washed with THF, swollen in 
2 mL THF and the temperature of the reaction vessel was adjusted to 25 °C. Prior 
to the deprotection step the THF was drained and the resin was washed with THF 
three times. For Azmb deprotection, 2 mL of a solution of PBu3 (7.5 or 15 equiv.) in 
THF containing 5% H2O was delivered to the reaction vessel at 45 °C. After 30 min 
the solution was drained and the whole procedure was repeated another five times. 
After Azmb deprotection was complete the resin was washed with THF and DCM.  
Module F: Acetylation. The temperature of the reaction vessel was adjusted to 
25 °C and the resin washed with pyridine (2 mL) three times. For capping, 1 mL pyridine 
and 1 mL acetic anhydride were delivered to the reaction vessel. After 30 min the reaction 
solution was drained and the whole procedure was repeated another two times. After cap-
ping was complete the resin was washed with pyridine and DCM. 
Module G: Benzoylation. The temperature was adjusted to 25 °C and the resin 
washed with pyridine (2 mL) three times. For benzoylation temperature was set to 40 °C 
and 2 mL pyridine and 1 mL of a solution containing 0.5 M benzoic anhydride and 0.25 M 
DMAP in DCE were delivered to the reaction vessel. After 30 min the reaction solution 
was drained and the whole procedure was repeated another two times. After capping was 
complete the resin was washed with DCM. 
Cleavage from the solid support. After assembly of the oligosaccharides, cleavage 
from the solid support was accomplished by modification of a previously published proto-
col,106 using the Vapourtec E-Series UV-150 photoreactor Flow Chemistry System. The 





The resin, suspended in DCM, was loaded into a plastic syringe. The suspension was 
then pumped using a syringe pump (PHD2000, Harvard Aparatus) at 1 mL/min through a 
10 mL reactor, constructed of 1/8 inch o.d. FEP tubing. The total volume within the photo-
reactor was 9 mL. The temperature of the photoreactor was maintained at 20 °C and the 
lamp power was 80%. The exiting flow was deposited in a 10 mL syringe containing a 
filter, with a collection flask beneath the syringe. 
3.3 Automated Glycan Assembly of Arabino- and 
Glucuronoxylan Oligosaccharides 




4-Methylphenyl 3-O-(2-methyl)naphtyl-1-thio-β-D-xylopyranoside 7b (1.50 g, 
3.78 mmol), Yb(OTf)3 (470 mg, 760 mol) and 2-(azidomethyl)benzoic anhydride (1.78 g, 
5.30 mmol) were dissolved in dioxane (30 mL) and stirred for 2 d. The reaction was 
quenched with MeOH (10 mL) and the solvent was evaporated. The crude product was 
purified by column chromatography (SiO2, EtOAc/hex = 9:1 to 6:1) to give 4-methylphenyl 
2-O-(azidomethyl)benzoyl-3-O-(2-methyl)naphtyl-4-O-fluorenylcarbox-ymethyl-1-thio-β-D-
xylopyranoside 7d (933 mg, 1.68 mmol, 44%) as a colorless solid. [𝛼]25
𝐷  = -7.6 (c 1.0, 
CHCl3). 1H NMR (400 MHz, CDCl3): δ = 8.06-7.91 (m, 1H, ArH), 7.82-7.70 (m, 4H, ArH), 
7.62-7.53 (m, 1H, ArH), 7.53-7.32 (m, 7H, ArH), 7.16-7.06 (m, 2H, ArH), 5.35 (t, J = 6.6 
Hz, 1H, H-2), 5.00 (d, J = 6.6 Hz, 1H, H-1), 4.95 (d, J = 11.9 Hz, 1H, CH2N3), 4.83 (d, J = 
11.9 Hz, 1H, CH2N3), 4.79 (d, J = 14.7 Hz, 1H, CH2Ar), 4.70 (d, J = 14.6 Hz, 1H, CH2Ar), 
4.41 (dd, J = 11.8, 4.0 Hz, 1H, H-5a), 3.85 (td, J = 6.9, 3.9 Hz, 1H, H-4), 3.74 (t, J = 6.6 
Hz, 1H, H-3), 3.49 (dd, J = 11.8, 7.1 Hz, 1H, H-6b), 2.33 (d, J = 3.0 Hz, 3H, CH3) ppm. 
13C 
NMR (101 MHz, CDCl3): δ = 165.0 (C=O), 138.1, 137.6, 134.9, 133.1, 133.0, 132.7, 
131.0, 129.8, 129.7, 128.4, 128.2, 128.1, 127.9, 127.7, 126.8, 126.2, 126.0, 125.6 (15 C, 
Ar), 87.1 (C-1), 80.0 (C-3), 73.9 (CH2N3), 71.4 (C-2), 68.7 (C-4), 66.4 (C-5), 52.9 (CH2Ar), 
21.1 (CH3) ppm. ESI-HRMS: m/z = [M+Na]
+ calcd. for C31H29N3NaO5S: 578.1726; found: 










boxyme-thyl-1-thio-β-D-xylopyranoside 7d (902 mg, 1.62 mmol) was dissolved in DCM 
(15 mL) and pyridine (15 mL) and FmocCl (504 mg, 1.94 mmol) were added. After stirring 
the reaction mixture for 2 h water was added and the phases were separated. The organic 
phase was washed with 10% HCl (50 mL) and brine (50 mL), and the combined organic 
phases were dried with Na2SO4. Column chromatography (SiO2, EtOAc/hex = 1:8 to 1:5) 
gave 4-methylphenyl 2-O-(azidomethyl)benzoyl-3-O-(2-methyl)naphtyl-4-O-fluorenyl-
carboxymethyl-1-thio-β-D-xylopyranoside 8d (862 mg, 1.11 mmol, 68%) as a colorless 
solid. [𝛼]25
𝐷  = -19.5 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 8.09-8.05 (m, 1H, ArH), 
7.76-7.71 (m, 6H, ArH), 7.52-7.34 (m, 6H, ArH), 7.29-7.19 (m, 4H, ArH), 7.11 (m, 3H, Ar 
ArH 5.37 (t, J = 5.6, 1H, H-2), 5.12 (d, J = 5.5 Hz, 1H, H-1), 4.91-4.82 (m, 3H, CH2-Ar, H-
4), 4.75 (s, 2H, CH2-Ar), 4.56 (dd, J = 12.4, 3.7 Hz, 1H, H-5a), 4.38 (dd, J = 7.1, 2.5 Hz, 
2H, Fmoc-CH2), 4.15 (t, J = 7.1 Hz, 1H, Fmoc-CH), 3.93 (t, J = 5.9 Hz, 1H, H-3), 3.67 (dd, 
J = 12.4, 5.8 Hz, 1H, H-5b), 2.32 (s, 3H, CH3) ppm. 
13C NMR (101 MHz, CDCl3): δ = 165.0 
(C=O), 154.3 (C=O), 143.1, 143.0, 141.2, 138.1, 137.8, 134.6, 133.1, 133.0, 132.6, 131.5, 
129.7, 129.5, 128.2, 128.0, 127.9, 127.6, 127.1, 126.8, 126.1, 126.0, 125.7, 125.0, 125.0, 
120.1 (Ar), 86.3 (C-1), 75.6 (C-4), 73.5 (CH2-Ar), 73.0 (C-4), 70.2 (C-2), 70.0 (Fmoc-CH2), 
62.4 (C-5), 52.9 (CH2-Ar), 46.7 (Fmoc-CH), 21.1 (CH3) ppm. ESI-HRMS: m/z [M+Na]
+ 





To a suspension of 1 g dried and powdered molecular sieves in DCM (10 mL) was 
added dibutyl phosphate (0.320 mL, 1.61 mmol) and the mixture was stirred for 30 min. 
The supernatant of this mixture was added to a solution of 4-methylphenyl 2-O-
(azidomethyl)benzoyl-3-O-(2-methyl)naphtyl-4-O-fluorenylcarboxy-methyl-1-thio-β-D-xylo-





Iodopyrrolidine-2,5-dione (174 mg, 0.770 mmol) and TfOH (20.0 L, 0.190 mmol) were 
added and the mixture was stirred for 90 min. The mixture was quenched with aq. sat. 
NaHCO3 solution (20 mL) and washed with aq. sat. Na2S2O3 solution (20 mL). The organic 
phase was separated and dried with Na2SO4. The residue was subjected to column 
chromatography (SiO2, EtOAc/hex=1:8) and dibutoxyphosphoryloxy 2-O-
(azidomethyl)benzoyl-3-O-(2-methyl)naphtyl-4-O-fluorenylcarboxymethyl-β-D-xylopyra-
noside 1d (350 mg, 410 mol, 63%, α/β ~ 1:13) was obtained as a colorless oil. 1H NMR 
(400 MHz, CDCl3, -anomer): δ = 8.05-8.02, 7.77-7.67, 7.66-7.61, 7.57-7.19 (m, 19H, 
ArH), 5.54 (dd, J = 6.9, 4.8 Hz, 1H, H-1), 5.33 (dd, J = 6.1, 4.8 Hz, 1H, H-2), 4.95-4.76 (m, 
3H, H-4, CH2Ar), 4.76-4.68 (m, 2H, CH2N3), 4.41-4.32 (m, 3H, H-5a, Fmoc-CH2), 4.16 (t, J 
= 7.1 Hz, 1H, Fmoc-CH), 4.08-4.00 (m, 2H, OBu), 3.93 (d, J = 12.7 Hz, 1H, H-3), 3.92-
3.75 (m, 2H, OBu), 3.71 (dd, J = 12.5, 6.0 Hz, 1H, H-5b), 1.65-1.58 (m, 2H, Bu), 1.45-1.30 
(m, 4H, Bu), 1.15 (h, J = 7.5 Hz, 2H, Bu), 0.89 (t, J = 7.4 Hz, 3H, CH3), 0.74 (t, J = 7.4 Hz, 
3H, CH3) ppm. 
13C NMR (101 MHz, CDCl3, -anomer): δ = 164.7 (C=O), 154.2 (C=O), 
143.1, 143.0, 141.3, 138.0, 134.6, 133.3, 133.1, 133.0, 131.5, 129.5, 128.2, 128.1, 127.9, 
127.9, 127.6, 127.3, 127.2, 127.2, 126.8, 126.1, 126.0, 125.6, 125.0, 125.0, 120.1 (28 C, 
Ar), 95.9 (C-1), 74.9 (C3-), 73.4 (CH2-Nap), 72.7 (C-4), 70.1 (Fmoc), 69.5 (C-2), 67.9 (2C, 
OBu), 61.1 (C-5), 52.9 (CH2-N3), 46.6 (Fmoc), 32.0, 31.9, 18.6, 18.4 (4C, Bu), 13.5, 13.4 
(2C, CH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for C47H50N3NaO11P: 886.3081; found: 












Linker-functionalized resin 9 (52.0 mg, 16.9 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module E: 15 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 2a, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected tetrasaccharide. 






The protected tetrasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected tetrasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated to provide the 
fully deprotected tetrasaccharide 10 (1.4 mg, 2.19 µmol, 13% over 11 steps, based on 
resin loading). 1H NMR (600 MHz, D2O): δ = 5.21 (s, 1H), 4.51 (d, J = 7.4 Hz, 1H), 4.39 (d, 
J = 7.8 Hz, 1H), 4.34 (d, J = 7.9 Hz, 1H), 4.11-4.08 (m, 1H), 4.08-4.01 (m, 3H), 3.92-3.86 
(m, 2H), 3.82-3.78 (m, 1H), 3.77-3.73 (m, 2H), 3.72-3.67 (m, 1H), 3.66-3.58 (m, 3H), 3.57-
3.53 (m, 1H), 3.49 (t, J = 9.2 Hz, 1H), 3.39-3.31 (m, 4H), 3.25-3.17 (m, 3H), 2.93 (t, J = 
7.5 Hz, 2H), 1.65-1.55 (m, 4H), 1.40-1.34 (m, 2H) ppm. 13C NMR (151 MHz, D2O): δ = 
108.5, 102.8, 101.9, 100.1, 84.5, 80.9, 79.0, 76.6, 76.4, 76.0, 75.6, 73.9, 73.7, 72.9, 72.8, 
70.1, 69.2, 65.2, 62.9, 62.8, 61.3, 39.3, 28.2, 26.4, 22.1 ppm. ESI-HRMS: m/z = [M+H]+ 
calcd. for C25H46NO17+: 632.2760, found 632.2804.  









Linker-functionalized resin 9 (52.0 mg, 16.9 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module E: 15 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 2a, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected tetrasaccharide. 






The protected tetrasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected tetrasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated to provide the 
fully deprotected tetrasaccharide 11 (4.4 mg, 6.92 µmol, 41% over 11 steps, based on 
resin loading). 1H NMR (600 MHz, D2O): δ = 5.29 (s, 1H), 4.57 (d, J = 7.5 Hz, 1H), 4.48 (d, 
J = 7.8 Hz, 1H), 4.43 (d, J = 7.8 Hz, 1H), 4.21-4.04 (m, 4H), 4.02-3.51 (m, 12H), 3.46-3.36 
(m, 3H), 3.35-3.25 (m, 3H), 3.02 (s, 2H), 1.76-1.62 (m, 4H), 1.52-1.41 (m, 2H) ppm. 13C 
NMR (151 MHz, D2O): δ = 111.1, 105.4, 104.3, 102.9, 87.2, 83.6, 80.7, 79.3, 79.0, 78.7, 
78.3, 76.5, 76.3, 75.5, 75.3, 72.7, 71.7, 67.6, 65.6, 65.5, 63.9, 42.0, 30.8, 29.0, 24.7 ppm. 
ESI-HRMS: m/z = [M+H]+ calcd. for C25H46NO17: 632.2766; found: 632.2770.  











Linker-functionalized resin 9 (104 mg, 33.8 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module E: 15 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 2a, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 





preparative YMC diol column gave the protected heptasaccharide. 
Crude NP-HPLC (ELSD trace): 
 
The protected heptasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected heptasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated to provide the 
fully deprotected heptasaccharide 12 (2.6 mg, 2.48 µmol, 7% over 17 steps, based on 
resin loading). 1H NMR (600 MHz, D2O): δ = 5.30 (t, J = 0.9 Hz, 1H), 4.60 (d, J = 7.4 Hz, 
1H), 4.52-4.46 (m, 4H), 4.43 (d, J = 7.9 Hz, 1H), 4.18 (dd, J = 2.9, 1.3 Hz, 1H), 4.17-4.07 
(m, 7H), 4.01-3.95 (m, 2H), 3.92-3.61 (m, 13H), 3.60-3.54 (m, 4H), 3.49-3.36 (m, 7H), 
3.35-3.25 (m, 6H), 3.01 (t, J = 7.6 Hz, 2H), 1.73-1.64 (m, 4H), 1.46 (p, J = 7.8 Hz, 2H) 
ppm. 13C NMR (151 MHz, D2O): δ = 111.0, 105.4, 104.4, 104.3, 104.3, 104.2, 102.6, 87.2, 
83.6, 80.5, 79.3, 79.0 (2C), 78.9 (2C), 78.6, 78.2, 76.4, 76.3, 76.2 (2C), 75.6, 75.4, 75.3 
(2C), 72.8, 71.8, 71.1, 67.8, 65.6, 65.5 (2C), 65.4, 63.9, 42.0, 30.8, 29.1, 25.9, 24.7, 22.6 
ppm. ESI-HRMS: m/z = [M+Na]+ calcd. for C40H70NO29: 1028.4034; found 1028.4050.  










Linker-functionalized resin 9 (104 mg, 33.8 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 





Module E: 15 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected heptasaccharide. 
Crude NP-HPLC (ELSD trace): 
 
The protected heptasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected heptasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated to provide the 
fully deprotected heptasaccharide 13 (3.8 mg, 3.69 µmol, 11% over 16 steps, based on 
resin loading). 1H NMR (600 MHz, D2O): δ = 4.68-4.62 (m, 2H), 4.52-4.46 (m, 4H), 4.43 
(d, J = 7.9 Hz, 1H), 4.17-4.06 (m, 5H), 4.01-3.95 (m, 2H), 3.92-3.74 (m, 7H), 3.72-3.51 (m, 
8H), 3.50-3.24 (m, 15H), 3.05-2.98 (m, 2H), 1.73-1.64 (m, 4H), 1.50-1.43 (m, 2H) ppm. 13C 
NMR (151 MHz, D2O): δ = 106.3, 105.4, 104.4, 104.3 (2C), 104.2, 102.7, 82.9, 78.9 (3C), 
78.8, 78.2, 78.0, 76.4, 76.3, 76.2 (3C), 75.7, 75.6, 75.4, 75.3 (2C), 72.7, 71.8, 67.8, 67.8, 
65.6, 65.5 (2C), 65.0, 41.9, 30.8, 29.0, 24.7 ppm. ESI-HRMS: m/z [M+H]+ calcd. for 
C40H70NO29: 1028.4034; found: 1028.4048. 











Linker-functionalized resin 9 (104 mg, 33.8 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 





Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module E: 15 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 2a, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected heptasaccharide. 
Crude NP-HPLC (ELSD trace): 
 
The protected heptasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected heptasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated to provide the 
fully deprotected heptasaccharide 14 (1.65 mg, 1.61 µmol, 5% over 17 steps, based on 
resin loading). 1H NMR (600 MHz, D2O): 5.22 (s, 1H), 4.49 (d, J = 7.6 Hz, 1H), 4.42 (d, J = 
7.7 Hz, 4H), 4.35 (d, J = 7.8 Hz, 1H), 4.12 – 3.99 (m, 6H), 3.92 (dd, J = 11.7, 5.4 Hz, 1H), 
3.88 (dd, J = 5.8, 2.9 Hz, 1H), 3.84 – 3.79 (m, 1H), 3.78 – 3.68 (m, 6H), 3.67 – 3.57 (m, 
4H), 3.53 – 3.45 (m, 6H), 3.38 – 3.29 (m, 6H), 3.27 – 3.19 (m, 6H), 2.94 (t, J = 7.6 Hz, 
2H), 1.61 (dp, J = 21.2, 7.2, 6.8 Hz, 4H), 1.38 (p, J = 7.9 Hz, 2H) ppm. 13C NMR (151 
MHz, D2O): δ = 108.4, 102.7, 101.6, 101.6, 100.2, 84.5, 80.9, 78.1, 76.6, 76.3, 76.2, 76.0, 
75.6, 73.8, 73.7, 73.6, 72.9, 72.6, 70.1, 69.0, 64.9, 63.0, 62.9, 62.8, 61.2, 39.3, 28.1, 26.3 





RP-HPLC of the deprotected heptasaccharide (ELSD trace): 
 
Aminopentyl β-D-xylopyranosyl-(1→4)-2-O-[α-L-arabinofuranosyl]-3-O-[α-L-arabino-
furanosyl] β-D-xylopyranosyl-(1→4)-β-D-xylopyranoside (15)  
 
Linker-functionalized resin 9 (104 mg, 33.8 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1d, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module E: 15 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 2a, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module D: DDQ, DCE/MeOH/H2O (64:16:1), 7 x 30 min, 40 °C 
Module B: 2 x 1.8 equiv 2a, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 





Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected pentasaccharide. 
Crude NP-HPLC (ELSD trace): 
 
The protected pentasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 1.00 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected pentasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated. After 
purification by preparative HPLC using a Hypercarb column fully deprotected 
pentasaccharide 15 (1.1 mg, 1.45 µmol, 4% over 13 steps, based on resin loading) was 
obtained. 1H NMR (700 MHz, D2O): δ = 5.14 (s, 1H), 5.09 (s, 1H), 4.50 (d, J = 7.2 Hz, 1H), 
4.29 (dd, J = 17.5, 7.9 Hz, 2H), 4.18 (d, J = 4.7 Hz, 1H), 4.06-3.95 (m, 5H), 3.86-3.39 (m, 
16H), 3.29 (t, J = 9.5 Hz, 3H), 3.13 (q, J = 11.0, 9.4 Hz, 3H), 2.84 (q, J = 7.1 Hz, 1H), 
1.58-1.46 (m, 4H), 1.37-1.26 (m, 2H) ppm. 13C NMR (176 MHz, D2O): δ = 111.3, 110.7, 
105.4, 104.0, 103.9, 102.5, 87.0, 83.8, 83.6, 83.3, 81.2, 80.1, 79.8, 79.2, 78.4, 78.2, 76.5, 
76.3, 75.6, 72.7, 71.8, 67.7, 65.5, 65.1, 63.8, 63.7, 41.9, 30.8, 29.0, 24.7 ppm. ESI-HRMS: 
m/z = [M+H]+ calcd. for C30H54NO21
+: 764.3188; found 764.3169. 










Linker-functionalized resin 9 (104 mg, 33.8 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1b, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  





Module F: Ac2O, pyridine, 30 min 
Module D: DDQ, DCE/MeOH/H2O (64:16:1), 7 x 30 min, 40 °C 
Module B: 2 x 1.8 equiv 2a, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected hexasaccharide. 
Crude NP-HPLC (ELSD trace): 
 
The protected Hexasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 1.00 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected hexasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated to provide the 
fully deprotected hexasaccharide 16 (15.5 mg, 17.3 µmol, 17% over 17 steps, based on 
resin loading). 1H NMR (600 MHz, D2O): δ = 5.56 (s, 1H), 4.57 (d, J = 7.9 Hz, 1H), 4.52 (d, 
J = 7.7 Hz, 1H), 4.49 (d, J = 7.7 Hz, 1H), 4.45 (d, J = 7.8 Hz, 1H), 4.43 (d, J = 7.9 Hz, 1H), 
4.31 (td, J = 5.5, 3.6 Hz, 1H), 4.29 – 4.26 (m, 1H), 4.16-4.05 (m, 4H), 3.98 (dd, J = 11.6, 
5.5 Hz, 1H), 3.95-3.53 (m, 13H), 3.50-3.21 (m, 12H), 3.02 (t, J = 7.6 Hz, 2H), 1.75-1.62 
(m, 4H), 1.50-1.40 (m, 2H) ppm. 13C NMR (151 MHz, D2O): δ = 109.0, 105.4, 105.2, 
104.3, 104.2, 104.0, 91.3, 86.6, 80.1, 79.0, 78.9, 78.3, 78.2, 78.1, 76.5, 76.2, 76.2, 75.8, 
75.6, 75.6, 75.4, 75.3, 72.7, 71.8, 71.7, 67.9, 67.7, 65.6, 65.5, 65.4, 63.5, 41.9, 30.8, 29.0, 
24.7 ppm. ESI-HRMS: m/z [M+H]+ calcd. for C35H62NO25: 896.3611; found: 896.3641. 










Linker-functionalized resin 9 (104 mg, 33.8 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1b, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module D: DDQ, DCE/MeOH/H2O (64:16:1), 7 x 30 min, 40 °C 





Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module B: 2 x 1.8 equiv 2a, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected octasaccharide. 
Crude NP-HPLC (ELSD trace): 
 
The protected octasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 1.00 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected octasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated to provide the 
fully deprotected octasaccharide 17 (2.4 mg, 2.07 µmol, 8% over 15 steps, based on resin 
loading). 1H NMR (600 MHz, D2O):  = 5.17 (s, 1H), 5.02 (s, 2H), 5.01 (s, 1H), 4.99 (s, 
1H), 4.38 (d, J = 7.7 Hz, 1H), 4.34 (d, J = 7.7 Hz, 1H), 4.31 (d, J = 7.7 Hz, 1H), 4.28 (d, J 
= 7.2 Hz, 4H), 4.20 – 4.18 (m, 1H), 4.13 – 4.08 (m, 2H), 4.03 – 3.92 (m, 7H), 3.91 – 3.87 
(m, 4H), 3.82 – 3.79 (m, 2H), 3.76 – 3.52 (m, 20H), 3.42 (t, J = 9.2 Hz, 2H), 3.38 (t, J = 9.2 
Hz, 1H), 3.32 – 3.21 (m, 5H), 3.20 – 3.10 (m, 5H), 2.87 (t, J = 7.6 Hz, 2H), 1.58 – 1.49 (m, 
4H), 1.31 (p, J = 7.8 Hz, 2H) ppm. 13C NMR (151 MHz, D2O):  = 110.8, 109.8, 109.6, 
108.3, 105.4, 104.2, 104.2, 103.7, 86.7, 86.3, 85.6, 85.2, 84.9, 84.7, 84.0, 83.7, 82.7, 
82.2, 81.2, 79.1, 78.9, 76.6, 76.4, 76.3, 76.2, 75.8, 75.5, 75.3, 72.7, 65.5, 65.5, 65.2, 63.8, 
63.7, 63.5, 63.1, 41.9, 30.8, 29.0, 24.7 ppm. ESI-HRMS: m/z [M+H]+ calcd. for 
C45H78NO33
+: 1160.4462; found: 1160.4506. 










4-Methylphenyl 4,6-di-O-benzylidene-1-thio--D-glucopyranoside (6.03 g, 16.1 mmol) 
was dissolved in DMF (25 mL) and cooled to 0 °C. Sodium hydride (1.55 g, 64.4 mmol, 
60% in mineral oil) was added slowly. After the mixture was stirred for 10 min, benzyl 
bromide (11.0 g, 64.4 mmoL) was added dropwise. The reaction mixture was stirred for 
2 h at 0 °C until the starting material was fully consumed. Then, aq. sat. NH4Cl solution 
was added until pH 7 was reached. The aqueous layer was extracted with EtOAc (3 x 
50 mL). The combined organic layers were washed with aq. sat. NH
4
Cl solution (40 mL), 
H
2
O (40 mL) and brine (40 mL). The organic phase was dried with Na2SO4 and the 
residue was submitted to column chromatography (SiO2, EtOAc/hex = 1:4) to afford 4-
methylphenyl 2,3-di-O-benzyl-4,6-di-O-benzylidene-1-thio--D-glucopyranoside 20 (6.65 
g, 12.0 mmol, 74%) as a colorless solid. 1H NMR (400 MHz, CDCl3):  = 7.50-7.23 (m, 17 
H, Ar), 7.13-7.09 (m, 2H, Ar), 5.58 (s, 1H, PhCH) 4.76-4.95 (m, 4H, CH2Ar), 4.69 (d, J = 
9.7, 1H, H-1), 4.38 (dd, J = 4.9, 10.4 Hz, 1H, H-6a), 3.86-3.76 (m, 2H, H-3, H-6b), 3.68 (t, 
J = 9.1 Hz, 1H, H-4), 3.53-3.39 (m, 2H, H-2, H-5), 2.34 (s, 3H, CH3) ppm. The analytical 
data is in agreement with literature data.243 
4-Methylphenyl 2,3-di-O-benzyl-1-thio--D-glucopyranoside (21) 
 
To a solution of 4-methylphenyl 2,3-di-O-benzyl-4,6-di-O-benzylidene-1-thio--D-
glucopyranoside 20 (6.65 g, 12.0 mmol) in DCM (25 mL) was added an aqueous solution 





aq. sat. NaHCO3 solution (50 mL) and extracted with DCM (2 x 50 mL). The organic layer 
was washed with brine (25 ml) and dried over Na2SO4. The organic layer was 
concentrated under reduced pressure to afford 4-methylphenyl 2,3-di-O-benzyl-1-thio--D-
glucopyranoside 21 (5.58 g, 12.0 mmol, quant.) as a colorless solid. [𝛼]25
𝐷  = +2.4 (c 0.7, 
CHCl3).
1H NMR (400 MHz, CDCl3): δ = 7.44-7.29 (m, 12H, ArH), 7.15-7.09 (m, 2H, ArH), 
4.97 (dd, J = 10.9, 3.6 Hz, 2H, CH2Ar), 4.75 (d, J = 10.2 Hz, 1H, CH2Ar), 4.70 (d, J = 11.5 
Hz, 1H, CH2Ar), 4.66 (d, J = 9.2 Hz, 1H, H-1), 3.87 (dd, J = 11.8, 3.5 Hz, 1H, H-6a), 3.74 
(dd, J = 11.8, 5.4 Hz, 1H, H-6b), 3.54 (t, J = 8.8 Hz, 1H, H-3), 3.49 (t, J = 8.3 Hz, 1H, H-4), 
3.44 (t, J = 8.5 Hz, 1H, H-2), 3.43-3.30 (m, 1H, H-5), 2.32 (s, 3H, CH3), 2.00 (br, 2H, OH) 
ppm. 13C NMR (100 MHz, CDCl3):  = 138.2, 138.0, 137.8, 132.5, 129.8, 129.4, 128.7, 
128.5, 128.3, 128.1, 128.0, 127.9 (18C, Ar-C), 88.0 (C-1), 86.0 (C-4), 80.8 (C-2), 79,0 (C-
5), 75.4 (CH2Ar), 70.4 (C-3), 62.7 (C-6), 21.1 (CH3) ppm. ESI-HRMS: m/z [M+Na]+ calcd. 
for C27H30O5SNa: 489.1712; found: 489.1711. IR (neat): max = 3408, 2871, 1454, 1355, 




A solution of 4-methylphenyl 2,3-di-O-benzyl-1-thio--D-glucopyranoside 21 (5.58 g, 
12.0 mmol) and TBDMSCl (1.80 g, 12.0 mmol) in DMF (20 mL) was cooled to 0 °C and 
imidazole (1.58 g, 23.2 mmol) was added. The reaction mixture was stirred at r.t. for 1 h. 
The reaction was quenched by the addition of water (25 mL) and the mixture was 
extracted with EtOAc (3 x 50 mL). The combined organic phases were washed with 1 M 
HCl (25 mL), water (25 mL) and brine (25 mL). The organic phase was dried over MgSO4, 
filtered and concentrated to give 4-methylphenyl 2,3-di-O-benzyl-6-O-
tertbutyldimethylsilyl-1-thio--D-glucopyranoside 22 (6.64 g, 11.4 mmol, 96%) as a 
colorless solid. [𝛼]25
𝐷  = +1.6 (c 0.8, CHCl3). 
1H NMR (400 MHz, CDCl3):  = 7.41-7.09 (m, 
14H, Ar), 4.94 (dd, J = 10.8, 3.3 Hz, 2H, CH2Ar), 4.72 (t, J = 10.9 Hz, 2H, CH2Ar), 4.64 (d, 
J = 9.4, 1H, H-1), 3.85 (dd, J = 11.3, 3.4 Hz, 1H, H-6a), 3.73 (dd, J = 11.9, 5.3 Hz, 1H, H-
6b), 3.56 (t, J= 9.1 Hz, 1H, H-3), 3.50 (t, J= 8.4 Hz, 1H, H-3), 3.46 (t, J = 9.3 Hz, 1H, H-4), 
3.34 (dt, J = 9.8, 5.0 Hz, 1H, H-5), 2.32 (s, 3H, CH3), 0.90 (s, 9H, Si(CH3)3), 0.08 (s, J = 
2.3, 6H, SiCH3) ppm. 
13C NMR (100 MHz, CDCl3):  = 138.3, 138.0, 137.9, 132.5, 129.8, 
129.5, 128.7, 128.5, 128.3, 128.1, 128.0, 127.9 (18 C, Ar), 88.0 (C-1), 86.0 (C-3), 80.8 (C-
4), 79,0 (C-5), 75.4 (C-2), 75.4 (C-6), 70.4 (CH2Ar), 62.7 (CH2Ar), 25.6 (Si(CH3)3), 21.1 










To a solution of 4-methylphenyl 2,3-di-O-benzyl-6-O-tertbutyldimethylsilyl-1-thio--D-
glucopyranoside 22 (6.64 g, 11.4 mmol) in DMF (25 mL) was added sodium hydride 
(550 mg, 22.8 mmol, 60% in mineral oil). The mixture was stirred for 10 min at 0 °C and 
CH3I (1.40 mL, 22.9 mmol) was added dropwise. After stirring the reaction mixture for 2 h 
at 0 °C aq. sat. NaHCO3 solution (50 mL) was added. The mixture was extracted with 
EtOAc (2 x 50 mL). The organic layer was washed with brine (50 mL) and dried over 
Na2SO4. The solution was filtered, and the solvent was evaporated. The crude product 
was submitted to column chromatography (SiO2, hex/EtOAc = 4:1) to afford 4-
methylphenyl 2,3-di-O-benzyl-4-O-methyl-6-O-tert-butyldimethylsilyl-1-thio--D-
glucopyranoside 23 (6.33 g, 10.6 mmol, 93%) as a colorless solid. [𝛼]25
𝐷  = +27.3 (c 1.0, 
CHCl3). 
1H NMR (400 MHz. CDCl3):  = 7.51-7.47 (m, 2H, Ar), 7.30-7.43 (m, 10H, Ar), 
7.10-7.07 (m, 2H, Ar), 4.92-4.74 (m, 3H, CH2Ar), 4.69 (d, J = 10.3 Hz, 1H, CH2Ar), 4.55 (d, 
J = 9.7, 1H, H-1), 3.93-3.80 (m, 2H, H-6), 3.58 (m, 4H, H-2, O-CH3), 3.41 (d, J = 9.2 Hz, 
1H, H-3), 3.35 (d, J = 9.4 Hz, 1H, H-4), 3.23-3.17 (m, 1H, H-5), 2.33 (s, 3H, CH3), 0.94 (s, 
9H, C(CH3)3), 0.14 (s, 3H, Si-CH3), 0.10 (s, 3H, Si-CH3) ppm. 
13C NMR (100 MHz. CDCl3): 
 = 138.4, 138.3, 137.6, 132.7, 129.7, 129.6, 128.4, 128.4, 128.1, 128.1, 127.8, 127.8 
(18C, Ar), 87.4 (H-1), 86.8 (H-2), 80.3 (H-3), 80.0 (H-5), 79.0 (H-4), 75.9 (CH2Ar), 75.3 
(CH2Ar), 62.0 (C-6), 60.6 (O-CH3), 25.9 (C(CH3)3), 21.1 (CH3), 18.3 (C(CH3)3), -5.1 (Si-
CH3i), -5.4 (Si-CH3) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C34H46O5SSiNa: 617.2733; 
found: 617.2704. IR (neat): max = 2928, 1494, 1455, 1253, 1151 cm
-1. 
4-Methylphenyl 2,3-di-O-benzyl-4-O-methyl-1-thio--D-glucopyranoside (24) 
 
To a solution of 4-methylphenyl 2,3-di-O-benzyl-4-O-methyl-6-O-tert-butyldime-
thylsilyl-1-thio--D-glucopyranoside 23 (6.33 g, 10.6 mmol) in THF (20 mL) was added 
TBAF (4.48 g, 17.2 mmol) and the mixture was stirred at r.t. for 3 h. Then the reaction was 
quenched by the addition of brine (50 mL) and extracted with EtOAc (3 x 50 mL). The 
combined organic layers were washed with brine (50 mL) and dried over Na2SO4. After 





chromatography (SiO2, hex/EtOAc = 4:1) to give 4-methylphenyl 2,3-di-O-benzyl-4-O-
methyl-1-thio--D-glucopyranoside 24 (4.85 g, 10.1 mmol, 95%) as a colorless solid. [𝜶]𝟐𝟓
𝑫  
= +18.8 (c 0.6, CHCl3). 
1H NMR (400 MHz, CDCl3):  = 7.45-7.28 (12H, Ar), 7.13-7.10 (m, 
2H, Ar), 4.91-4.81 (m, 3H, CH2Ar), 4.75 (d, J = 10.2 Hz, 1H, CH2Ar), 4.60 (d, J = 9.8 Hz, 
1H, H-1), 3.87 (dd, J = 12.6, 3.9 Hz 1H, H-6a), 3.72 (dd, J = 3.7, 11.7 Hz, 1H, H-6b), 3.59 
(t, J = 8.6 Hz, 1H, H-3), 3.53 (s, 3H, O-CH3), 3.39 (t, J = 9.1, 1H, H-2), 3.30-3.22 (m, 2H, 
H-4, H-5), 2.32 (s, 3H, CH3) ppm. 
13C NMR (100 MHz, CDCl3):  = 138.3, 138.0, 137.9, 
132.7, 129.8, 129.3, 128.4, 128.4, 128.2, 127.9, 127.9, 127.7 (18C, Ar), 87.7 (C-1), 86.4 
(C-3), 80.8 (C-2), 79.7 (C-5), 79.2 (C-4), 75.7 (CH2Ar), 75.5 (CH2Ar), 62.1 (C-6), 60.8 (O-
CH3), 21.1 (CH3) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C28H32O5SNa: 503.1868; found: 





To a solution of compound 24 (595 mg, 1.24 mmol) in DCM (2.00 mL) was added 
levulinic acid (432 mg, 372 mmol) at 0 °C. DCC (511 mg, 2.48 mmol) and DMAP (160 mg, 
1.24 mmol) were added. The resulting mixture was stirred at r.t. overnight. The reaction 
mixture was filtered through a plug of silica in EtOAc and the solvents were evaporated. 
Column chromatography (SiO2, hex/EtOAc = 6:1) afforded 4-methylphenyl 2,3-di-O-
benzyl-4-O-methyl-6-O-levulinoyl-1-thio-β-D-xylopyranoside 18a as a colorless solid 
(356 mg, 0.611 mmol, 50%). [𝜶]𝟐𝟓
𝑫  = +2.44 (c 0.7, CHCl3). 
1H NMR (400 MHz):  = 7.44 
(d, J= 7.4 Hz, 2H, ArH), 7.29-7.42 (m, 10H, ArH), 7.10 (d, J= 7.4 Hz, 2H, ArH), 4.72 - 4,81 
(m, 4H, CH2Ar), 4.57 (d, J = 4,6, 1H, H-1), 4.38 (dd, J = 2.0 and 11.8 Hz, 1H, H-6), 3.60 (t, 
J= 3.6 Hz 1H, H-3), 3.53 (s, 3H, OCH3), 3.44 (q, J= 3,4 Hz, 1H, H-5), 3.42 (t, J = 3.4 Hz, 
1H, H-4), 2.77 (m, 2H, H2C-C=O), 2.64 (t, J = 2.64 Hz, 1H, CH2-C(O)=O), 2.34 (s, 3H, 
CH3) and 2.20 (s, 3H, H3C-C=O) ppm. 
13C NMR (100 MHz): 206.4 (C=O), 172.5 (CO=O), 
138.2, 136.0, 132.7, 129.6, 128.4, 128.4, 128.2, 127.9, 127.9, 127.8 (18C, Ar), 87.7 (C-1), 
86.4 (C-3), 80.5 (C-2), 79.8 (C-4), 76.9 (C-5), 75.8 (CH2Ar), 75.4 (CH2Ar), 63.5 (C-6), 60.9 
(OCH3), 37,9 (H2C-C=O), 29.9 (H3C-C=O), 27.9 (H2C-C(O)=O) and 21.1 (CH3) ppm. ESI-
HRMS: m/z [M+Na]+ calcd. for C33H38O7SNa
+: 601.2236; found 601.2216. IR (neat) max 









4-Methylphenyl 2,3-di-O-benzyl-4-O-methyl-1-thio-β-D-xylopyranoside 24 (1.00 g, 
2.08 mmol) was dissolved in pyridine (10 mL). DMAP (30.0 mg, 210 mol) and acetic 
anhydride (400 l, 4.16 mmol) were added and the reaction mixtures was stirred at r.t. for 
2 h. The reaction mixture was diluted with EtOAc (10 mL) and washed with 1 M HCl 
(10 mL) and brine (10 mL). The combined organic layers were dried over Na2SO4 and the 
solvent was evaporated. Column chromatography (SiO2, EtOAc/hex = 1:15 to 1:10) gave 
4-methylphenyl 2,3-di-O-benzyl-4-O-methyl-6-O-acetyl-1-thio-β-D-xylopyranoside 18b 
(898 mg, 1.71 mmol, 83%) as a colorless solid. [𝛼]25
𝐷  = +13.6 (c 0.5, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 7.42-7.32 (m, 4H, Ar), 7.31-7.17 (m, 8H, Ar), 7.03 (m, 2H, Ar), 4.87-4.68 
(m, 3H, CH2Ar), 4.66 (d, J = 10.3 Hz, 1H, CH2Ar), 4.50 (d, J = 9.4 Hz, 1H, H-1), 4.32 (d, J 
= 11.6 Hz, 1H, H-6a), 4.16 (dd, J = 11.6, 5.8 Hz, 1H, H-6b), 3.53 (t, J = 8.9 Hz, 1H), 3.45 
(s, 3H, O=CCH3), 3.40-3.32 (m, 2H, H-2, H-6), 3.14 (t, J = 9.4 Hz, 1H), 2.26 (s, 3H, CH3), 
2.04 (s, 3H, OCH3) ppm. 
13C NMR (101 MHz, CDCl3): δ = 170.9 (C=O), 138.3, 138.1, 
138.0, 132.8, 129.7, 129.7, 128.6, 128.5, 128.3, 128.1, 128.0, 127.9 (12 Ar), 87.8 (C-1), 
86.6 (C-3), 80.7 (C-2), 80.0 (C-4), 77.0 (C-5), 75.9 (CH2Ar), 75.6 (CH2Ar), 63.5 (C-6), 61.0 
(O=CCH3), 21.2 (CH3), 21.0 (O-CH3) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for 












Linker-functionalized resin 9 (104 mg, 66.7 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module E: 40 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 18b, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected tetrasaccharide (26.0 mg, 16.7 µmol, 
25%) as a single stereoisomer. 






The protected tetrasaccharide (26.0 mg, 16.7 µmol) was dissolved in DCM/MeOH 
(2:1, 3 mL) and NaOMe (0.5 M in MeOH, 0.600 mL) was added. The reaction mixture was 
stirred overnight and subsequently neutralized by the addition of prewashed Amberlite IR-
120 (H+) resin. The resin was filtered off and the solvents were removed in vacuo. The 
crude product was purified by reversed phase HPLC using a semi-preparative C5 column 
affording the semi-protected tetrasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter the solvents were evaporated to provide the fully 
deprotected tetrasaccharide 27 (1.0 mg, 1.51 mol, 9% over 9 steps, based on resin 
loading). 1H NMR (600 MHz, D2O):  = 5.13 (d, J = 3.8 Hz, 1H), 4.51 (d, J = 7.3 Hz, 1H), 
4.33 (d, J = 7.8 Hz, 1H), 4.28 (dd, J = 7.9, 1.5 Hz, 1H), 4.02 – 3.92 (m, 3H), 3.84 (dd, J = 
11.7, 5.4 Hz, 1H), 3.78 – 3.72 (m, 1H), 3.71 – 3.61 (m, 5H), 3.58 – 3.41 (m, 7H), 3.39 (dd, 
J = 9.9, 3.8 Hz, 1H), 3.34 – 3.22 (m, 4H), 3.20 – 3.08 (m, 4H), 3.03 (t, J = 5.8 Hz, 1H), 
2.90 – 2.85 (m, 1H), 1.59 – 1.50 (m, 4H), 1.32 (p, J = 7.7 Hz, 2H) ppm. 13C NMR (176 
MHz, D2O):  = 105.4, 104.6, 100.3, 81.6, 79.4, 79.1, 78.7, 78.2, 76.5, 75.6, 75.4, 75.2, 
75.1, 74.0, 73.2, 72.8, 71.8, 67.8, 65.4, 62.6, 62.5, 47.2, 42.0, 30.8, 29.0, 24.8, 24.1 ppm. 
ESI-HRMS: m/z [M+H]+ calcd. for C27H50NO18
+: 676.3028; found: 676.2969. 









(1→4)-β-D-xylopyranosyl-(1→4) (28)  
 
Linker-functionalized resin 9 (104 mg, 33.8 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module E: 40 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 18b, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photo-
reactor afforded the crude product. Purification by normal phase HPLC using a pre-
parative YMC diol column gave the protected heptasaccharide (12.6 mg, 5.06 µmol, 15%) 
as a single stereoisomer. 






The protected heptasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 1.00 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected heptasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter (RC 0.45 m) the solvents were evaporated to provide the 
fully deprotected heptasaccharide 28 (1.82 mg, 1.70 µmol, 5% over 15 steps, based on 
resin loading). 1H NMR (600 MHz, D2O): δ = 5.15 (d, J = 3.8 Hz, 1H), 4.52 (d, J = 7.5 Hz, 
1H), 4.41 – 4.26 (m, 5H), 4.06 – 3.91 (m, 4H), 3.85 (dd, J = 11.6, 5.4 Hz, 1H), 3.80 – 3.37 
(m, 19H), 3.35 – 3.07 (m, 13H), 2.88 (t, J = 7.6 Hz, 2H), 1.62 – 1.51 (m, 4H), 1.38 – 1.26 
(m, 2H) ppm. 13C NMR (176 MHz, D2O): δ = 105.4, 104.4, 104.2, 103.9, 100.2, 81.6, 79.3, 
79.1, 79.0, 78.2, 76.2, 75.5, 75.3, 75.2, 75.1, 75.0, 73.9, 73.2, 72.7, 71.7, 68.6, 67.8, 65.5, 
62.4, 42.0, 30.8, 29.2, 24.7, 16.7 ppm. ESI-HRMS: m/z [M+H]+ calcd. for C42H74NO30
+: 
1072.4296; found: 1072.4302. 











Linker-functionalized resin 9 (104 mg, 66.7 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module E: 40 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 18b, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module G: 0.5 M Bz2O and 0.25 M DMAP in DCE 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave protected tetrasaccharide 30 (26.5 mg, 16.4 µmol, 
24%) as a single stereoisomer. 










Fully protected tetrasaccharide 30 was dissolved in DCM (1.8 mL) and MeOH 
(0.2 mL) and pTsOH (3.12 mg, 16.4 mol) was added. The mixture was refluxed overnight 
and then washed with aq. sat. NaHCO3 solution. The organic phase was dried and 
concentrated and the crude tetrasaccharide was used in the next step without further puri-
fication. The crude tetrasaccharide was dissolved in DCM (10 mL) and Dess-Martin-Perio-
dinate (10.4 mg, 24.6 mol) and water (1.00 L) were added. The reaction mixture was 
stirred at r.t. for 2 d. DCM (5 mL) was added and the reaction was quenched by the 
addition of aq. sat. Na2S2O3 solution (5 mL) and aq. sat. NaHCO3 solution (5 mL). The 
organic phase was separated, and the aqueous phase was extracted twice with DCM 
(10 mL). The combined organic phases were dried over Na2SO4 and the solvent was 
removed in vacuo. 






The crude aldehyde was taken up in THF (5 mL) and tBuOH (10 mL) and 2-methyl-
but-2-ene (90.0 L, 820 mol) were added. NaClO2 (14.8 mg, 164 mol) and NaH2PO4 
(14.8 mg, 123 mol) in water (5 mL) were added and the reaction mixture was stirred at 
r.t. for 2 h. The reaction was quenched by the addition of 1 M HCl solution (10 mL) and 
the aqueous phase was extracted with DCM (3 x 5 mL). The organic phase was dried, 
and the solvents were evaporated. Purification by normal phase HPLC using a preparative 
YMC diol column gave the protected glucuronic acid tetrasaccharide (14.2 mg, 8.95 µmol, 
54% over 3 steps). 
Crude NP-HPLC (ELSD trace): 
 
The protected glucuronic acid tetrasaccharide was dissolved in in DCM/MeOH (2:1, 
3 mL) and NaOMe (0.5 M in MeOH, 0.6 mL) was added. The reaction mixture was stirred 
overnight and subsequently neutralized by the addition of prewashed Amberlite IR-120 
(H+) resin. The resin was filtered off and the solvents were removed in vacuo. The crude 
product was purified by reversed phase HPLC using a semi-preparative C5 column 
affording the semi-protected tetrasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter the solvents were evaporated to provide the fully 
deprotected tetrasaccharide 34 (1.3 mg, 1.89 mol, 3% over 12 steps, based on resin 
loading). 1H NMR (400 MHz, D2O): δ = 5.27 (d, J = 3.8 Hz, 1H), 4.61 (d, J = 7.5 Hz, 1H), 
4.44 (d, J = 7.8 Hz, 1H), 4.39 (d, J = 7.9 Hz, 1H), 4.31 (d, J = 10.1 Hz, 1H), 4.09 (dt, J = 
11.8, 5.8 Hz, 2H), 3.96 (dd, J = 11.6, 5.4 Hz, 1H), 3.89-3.49 (m, 9H), 3.46-3.14 (m, 11H), 
2.98 (t, J = 7.6 Hz, 2H), 1.73-1.57 (m, 4H), 1.49-1.38 (m, 2H) ppm. 13C NMR (176 MHz, 
D2O): δ = 110.0, 102.7, 101.9, 101.3, 97.3, 82.4, 76.7, 76.3, 75.9, 75.5, 73.8, 72.8, 72.7, 
72.3, 72.1, 71.2, 70.0, 69.1, 65.1, 62.8, 62.7, 59.8, 39.3, 28.1, 26.3, 22.0 ppm. ESI-HRMS: 
m/z [M+H]+ calcd. for C27H48NO19: 690.2821; found: 676.2815. 







3.3.5 Synthesis of Glucose Building Block 36 
4-Methylphenyl 2,3,4-tri-O-benzyl-1-thio--D-glucopyranoside (35) 
 
A 1 M solution of borane tetrahydrofurane complex (15.1 mL, 15.1 mmol) and 
TMSOTf (0.34 mL, 1.89 mmol) were sequentially added to a solution of 4-methylphenyl 
2,3-di-O-benzyl-4,6-di-O-benzylidene-1-thio--D-glucopyranoside 20 (2.10 g, 3.79 mmol) 
in DCM (25 mL) at 0 °C. After stirring the reaction mixture for 4 h, triethylamine (10 mL) 
and methanol (50 mL) were added. The resulting mixture was concentrated under 
reduced pressure. The residue was purified by column chromatography (SiO2, EtOAc/hex 
= 1:4 to 2:3) to afford 4-methylphenyl 2,3,4-tri-O-benzyl-1-thio--D-glucopyranoside 35 
(1.03 g, 1.85 mmol, 49%) as a colorless solid. 1H NMR (400 MHz, CDCl3):  = 7.44 - 7.27 
(m, 17H, ArH), 7.12 (d, J = 7.9 Hz, 2H, ArH), 4.94 - 4.82 (m, 4H, ArCH2), 4.76 (d, J = 10.2 
Hz, 1H, ArCH2), 4.64 (d, J = 10.3 Hz, 2H, ArCH2, H-1), 3.87 (dd, J = 12.0, 2.6 Hz, 1H, H-
6a), 3.76 - 3.65 (m, 2H, H-4, H-6b), 3.55 (t, J = 9.4 Hz, 1H, H-3), 3.46 (dd, J = 9.7, 8.8 Hz, 
1H, H-2), 3.36 (ddd, J = 9.7, 4.9, 2.7 Hz, 1H, H-5), 2.34 (s, 3H, CH3) ppm. The analytical 
data is in agreement with literature data.246 
4-Methylphenyl 2,3,4-tri-O-benzyl-6-O-acetyl-1-thio--D-glucopyranoside (36) 
 
4-Methylphenyl 2,3,4-tri-O-benzyl-1-thio--D-glucopyranoside 35 (1.03 g, 1.85 mmol) 
was dissolved in anhydrous DCM (50 mL) and acetic anhydride (5.25 mL, 55.5 mmol) and 
DMAP (23.0 mg, 0.185 mmol) were added. The reaction mixture was stirred at r.t. for 2 h. 
The reaction mixture was quenched by the addition of 1 M HCl solution (20 mL) and the 





with Na2SO4. The crude product was purified by column chromatography (SiO2, 
EtOAc/hex = 1:6) to afford 4-methylphenyl 2,3,4-tri-O-benzyl-6-O-acetyl-1-thio--D-gluco-
pyranoside 36 (1.03 g, 1.85 mmol, 89%) as a colorless solid. 1H NMR (400 MHz, CDCl3): 
 = 7.50 – 7.43 (m, 2H, ArH), 7.42 – 7.38 (m, 2H, ArH), 7.36 – 7.27 (m, 13H, ArH), 7.13 – 
7.06 (m, 2H, ArH), 4.93 (dd, J = 10.5, 3.1 Hz, 2H, ArCH2), 4.88 – 4.81 (m, 2H, ArCH2), 
4.74 (d, J = 10.3 Hz, 1H, ArCH2), 4.61 – 4.54 (m, 2H, H-1, ArCH2), 4.36 (d, J = 11.8 Hz, 
1H, H-6a), 4.20 (dd, J = 11.5, 3.6 Hz, 1H, H-6b), 3.77 – 3.67 (m, 1H, H-5), 3.60 – 3.37 (m, 
3H, H-2, H-3, H-4), 2.34 (s, 3H, CH3), 2.05 (s, 3H, CH3) ppm. The analytical data is in 
agreement with literature data.247 






Linker-functionalized resin 9 (104 mg, 64.7 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1c, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 





Module E: 40 equiv. PBu3, 5% H2O in THF, 6 x 30 min, 45 °C 
Module B: 2 x 1.8 equiv 36, NIS, DCM/dioxane, 2 x 45 min, -20 to -5 °C 
Module G: 0.5 M Bz2O and 0.25 M DMAP in DCE 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave protected tetrasaccharide 38 (9.00 mg, 5.32 µmol, 8%) 
as a single stereoisomer. 






Fully protected tetrasaccharide 37 (9.00 mg, 5.32 µmol) was dissolved in DCM 
(1.8 mL) and MeOH (0.2 mL) and pTsOH (1.13 mg, 5.91 mol) was added. The mixture 
was refluxed overnight and then washed with aq. sat. NaHCO3 solution (1 mL). The 
organic phase was dried and concentrated and the crude tetrasaccharide was used in the 
next step without further purification. The crude tetrasaccharide was dissolved in DCM 
(5 mL) and Dess-Martin-Periodinate (3.47 mg, 8.19 mol) and water (0.1 L) were added. 
The reaction mixture was stirred at r.t. for 2 d. DCM (5 mL) was added and the reaction 
was quenched by the addition of aq. sat. Na2S2O3 solution (5 mL) and then aq. sat. 
NaHCO3 solution (5 mL). The organic phase was separated, and the aqueous phase was 
extracted twice with DCM (10 mL). The combined organic phases were dried over Na2SO4 
and the solvent was removed in vacuo. The crude aldehyde was taken up in THF (2 mL) 
and tBuOH (4 mL) and 2-methylbut-2-ene (29.0 L, 273 mol) were added. NaClO2 
(4.94 mg, 54.6 mol) and NaH2PO4 (4.91 mg, 41.0 mol) in water (2 mL) were added and 





addition of 1 M HCl solution (5 mL) and the aqueous phase was extracted with DCM (3 x 
5 mL). The organic phase was dried, and the solvents were evaporated. Purification by 
normal phase HPLC using a preparative YMC diol column gave the protected glucuronic 
acid tetrasaccharide (2.50 mg, 1.50 µmol, 28% over 3 steps). 
Crude NP-HPLC (ELSD trace): 
 
The protected glucuronic acid tetrasaccharide was dissolved in THF (1 mL) and 
NaOMe (0.5 M in MeOH, 0.100 mL) was added. The reaction mixture was stirred 
overnight and was subsequently neutralized by the addition of prewashed Amberlite IR-
120 (H+) resin. The resin was filtered off and the solvents were removed in vacuo. The 
crude product was purified by reversed phase HPLC using a semi-preparative C5 column 
affording the semi-protected tetrasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 1.00 mL) and the resulting solution was added to a 
round-bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated 
with H2 for 30 min and stirred under a H2-atmosphere overnight. After filtration of the 
reaction mixture through a syringe filter the solvents were evaporated to provide the fully 
deprotected tetrasaccharide 38 (0.8 mg, 0.592 mol, 0.9% over 12 steps, based on resin 
loading). 1H NMR (400 MHz, D2O):  = 5.18 (d, J = 3.8 Hz, 1H), 4.33 (d, J = 7.8 Hz, 1H), 
4.31 – 4.21 (m, 2H), 3.99 (dt, J = 12.3, 6.2 Hz, 2H), 3.84 (dd, J = 11.6, 5.4 Hz, 1H), 3.80 – 
3.08 (m, 18H), 2.87 (t, J = 7.5 Hz, 2H), 1.61 – 1.45 (m, 4H), 1.40 – 1.25 (m, 2H) ppm. ESI-
HRMS: m/z [M+H]+ calcd. for C26H45NNaO19
+: 698.2483; found: 698.2497. 






3.4 Artificial Polysaccharides with Well-Defined 
Branching Patterns 
3.4.1 Automated Glycan Assembly of Arabinoxylan 
Oligosaccharides with Free Reducing Ends 
β-D-Xylopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-D-xylopyranose (40) 
 
Linker-functionalized resin 39 (170 mg, 44.2 mol) was placed in the synthesizer and 
synthesizer modules were applied as follows: 
Module A: 2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C  
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Module A: 2 x 1.8 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C: 20% NEt3 in DMF, 4 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected tetrasaccharide (30.1 mg, 23.8 mol, 
54%). 






The protected trisaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected trisaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter the solvents were evaporated until approx. 1 mL of the 
solvent mixture was left. The fully deprotected trisaccharide 40 was stirred with a spatula 
tip of H+-Amberlite resin to hydrolyze the side product that has formed by condensation of 
the oligosaccharide with the cleaved linker. Without removal of the water the fully 
deprotected trisaccharide 40 was directly purified by reversed phase HPLC using a semi-
preparative hypercarb column to give an -mixture of the trisaccharide 40 (1.9 mg, 
4.64 µmol, 10% over 9 steps, based on resin loading). 1H NMR (400 MHz, D2O): δ = 5.04 
(d, J = 3.7 Hz, -1H), 4.44 (d, J = 7.9 Hz, -1H), 4.32 (t, J = 7.2 Hz, 5H), 3.96 (dd, J = 
11.8, 5.3 Hz, 2H), 3.95 – 3.86 (m, 2H), 3.82 (dd, J = 11.6, 5.5 Hz, 2H), 3.70 – 3.56 (m, 
9H), 3.52 – 3.36 (m, 9H), 3.31 – 3.19 (m, 6H), 3.19 – 3.07 (m, 9H) ppm. 13C NMR (101 
MHz, D2O): δ = 101.8, 101.6, 96.4, 91.9, 76.5, 76.3, 75.5, 73.9, 73.8, 73.6, 72.7, 72.6, 
71.3, 70.9, 69.1, 65.1, 62.9 ppm. ESI-HRMS: m/z = [M+Na]+ calcd. for C15H26NaO13
+: 
437.1271; found 437.1254. 








Linker-functionalized resin 39 (170 mg, 44.2 mol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A: 2 x 1.4 equiv 1b, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module D: 0.1 M DDQ in DCE/MeOH/H2O (64:16:1) 
Module B: 2 x 1.4 equiv 2a, NIS, 2 x 35 min, -40 °C to -20 °C 
Module C: 20% NEt3 in DMF, 3 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected disaccharide (10.2 mg, 10.6 mol, 24%) 
Crude NP-HPLC (ELSD trace):  
 
The protected disaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected disaccharide. The product was dissolved in a mixture of 





bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter the solvents were evaporated until approx. 1 mL of the 
solvent mixture was left. The fully deprotected disaccharide 42 was stirred with a spatula 
tip of H+-Amberlite resin to hydrolyze the side product that has formed by condensation of 
the oligosaccharide with the cleaved linker. Without removal of the water the fully 
deprotected disaccharide 42 was directly purified by reversed phase HPLC using a semi-
preparative hypercarb column to give an -mixture of the disaccharide 42 (2.2 mg, 
7.72 µmol, 18% over 7 steps, based on resin loading). 1H NMR (400 MHz, D2O): δ = 5.13 
(d, J = 13.8 Hz, 1H), 5.00 (d, J = 3.4 Hz, 1H, -1H), 4.42 (d, J = 8.0 Hz, 1H, -1H), 4.08 – 
3.95 (m, 2H), 3.85 – 3.70 (m, 2H), 3.68 – 3.36 (m, 6H), 3.25 – 3.10 (m, 1H) ppm. 13C NMR 
(101 MHz, D2O): δ = 108.1, 108.0, 96.3, 92.1, 83.8, 83.7, 81.8, 81.0, 79.2, 76.3, 73.8, 
71.1, 67.8, 67.7, 64.8, 61.0, 60.8 ppm. ESI-HRMS: m/z = [M+Na]+ calcd. for C10H18NaO9
+: 
305.0849; found 305.0848. 










Linker-functionalized resin 39 (340 mg, 88.4 mol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A: 2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C: 20% NEt3 in DMF, 3 x 5 min, r.t. 
Module A: 2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C: 20% NEt3 in DMF, 3 x 5 min, r.t. 
Module A: 2 x 1.4 equiv 1b, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module D: 0.1 M DDQ in DCE/MeOH/H2O (64:16:1) 
Module B: 2 x 1.4 equiv 2a, NIS, 2 x 35 min, -40 °C to -20 °C 
Module C: 20% NEt3 in DMF, 3 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photo-
reactor afforded the crude product. Purification by normal phase HPLC using a pre-
parative YMC diol column gave the protected tetrasaccharide (30.0 mg, 18.5 mol, 21%). 






The protected tetrasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected tetrasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter the solvents were evaporated until approx. 1 mL of the 
solvent mixture was left. The fully deprotected tetrasaccharide 43 was stirred with a 
spatula tip of H+-Amberlite resin to hydrolyze the side product that has formed by conden-
sation of the oligosaccharide with the cleaved linker. Without removal of the water the fully 
deprotected tetrasaccharide 43 was directly purified by reversed phase HPLC using a 
semi-preparative hypercarb column to give an -mixture of the tetrasaccharide 43 
(0.75 mg, 1.37 µmol, 2% over 11 steps, based on resin loading). For characterization see 
chemical solution-phase synthesis of 43 (chapter 3.4.3). 










Linker-functionalized resin 39 (170 mg, 44.2 mol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A: 2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C: 20% NEt3 in DMF, 3 x 5 min, r.t. 
Module A: 2 x 1.4 equiv 1b, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C: 20% NEt3 in DMF, 3 x 5 min, r.t. 
Module A: 2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module D: 0.1 M DDQ in DCE/MeOH/H2O (64:16:1) 
Module B: 2 x 1.4 equiv 2a, NIS, 2 x 35 min, -40 °C to -20 °C 
Module C: 20% NEt3 in DMF, 3 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow 
photoreactor afforded the crude product. Purification by normal phase HPLC using a 
preparative YMC diol column gave the protected tetrasaccharide (28.1 mg, 17.4 mol, 
40%). 






The protected tetrasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected tetrasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter the solvents were evaporated until approx. 1 mL of the 
solvent mixture was left. The fully deprotected tetrasaccharide 44 was stirred with a 
spatula tip of H+-Amberlite resin to hydrolyze the side product that has formed by conden-
sation of the oligosaccharide with the cleaved linker. Without removal of the water the fully 
deprotected trisaccharide 44 was directly purified by reversed phase HPLC using a semi-
preparative hypercarb column to give an -mixture of the tetrasaccharide 44 (2.6 mg, 
4.68 µmol, 11% over 11 steps, based on resin loading). 1H NMR (400 MHz, D2O): δ = 5.37 
(s, 1H), 5.16 (s, 1H, -1H), 4.56 (d, J = 7.9 Hz, 1H, -1H), 4.48 (d, J = 7.6 Hz, 1H), 4.42 
(d, J = 7.8 Hz, 1H), 4.29 – 4.21 (m, 1H), 4.16 – 4.00 (m, 3H), 3.95 – 3.64 (m, 9H), 3.61 – 
3.47 (m, 3H), 3.45 – 3.31 (m, 4H), 3.30 – 3.16 (m, 3H) ppm. 13C NMR (101 MHz, D2O): δ 
= 107.5, 101.6, 101.4, 96.4, 92.0, 84.7, 80.6, 77.2, 77.1, 76.6, 76.4, 75.5, 73.9, 73.8, 73.5, 
73.2, 72.9, 71.3, 69.1, 65.0, 62.9, 62.7, 61.2, 58.7 ppm. ESI-HRMS: m/z = [M+Na]+ calcd. 
for C20H34NaO17
+: 569.1694; found 569.1697. 










Linker-functionalized resin 39 (170 mg, 44.2 mol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A: 2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C20% NEt3 in DMF, 3 x 5 min, r.t. 
Module A2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C20% NEt3 in DMF, 3 x 5 min, r.t. 
Module A2 x 1.4 equiv 1b, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C20% NEt3 in DMF, 3 x 5 min, r.t. 
Module A2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module E0.1 M DDQ in DCE/MeOH/H2O (64:16:1) 
Module B2 x 1.4 equiv 2a, NIS, 2 x 35 min, -40 °C to -20 °C 
Module C20% NEt3 in DMF, 3 x 5 min, r.t. 
Module A2 x 1.4 equiv 1a, TMSOTf, DCM, 2 x 35 min, -35 °C to -15 °C 
Module C20% NEt3 in DMF, 3 x 5 min, r.t. 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photo-
reactor afforded the crude product. Purification by normal phase HPLC using a pre-
parative YMC diol column gave the protected hexasaccharide (22.1 mg, 9.73 mol, 22%). 






The protected hexasaccharide was dissolved in DCM/MeOH (2:1, 3 mL) and NaOMe 
(0.5 M in MeOH, 0.500 mL) was added. The reaction mixture was stirred overnight and 
subsequently neutralized by addition of prewashed Amberlite IR-120 (H+) resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected hexasaccharide. The product was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10.0 mg). The suspension was saturated with H2 
for 30 min and stirred under a H2-atmosphere overnight. After filtration of the reaction 
mixture through a syringe filter the solvents were evaporated until approx. 1 mL of the 
solvent mixture was left. The fully deprotected hexasaccharide 45 was stirred with a 
spatula tip of H+-Amberlite resin to hydrolyze the side product that has formed by conden-
sation of the oligosaccharide with the cleaved linker. Without removal of the water the fully 
deprotected trisaccharide 45 was directly purified by reversed phase HPLC using a semi-
preparative hypercarb column to give an -mixture of the hexasaccharide 45 (1.0 mg, 
1.25 µmol, 3% over 15 steps, based on resin loading). 1H NMR (400 MHz, D2O): δ = 5.20 
(s, 1H), 4.99 (d, J = 3.6 Hz, 1H, -1H), 4.39 (dd, J = 7.7, 1.7 Hz, 1H), 4.34 – 4.22 (m, 4H), 
4.09 (q, J = 5.1 Hz, 1H), 3.98 – 3.83 (m, 4H), 3.80 – 3.69 (m, 3H), 3.68 – 3.30 (m, 15H), 
3.29 – 3.02 (m, 10H) ppm. 13C NMR (151 MHz, D2O): δ = 110.2, 110.0, 104.9, 104.4, 
104.2, 103.9, 87.3, 83.3, 82.6, 82.5, 79.9, 79.8, 79.1, 79.0, 78.9, 78.2, 76.2, 76.2, 75.9, 
75.6, 75.5, 75.3, 75.3, 74.0, 72.5, 71.8, 67.8, 65.5, 65.5, 65.4, 65.2, 63.9, 63.9, 63.2 ppm. 
ESI-HRMS: m/z = [M+Na]+ calcd. for C20H34NaO17
+: 833.2539; found 833.2526. 






3.4.2 Synthesis of Glycosyl Fluorides and Glycosynthase-
catalyzed Polymerization 
-D-Xylopyranosyl-(1→4)--D-xylopyranosyl-(1→4)--D-xylopyranosyl fluoride (47) 
 
-D-Xylopyranosyl-(1→4)--D-xylopyranosyl-(1→4)-D-xylopyranose 40 (1.90 mg, 
4.64 µmol) was dissolved in acetic anhydride (1.50 mL) and pyridine (1.50 mL) and the 
reaction mixture was stirred at r.t. for 2 h. The reaction mixture was diluted with DCM 
(5 mL) and washed with 1 M HCl solution (2 mL). The phases were separated and the 
organic phase was dried with Na2SO4. The solvent was evaporated to give the crude 
product (2.51 mg). The protected trisaccharide was dissolved in anhydrous DCM (0.5 mL) 
in a plastic vessel. The solution was cooled to -25 °C and HF/pyridine (0.5 mL) was 
added. The biphasic reaction mixture was rigorously stirred at -10 °C for 5 h. The reaction 
mixture was quenched by dropping the mixture carefully into an aq. ammonia solution 
(25%, 2 mL). The phases were separated and the organic phase was washed with aq. 
sat. NaHCO3 solution (2 mL). The aqueous phase was reextracted with DCM (2 x 2 mL) 
and the combined organic phases were dried with Na2SO4. After evaporation of the 
solvent the crude product was purified by NP HPLC using a Luna Silica Prep Column to 
give trisaccharide fluoride 46 (1.41 mg, 1.98 mol, 51%) as a colorless solid. Disaccharide 
fluoride 46 (1.41 mg, 1.98 mol,) was dissolved in anhydrous MeOH (1.00 mL) at 0 °C. 
NaOMe (0.5 M in MeOH, 4.00 L, 1.98 mol) was added dropwise and the solution was 
stirred at 0 °C for 1 h. The reaction mixture was neutralized by the careful addition of 
Amberlite IR-120 (H+) resin. The resin was filtered off and the solvents were evaporated to 
give the fully unprotected fluoride 47 (0.830 mg, 1.99 mol, 100%) as a colorless solid. 1H 
NMR (400 MHz, D2O): δ = 5.46 (d, J = 53.3 Hz, 1H), 4.29 (t, J = 8.5 Hz, 3H), 3.93 (dd, J = 







xylopyranosyl fluoride (48) 
 
For synthesis of glyocsyl fluoride 48 see chapter 3.4.5.1. 
 
-D-Xylopyranosyl-(1→4)-3-O-[-L-arabinofuranosyl]--D-xylopyranosyl-(1→4)--D-
xylopyranosyl fluoride (49) 
 
Tetrasaccharide 43 (2.28 mg, 4.17 mol) was dissolved in acetic anhydride (1.50 mL) 
and pyridine (1.50 mL) and the reaction mixture was stirred at r.t. for 3 h. The reaction 
mixture was diluted with DCM (5 mL) and washed with 1 M HCl (2 mL) solution. The 
phases were separated and the organic phase was dried with Na2SO4. The solvent was 
evaporated to give the crude product (2.52 mg). The protected trisaccharide was 
dissolved in anhydrous DCM (3.00 mL) in a plastic vessel. The solution was cooled to -
25 °C and HF/pyridine (3.00 mL) was added. The biphasic system was stirred rigorously 
for 4 h at -10 °C. The reaction mixture was diluted with DCM (2 mL) and was quenched by 
dropping the mixture carefully into aq. ammonia solution (25%, 2 mL). The organic phase 
was washed with aq. sat. NaHCO3 solution (2 mL) and reextracted with DCM (2 x 20 mL). 
The combined organic phases were dried with Na2SO4 and the solvents were evaporated. 
The crude product was purified using a Luna Silica Prep Column to give the protected 
tetrasaccharide fluoride (1.72 mg, 1.85 mol) as a colorless solid. The tetrasaccharide 
fluoride (1.72 mg, 1.85 mol) was dissolved in anhydrous MeOH (1.00 mL) at 0 °C. 
NaOMe (0.5 M in MeOH, 3.70 L, 1.85 mol) was added dropwise and the solution was 
stirred at 0 °C for 1 h. The reaction mixture was neutralized by the careful addition of 
Amberlite IR-120 (H+) resin. The resin was filtered off and the solvents were evaporated to 
give fully deprotected tetrasaccharide fluoride 49 (88.0 mg, 0.211 mmol, 100%) as a 
colorless solid. 1H NMR (400 MHz, D2O): δ = 5.46 (dd, J = 53.4, 2.8 Hz, 1H), 5.21 (s, 1H), 
4.33 (d, J = 7.7 Hz, 1H), 4.26 (d, J = 7.6 Hz, 1H), 4.10 – 4.06 (m, 1H), 3.99 – 3.89 (m, 2H), 






(1→4)--D-Xylan (XX)n (50) 
 
An aqueous solution of fluoride donor 47 (10 mM, 99.0 L) and a phosphate buffered 
solution of XynAE265G (9.30 mg/mL, 25.0 L) were added to sodium phosphate buffer 
(100 mM, pH 7, VFluoride/Vbuffer = 1:5). The reaction was shaken at r.t. overnight. A white 
precipitate was formed. It was centrifuged and washed three times with MilliQ water and 






For synthesis of polysaccharide from glycosyl fluoride 48 see chapter 3.4.5.2. 
 
3.4.3 Chemical Solution-Phase Synthesis of Arabinoxylan 
Oligosaccharides 
Benzyl 2-O-benzoyl-3-O-benzyl--D-xylopyranoside (54) 
 
A mixture of xylose BB 8a (5.00 g, 7.43 mmol), benzyl alcohol (3.09 mL, 29.7 mmol) 
and molecular sieves (2.00 g) in anhydrous DCM (250 mL) was stirred under an 
atmosphere of Argon for 30 min. The mixture was cooled to -20 °C and NIS (2.51 g, 
11.2 mmol) and TfOH (0.131 mL, 1.49 mmol) were added. After stirring for 40 min at -
20 °C NEt3 (10 mL) was added and the reaction mixture was stirred for another 30 min. 
The mixture was filtered and the filtrate was washed with 1 M HCl solution (100 mL) and 





combined organic phases were dried with Na2SO4 and the solvent was evaporated. The 
pale yellow oil was purified by column chromatography (SiO2, EtOAc/Hex = 1:6) to give 54 
(3.01 g, 6.93 mmol, 93%) as a colorless solid. [𝑎]𝐷
25 = -18.4 (c 0.8, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 8.08 − 8.04 (m, 2H, ArH), 7.67 − 7.62 (m, 1H, ArH), 7.53 − 7.48 (m, 6H, 
ArH), 7.41 − 7.38 (m, 1H, ArH), 7.30 − 7.21 (m, 9H, ArH), 5.36 (dd, J = 8.0 Hz, J = 6.4 Hz, 
1H, H-2), 4.90 (d, J = 12.5 Hz, 1H, CH2Ph), 4.79 (d, J = 11.5 Hz, 1H, CH2Ph), 4.67 (d, J = 
11.5 Hz, 1H, CH2Ph), 4.65 (d, J = 12.5 Hz, 1H, CH2Ph), 4.65 (d, J = 6.4 Hz, 1H, H-1), 4.16 
(dd, J = 11.6 Hz, 4.6 Hz, 1H, H-5a), 3.90 (td, J = 8.1 Hz, J = 4.6 Hz, 1H, H-4), 3.66 (t, 
J = 7.7 Hz, 1H, H-3), 3.39 (dd, J = 11.7 Hz, 8.6 Hz, 1H, H-5b), 2.69 − 2.40 (br, 1H, 
OH) ppm. 13C NMR (100 MHz, CDCl3): δ = 165.3, 137.9, 137.1, 133.4, 129.9, 129.8, 
128.6, 128.5, 128.4, 128.0, 127.9, 127.8, 127.1 (19C, Ar), 99.4 (C-1), 80.8 (C-3), 73.9 
(CH2Ph), 72.4 (C-2), 70.0 (CH2Ph), 69.2 (C-4), 64.5 (C-5) ppm. ESI-HRMS: m/z [M+Na]
+ 
calcd. for C26H26O6Na





A mixture of compound 54 (6.04 g, 8.98 mmol), xylose BB 8a (3.00 g, 6.90 mmol) and 
activated molecular sieves (4 Å, 2.00 g) in anhydrous DCM (45 mL) was stirred at r.t. for 
30 min under an Argon atmosphere. After the mixture was cooled to −30 °C, NIS (6.21 g, 
27.6 mmol) and TfOH (0.121 mL, 1.38 mmol) were added. After the reaction mixture was 
stirred for 30 min at −30 °C, the reaction mixture was diluted with DCM (50 mL) and 
quenched by the addition of aq. sat. NaHCO3 solution (50 mL). The phases were 
separated and the organic phase was washed with aq. sat. Na2S2O3 solution (1 x 50 mL) 
and H2O (50 mL). The organic layer was dried with Na2SO4 and the solvent was 
evaporated. The crude product was purified by column chromatography (EtOAc/Hex = 
1:6) to give 55 (6.50 g, 6.61 mmol, 96 %) as a colorless solid. [𝑎]𝐷
25 = -18.4 (c 0.8, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 8.19 - 8.08 (m, 2H, ArH), 8.01 - 7.93 (m, 2H, ArH), 7.83 - 
7.72 (m, 2H, ArH), 7.68 - 7.54 (m, 4H, ArH), 7.52 - 7.39 (m, 6H, ArH), 7.36 - 7.06 (m, 17H, 
ArH), 5.35 - 5.26 (m, 2H, H-2, H-2'), 4.91 - 4.78 (m, 4H, H-1', H-4', CH2Ph), 4.76 - 4.67 (m, 
2H, CH2Ph), 4.65 (d, J = 11.4 Hz, 1H, CH2Ar), 4.58 (d, J = 12.6 Hz, 1H, CH2Ph), 4.50 (d, J 
= 7.2 Hz, 1H, H-1), 4.45 (dd, J = 7.3, 3.3 Hz, 2H, H-5'a, Fmoc-CH2), 4.34 - 4.22 (m, 2H, H-
5'a, Fmoc-CH), 4.12 - 4.02 (m, 2H, H-4, H-5a), 3.91 (t, J = 6.4 Hz, 1H, H-3'), 3.69 (t, J = 





13C NMR (101 MHz, CDCl3): δ = 165.2, 165.2, 154.4 (3C, C=O), 143.2, 143.2, 141.3, 
141.3, 137.9, 137.3, 137.0, 133.5, 133.1, 129.9, 129.9, 129.5, 128.6, 128.4, 128.3, 128.3, 
128.2, 128.1, 128.0, 127.9, 127.9, 127.7, 127.6, 127.5, 127.3, 127.2, 125.1, 120.2 (41C, 
Ar), 99.8 (C-1), 98.5 (C-1'), 79.2 (C-3), 75.8 (C-3'), 75.6 (C-4), 74.5 (CH2Ph), 73.4 
(CH2Ph), 73.3 (C-4'), 72.6 (C-2), 70.6 (C-2'), 70.1 (Fmoc-CH2), 70.0 (CH2Ph), 62.6 (C-5), 
60.6 (C-5'), 46.8 (Fmoc-CH) ppm. ESI-HRMS: m/z = [M+H]+ calcd. for C60H54NaO13
+: 
1005.3462; found 1005.3480. IR(neat): 𝜈max = 1728, 1452, 1225, 1097 cm
-1. 
Benzyl 3-O-benzyl--D-xylopyranosyl-(1→4)-3-O-benzyl--D-xylopyranoside (SI2) 
 
The protected disaccharide 55 (3.00 g, 3.05 mmol) was dissolved in DCM (10 mL) 
and MeOH (20 mL). NaOMe (0.5 M in MeOH, 10.4 mL, 5.19 mmol) was added and the 
reaction mixture was stirred at r.t. for 18 h. The reaction mixture was neutralized by the 
addition of Amberlite IR-120 (H+) resin. The resin was filtered off and the solvents were 
evaporated. The crude product was filtered through a plug of silica gel (SiO2, EtOAc/Hex = 
1:1) to give SI2 (1.20 g, 2.17 mmol, 71%) as a yellow oil. [𝑎]𝐷
25 = -4.5 (c 0.68, CHCl3). 
1H 
NMR (400 MHz, CDCl3):  = 7.30 – 7.13 (m, 15H, ArH), 4.83 (d, J = 11.5 Hz, 1H, CH2Ar), 
4.78 (d, J = 11.8 Hz, 1H, CH2Ar), 4.74 (d, J = 11.4 Hz, 1H, CH2Ar), 4.67 (d, J = 11.3 Hz, 
1H, CH2Ar), 4.59 (d, J = 11.6 Hz, 1H, CH2Ar), 4.59 (d, J = 11.6 Hz, 1H, CH2Ar), 4.54 – 
4.45 (m, 1H, CH2Ar), 4.41 (d, J = 5.5 Hz, 1H, H-1), 4.31 (d, J = 7.0 Hz, 1H, H-1’), 4.03 (dd, 
J = 12.0, 4.1 Hz, 1H, H-5a), 3.92 (dd, J = 11.6, 5.0 Hz, 1H, H-5a’), 3.82 – 3.76 (m, 1H, H-
4), 3.64 – 3.53 (m, 2H, H-2, H-4’), 3.52 – 3.45 (m, 2H, H-3, H-2’), 3.32 – 3.24 (m, 2H, H-3’, 
H-5b), 3.14 (dd, J = 11.6, 9.3 Hz, 1H, H-5b’), 2.78 (s, 1H, OH), 2.64 (s, 1H, OH), 2.13 (s, 
1H, OH) ppm. 13C NMR (101 MHz, CDCl3):  = 138.4, 138.1, 137.3, 128.8, 128.6, 128.6, 
128.5, 128.3, 128.2, 128.1, 128.0 (18C, Ar), 102.0 (C-1’), 101.6 (C-1), 82.7 (C-3’), 79.1 
(C-3), 74.5 (CH2Ar), 73.9 (CH2Ar), 73.8 (C-4), 72.5 (C-2’), 72.0 (C-2), 70.6 (CH2Ar), 69.2 
(C-4’), 65.2 (C-5’), 62.2 (C-5) ppm. ESI-HRMS: m/z = [M+H]+ calcd. for 
C31H36NaO9




The semi-protected disaccharide SI2 (1.20 g, 2.17 mmol) was dissolved in MeOH 
(15 mL) and Pd/C (300 mg, 10% Pd) was added. Hydrogen gas was bubbled through the 





atmosphere for 2 d. The reaction mixture was diluted with H2O (5 mL) and the catalyst 
was filtered off by using a syringe filter (4.5 m). After evaporation of the solvents fully 
deprotected disaccharide 52 (480 mg, 1.70 mmol, 78%, / ~ 1:1) was obtained as a 
colorless solid. 1H NMR (400 MHz, D2O): δ = 5.16 (d, J = 3.6 Hz, 0.5H, H-1), 4.56 (d, J = 
7.8 Hz, 0.5H, H-1), 4.43 (d, J = 7.8 Hz, 1H, H-1’), 4.03 (dd, J = 11.7, 5.3 Hz, 0.5H), 3.94 
(dd, J = 11.6, 5.4 Hz, 1H), 3.84 – 3.69 (m, 2.5H), 3.64 – 3.48 (m, 2.5H), 3.44 – 3.37 (m, 





A mixture of compound 54 (10.4 g, 14.4 mmol), BB 8b (5.00 g, 11.5 mmol) and 
activated molecular sieves (4 Å, 2.00 g) in anhydrous DCM (50 mL) was stirred at r.t. for 
30 min under an Argon atmosphere. After the mixture was cooled to −30 °C, NIS (10.4 g, 
46.0 mmol) and TfOH (0.417 mL, 2.30 mmol) were added and the reaction mixture was 
stirred at −30 °C for 30 min. The reaction mixture was diluted with DCM (50 mL) and 
quenched by the addition of aq. sat. NaHCO3 solution (50 mL). The phases were 
separated and the organic phase was washed with aq. sat. Na2S2O3 solution (50 mL) and 
H2O (50 mL). The organic layer was dried with Na2SO4 and the solvent was evaporated. 
The crude product was purified by column chromatography (EtOAc/Hex = 1:6) to give 56 
(10.0 g, 9.71 mmol, 84%) as a colorless solid. [𝑎]𝐷
25 = -21.5 (c 0.9, CHCl3). 
1H-NMR (400 
MHz, CDCl3): δ = 8.16 − 8.12 (m, 1H, ArH), 8.04 − 7.99 (m, 2H, ArH), 7.84 − 7.60 (m, 8H, 
ArH), 7.52 − 7.13 (m, 12H, ArH), 7.28 − 7.11 (m, 12H, ArH), 5.40 (dd, J = 6.7, 5.2 Hz, 1H, 
H-2), 5.35 (dd, J = 8.8, 7.2 Hz, 1H, H-2’), 4.99 − 4.95 (m, 3H, H-4, CH2Ph), 4.93 − 4.83 
(m, 3H, H-1, CH2Ph), 4.67 (d, J = 11.4 Hz, 1H, CH2Ph), 4.61 (d, J = 12.6 Hz, 1H, CH2Ph), 
4.54 − 4.48 (m, 3H, H-1’, Fmoc-CH2), 4.34 (dd, J = 12.3, 4.0 Hz, 1H, H-5a), 4.29 − 4.24 
(m, 1H, Fmoc-CH), 4.13 − 4.05 (m, 2H, H-4’, H-5a’), 3.99 (t, J = 6.6 Hz, 1H, H-3), 3.72 (t, 
J = 8.2 Hz, 1H, H-3’), 3.54 (dd, J = 12.3, 6.8 Hz, 1H, H-5b), 3.27 (td, J = 10.9, 4.9 Hz, 1H, 
H-5b’) ppm. 13C-NMR (100 MHz, CDCl3): δ = 162.6, 162.5 (3C, C=O), 151.8, 140.7, 140.6, 
138.8, 135.4, 135.3, 134.5, 132.3, 130.9, 130.6, 130.5, 130.5, 127.4, 127.4, 127.3, 126.9, 
126.5, 126.0, 125.7, 125.7, 125.7, 125.6, 125.6, 125.6, 125.5, 125.4, 125.2, 125.1, 125.1, 
124.9, 124.7, 124.7, 124.5, 123.6, 123.4, 122.8, 122.6, 117.6 (46C, Ar), 97.2 (C-1’), 96.2 
(C-1), 76.7 (C-3’), 73.5 (C-3), 73.2 (C-4’), 71.8 (CH2Ph), 71.0 (C-4), 71.0 (CH2Ph), 70.0 





CH) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C64H56NaO13
+: 1055.3619; found: 





The protected disaccharide 56 (10.0 g, 9.71 mmol) was dissolved in a mixture of 
DCM (50 mL), MeOH (12.5 mL) and H2O (0.5 mL), and DDQ (6.61 g, 29.1 mmol) was 
added. The reaction mixture was stirred at r.t. for 4 h. The reaction mixture was diluted 
with DCM (30 mL) and washed with aq. sat. NaHCO3 solution (30 mL) and H2O (30 mL). 
The organic layers were dried with Na2SO4 and the solvent was evaporated. The crude 
product was purified by column chromatography (SiO2, Hex/EtOAc = 4:1) to give SI3 
(6.89 g, 7.72 mmol, 79%) as a colorless oil. [𝑎]𝐷
25 = -30.9 (c 0.75, CHCl3). 
1H-NMR (400 
MHz, CDCl3): δ = 8.01 − 7.96 (m, 2H, ArH), 7.86 − 7.80 (m, 2H, ArH), 7.62 − 7.53 (m, 2H, 
ArH), 7.48 − 7.36 (m, 4H, ArH), 7.32 − 7.20 (m, 6H, ArH), 7.17 − 6.96 (m, 12H, ArH), 5.16 
(dd, J = 8.5, 7.0 Hz, 1H, H-2), 4.98 (dd, J = 6.7, 5.1 Hz, 1H, H-2’), 4.69 (d, J = 5.1 Hz, 1H, 
H-1’), 4.65 (d, J = 12.6 Hz, 1H, CH2Ph), 4.60 (d, J = 11.2 Hz, 1H, CH2Ph), 4.53 (d, J = 
11.2 Hz, 1H, CH2Ph), 4.40 (d, J = 12.6 Hz, 1H, CH2Ph), 4.35 (d, J = 7.0 Hz, 1H, H-1), 4.28 
− 4.20 (m, 2H, Fmoc-CH2), 4.10 − 4.00 (m, 2H, H-5a’, Fmoc-CH), 3.95 − 3.85 (m, 3H, H-4, 
H-5a, H-3’), 3.55 (t, J = 8.2 Hz, 1H, H-3), 3.32 (dd, J = 12.5, 6.5 Hz, 1H, H-5b’), 3.14 − 
3.06 (m, 1H, H-5b) ppm. 13C-NMR (100 MHz, CDCl3): δ = 165.8, 165.2, 154.7 (3C, C=O), 
143.3, 143.1, 141.3, 137.6, 137.0, 133.6, 133.2, 130.0, 129.9, 129.8, 129.3, 128.6, 128.5, 
128.4, 128.3, 128.3, 128.1, 128.0, 127.7, 127.3, 125.2, 125.1, 120.1 (36C, Ar), 99.6 (C-1), 
98.5 (C-1’), 79.0 (C-3), 75.4 (C-3’), 74.4 (CH2Ph), 74.0 (C-4’), 72.5 (C-2), 71.9 (C-2’), 70.2 
(Fmoc-CH2), 70.0 (CH2Ph), 69.8 (C-4), 62.3 (C-5), 60.5 (C-5’), 46.7 (Fmoc-CH) ppm. ESI-
HRMS: m/z [M+Na]+ calcd. for C53H48O13Na
+: 915.2987; found: 915.2817. IR (neat): 𝜈max = 










A mixture of SI3 (6.95 g, 7.78 mmol), arabinose BB 2a (5.13 g, 10.1 mmol) and 
activated molecular sieves (4 Å, 1.00 g) in anhydrous DCM (50 mL) was stirred at r.t. for 
30 min under an Argon atmosphere. After the mixture was cooled to −40 °C, NIS (7.00 g, 
31.1 mmol) and TfOH (0.137 mL, 1.56 mmol) were added. The reaction mixture was 
allowed to warm to −20 °C for 30 min. The reaction mixture was diluted with DCM (50 mL) 
and quenched by the addition of aq. sat. NaHCO3 solution (50 mL). The phases were 
separated and the organic phase was washed with aq. sat. Na2S2O3 solution (50 mL) and 
H2O (50 mL). The organic layer was dried with Na2SO4 and the solvent was evaporated. 
The crude product was purified via column chromatography (SiO2, EtOAc/Hex = 1:4) to 
give fully protected trisaccharide 57 (9.64 g, 7.21 mmol, 93%) as a colorless solid. [𝑎]𝐷
25 = 
-26.3 (c 1.0, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 8.10 – 7.88 (m, 8H, ArH), 7.71 – 7.27 
(m, 22H, ArH), 7.21 – 7.06 (m, 13H, ArH), 5.57 – 5.49 (m, 1H, H-4‘‘), 5.46 (d, J = 6.8 Hz, 
1H, H-1‘‘), 5.44 – 5.38 (m, 1H, H-2‘), 5.37 (s, 1H, H-2‘‘), 5.22 (t, J = 8.7 Hz, 1H, H-2), 4.98 
– 4.84 (m, 1H, H-4‘), 4.84 (d, J = 11.4 Hz, 1H, CH2Ph), 4.82 – 4.72 (m, 2H, H-5a‘‘, H-1‘), 
4.71 – 4.54 (m, 4H, H-3‘‘, CH2Ph, CH2Ph), 4.50 (d, J = 13.2 Hz, 1H, H-5b‘‘), 4.40 (d, J = 
7.3 Hz, 1H, H-1), 4.35 – 4.26 (m, 1H, H-3‘), 4.26 – 4.19 (m, 1H, H-5a‘), 4.15 – 4.08 (m, 
1H, Fmoc-CH2), 4.05 – 3.92 (m, 4H, H-4, H-5a, Fmoc-CH, Fmoc-CH2), 3.67 (t, J = 8.4 Hz, 
1H, H-3), 3.52 – 3.40 (m, 1H, H-5b‘), 3.12 (t, J = 10.3 Hz, 1H, H-5b) ppm. 13C-NMR (100 
MHz, CDCl3): δ = 166.2, 165.6, 165.2, 165.1, 165.0, 164.9 (6C, C=O), 154.2, 154.1, 
145.5, 145.3, 144.5, 144.0, 143.1, 142.2, 140.9, 140.8, 140.3, 140.1, 140.0, 139.8, 137.9, 
137.1, 137.0, 136.9, 134.3, 134.2, 133.9, 133.8, 133.7, 133.4, 133.3, 133.0, 130.0, 129.9, 
129.8, 129.7, 129.6, 129.5, 129.4, 128.9, 128.8, 128.7, 128.6, 128.5, 128.3, 128.2, 128.1, 
127.8, 127.7, 127.6, 127.5, 125.0, 124.9, 121.8, 121.7, 120.2 (54C, Ar), 105.7 (C-1‘‘), 
100.4 (C-1‘), 99.7 (C-1), 82.1 (2C, C-3‘‘, C-2‘‘), 78.9 (C-3), 77.5 (C-4‘‘), 77.3 (C-4), 74.5 
(CH2Ph), 74.3 (C-3’), 73.2 (C-4’), 72.4 (C-2), 70.0 (C-5‘‘), 69.6 (Fmoc-CH2), 63.8 (CH2Ph), 
62.8 (C-5), 62.3 (C-5‘), 46.3 (Fmoc-CH) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for 
C79H68O20Na





The protected trisaccharide 57 (2.50 g, 1.87 mmol) was dissolved in DCM (6 mL) and 





reaction mixture was stirred at r.t. for 18 h. The reaction was neutralized by the addition of 
Amberlite IR-120 (H+) resin until the pH was 7. The resin was filtered off and the solvents 
were evaporated. The crude product was purified by column chromatography (SiO2, 
EtOAc to EtOAc/MeOH =20:1) to give semi-protected trisaccharide SI4 (813 mg, 
1.37 mmol, 73%) as a yellow oil. [𝑎]𝐷
25 = -8.7 (c 0.71, CHCl3). 
1H NMR (400 MHz, CDCl3): 
δ = 7.34 - 7.21 (m,8H, ArH), 5.30 (d, J = 1.7 Hz, 1H, H-1''), 4.79 (d, J = 11.9 Hz, 1H, 
CH2Ph), 4.74 - 4.60 (m, 3H, H-1', CH2Ph), 4.48 (d, J = 11.9 Hz, 1H, CH2Ph), 4.35 (d, J = 
6.3 Hz, 1H, H-1), 4.21 (s, 1H, H-2''), 4.18 - 4.06 (m, 3H, H-3, H-4, H-5a), 4.01 - 3.90 (m, 
1H, H-5a''), 3.88 - 3.77 (m, 2H, H-3', H5a'), 3.76 - 3.60 (m, 4H, H-2', H-4', H-5b' H-4''), 
3.50 (d, J = 7.2 Hz, 3H, H-2, H5b, H-3''), 3.19 (t, J = 10.3 Hz, 1H, H-5b'') ppm. 13C NMR 
(101 MHz, CDCl3): δ = 138.1, 137.5, 128.5, 128.5, 128.1, 127.9, 127.9, 127.8 (8C, Ar), 
108.5 (C-1’’), 101.8 (C-1’), 100.7 (C-1), 84.3, 82.9, 81.4, 77.4, 76.4, 73.9, 72.7, 70.1, 68.9, 
68.6, 65.5, 61.4, 59.3 ppm. ESI-HRMS: m/z = [M+Na]+ calcd. for C29H38NaO13
+: 617.2210; 




The semi-protected trisaccharide SI4 (813 mg, 1.37 mmol) was dissolved in MeOH 
(8 mL) and Pd/C (300 mg, 10% Pd) was added. Hydrogen gas was bubbled through the 
reaction mixture for 10 min and the reaction mixture was stirred under a hydrogen 
atmosphere for 2 d. The reaction mixture was diluted with H2O (5 mL) and the catalyst 
was filtered off by using a syringe filter (4.5 m). After evaporation of the solvents fully 
deprotected trisaccharide 53 (565 mg, 1.36 mmol, 99%) was obtained as a colorless solid. 
1H NMR (400 MHz, D2O): δ = 5.16 (d, J = 1.8 Hz, 1H, H-1’’), 5.02 (d, J = 3.6 Hz, 0.5H, H-
1), 4.41 (d, J = 7.9 Hz, 0.5H, H-1), 4.31 (d, J = 7.8 Hz, 1H; H-1’), 4.00 (dd, J = 5.5, 3.6 
Hz, 2H), 3.91 – 3.76 (m, 3H), 3.68 – 3.47 (m, 6H), 3.42 (t, J = 8.1 Hz, 1H), 3.37 (t, J = 8.0 
Hz, 1H), 3.28 – 3.09 (m, 3H), 3.08 (dd, J = 9.4, 7.8 Hz, 1H) ppm. 13C NMR (101 MHz, 
D2O): δ = 107.9 (C-1’’), 101.6 (C-1’), 101.6 (C-1), 96.3 (C-1), 91.8, 83.8, 81.2, 81.2, 
81.0, 76.5, 76.4, 76.3, 73.8, 73.7, 72.7, 72.7, 71.2, 70.8, 67.6, 64.9, 62.8, 61.1, 58.7 ppm. 
ESI-HRMS: m/z = [M+Na]+ calcd. for C15H26NaO13
+: 437.1271; found 437.1342. IR (neat): 










The protected disaccharide 55 (6.05 g, 6.11 mmol) was dissolved in DCM (50 mL). 
NEt3 (8.45 mL, 61.1 mmol) was added and the reaction mixture was stirred at r.t. for 2 h. 
The reaction mixture was quenched by the addition of 1 M HCl solution (50 mL). The 
phases were separated and the organic phase was dried with Na2SO4. The solvent was 
evaporated and the crude product was purified by column chromatography (SiO2, 
Hex/EtOAc = 2:1) to give compound SI5 (4.17 g, 5.49 mmol, 90%) as a colorless solid. 
[𝑎]𝐷
25 = -33.0 (c 0.74, CHCl3). 
1H NMR (400 MHz, CDCl3):  = 8.08 – 8.03 (m, 2H, ArH), 
7.95 – 7.90 (m, 2H, ArH), 7.65 – 7.54 (m, 2H, ArH), 7.52 – 7.39 (m, 4H, ArH), 7.25 – 7.05 
(m, 15H, ArH), 5.25 – 5.19 (m, 2H, H-2, H-2’), 4.79 – 4.71 (m, 3H, CH2Ar), 4.70 (d, J = 5.9 
Hz, 1H, H-1), 4.61 (dd, J = 11.5, 3.1 Hz, 2H, CH2Ar), 4.52 (d, J = 12.6 Hz, 1H, CH2Ar), 
4.43 (d, J = 7.2 Hz, 1H, H-1’), 4.09 (dd, J = 11.8, 4.4 Hz, 1H, H-5a’), 4.03 – 3.94 (m, 2H, 
H-5a, H-4’), 3.83 – 3.74 (m, 1H, H-4), 3.67 – 3.60 (m, 2H, H-3, H-3’), 3.31 (dd, J = 11.9, 
8.0 Hz, 1H, H-5b’), 3.20 – 3.12 (m, 1H, H-5b) ppm. 13C NMR (101 MHz, CDCl3):  = 165.1, 
165.0 (2C, C=O), 137.9, 137.6, 137.0, 133.4, 133.0, 129.9, 129.8, 129.7, 129.5, 128.6, 
128.5, 128.2, 128.1, 128.0, 127.6, 127.4 (30C, Ar), 99.8 (C-1), 99.6 (C-1’), 80.2 (C-3), 
79.0 (C-3’), 76.1 (C-4’), 74.2 (CH2Ar), 73.8 (CH2Ar), 72.4 (C-2), 72.2 (C-2’), 69.9 (CH2Ar), 
68.7 (C-4), 64.1 (C-5’), 62.6 (C-5) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C45H44NaO11
+: 






Disaccharide SI5 (3.70 g, 4.87 mmol), xylose BB 8b (4.22 g, 5.84 mmol) and 
powdered molecular sieves (4 Å, 500 mg) in anhydrous DCM (27.0 mL) were cooled to -
30 °C. NIS (4.38 g, 19.4 mmol) and TfOH (1.06 mL, 5.84 mmol) were added and the 
reaction mixture was stirred at −30 °C. After 30 min, the reaction mixture was diluted with 
DCM (25 mL) and quenched by the addition of aq. sat. NaHCO3 solution (50 mL). The 
phases were separated and the organic phase was washed with aq. sat. Na2S2O3 solution 
(50 mL) and H2O (50 mL). The organic layer was dried with Na2SO4 and the solvent was 





trisaccharide 58 (7.00 g). The crude trisaccharide 58 (3.40 g) was dissolved in a mixture 
of DCM (20.0 mL), MeOH (5.00 mL) and H2O (0.100 mL) and DDQ (1.69 g, 7.51 mmol) 
was added. The reaction mixture was stirred at r.t. for 4 h. The reaction mixture was 
diluted with DCM (20 mL) and washed with aq. sat. NaHCO3 solution (30 mL) and H2O 
(30 mL). The organic layer was dried with Na2SO4 and the solvents were evaporated. The 
crude product was purified by column chromatography (SiO2, Hex/EtOAc = 4:1) to give 
compound SI6 (2.28 g, 1.87 mmol, 75% over 2 steps). [𝑎]𝐷
25 = -36.8 (c 0.6, CHCl3). 
1H 
NMR (400 MHz, CDCl3):  = 8.15 – 8.09 (m, 2H, ArH), 8.02 – 7.96 (m, 2H, ArH), 7.92 – 
7.87 (m, 2H, ArH), 7.80 – 7.75 (m, 2H, ArH), 7.64 – 7.38 (m, 14H, ArH), 7.32 – 7.27 (m, 
2H, ArH), 7.22 – 7.03 (m, 14H, ArH), 5.23 – 5.15 (m, 2H, H-2, H-2’), 5.07 (dd, J = 7.0, 5.3 
Hz, 1H, H-2’’), 4.80 – 4.55 (m, 8H, H-1’, H-1’’, H-4’’, CH2Ar), 4.48 (d, J = 12.6 Hz, 
1H,CH2Ar), 4.42 (dd, J = 7.4, 1.8 Hz, 2H, Fmoc-CH2), 4.37 (d, J = 7.3 Hz, 1H, H-1), 4.23 
(t, J = 7.3 Hz, 1H, Fmoc-CH), 4.18 (dd, J = 12.6, 4.3 Hz, 1H, H-5a’’), 4.05 – 3.86 (m, 5H, 
H-4, H-5a, H-5a’, H-4’, H-3’’), 3.72 (t, J = 7.9 Hz, 1H, H-3’), 3.63 – 3.54 (m, 1H, H-3), 3.45 
(dd, J = 12.5, 6.9 Hz, 1H, H-5b’’), 3.22 (dd, J = 11.6, 8.3 Hz, 1H, H-5b’), 3.12 – 3.01 (m, 
1H, H-5b) ppm. 13C NMR (101 MHz, CDCl3):  = 165.9, 165.2, 165.1, 154.6 (4C, C=O), 
143.2, 143.0, 141.3, 138.0, 137.5, 136.9, 133.8, 133.4, 133.0, 129.9, 129.8, 129.5, 129.2, 
128.7, 128.6, 128.3, 128.3, 128.2, 128.1, 128.0, 127.8, 127.6, 127.6, 127.4, 127.2, 125.2, 
125.1, 120.1 (48C, Ar), 100.1 (C-1’’), 99.6 (C-1), 98.5 (C-1’), 78.8 (C-3), 78.6 (C-3’), 76.5 
(C-4), 75.1 (C-4’), 74.3 (CH2Ar), 74.2 (CH2Ar), 74.1 (C-4’’), 72.5, 72.3 (2C, C-2, C-2’), 72.0 
(C-1’’), 70.3 (C-3’’), 70.2 (Fmoc-CH2), 70.0 (2C, CH2Ar), 62.6 (C-5), 62.0 (C-5’), 60.6 (C-
5’’), 46.6 (Fmoc-CH) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C72H66NaO18
+: 1241.4147; 






Trisaccharide SI6 (2.07 g, 1.70 mmol), arabinose BB 2a (1.12 g, 2.21 mmol) and 
powdered molecular sieves (4 Å, 250 mg) in anhydrous DCM (15.0 mL) were cooled to -
40 °C. NIS (1.52 g, 6.80 mmol) and TfOH (30.0 L, 0.340 mmol) were added and the 
reaction mixture was stirred at −20 °C. After 30 min, the reaction mixture was diluted with 
DCM (20 mL) and quenched by the addition of aq. sat. NaHCO3 solution (25 mL). The 





(25 mL) and H2O (25 mL). The organic layer was dried with Na2SO4 and the solvent was 
evaporated. The crude product was purified by column chromatography (SiO2, Hex/EtOAc 
= 4:1) to give tetrasaccharide 59 (2.26 g, 1.36 mmol, 79%) as a colorless solid. [𝑎]𝐷
25 = -
41.2 (c 0.7, CHCl3). 
1H NMR (400 MHz, CDCl3):  =8.00 – 7.75 (m, 10H, ArH), 7.68 (s, 1H, 
ArH), 7.61 – 6.88 (m, 42H, ArH), 5.45 – 5.40 (m, 1H, H-4’’’), 5.38 – 5.30 (m, 2H, H-2’’, H-
1’’’), 5.28 (s, 1H, H-2’’’), 5.08 – 5.00 (m, 2H, H-2, H-2’), 4.87 – 4.79 (m, 1H, H-4’’), 4.75 (d, 
J = 11.5 Hz, 1H, CH2Ar), 4.70 – 4.44 (m, 8H, H-1’’, H-3’’’, H-5a’’’, CH2Ar), 4.40 – 4.33 (m, 
2H, H-1’, H-5a’’’), 4.27 – 4.17 (m, 2H, H-1, H-3’’), 4.13 (dd, J = 11.8, 4.9 Hz, 1H, H-5a’’), 
4.03 – 3.69 (m, 7H, H-4, H-4’, Fmoc-CH2, Fmoc-CH, H-5a, H-5a’), 3.58 (t, J = 8.3 Hz, 1H, 
H-3’), 3.45 (t, J = 8.2 Hz, 1H, H-3), 3.41 – 3.29 (m, 1H, H-5b’’’), 3.00 – 2.86 (m, 2H, H-5b, 
H-5b’) ppm. 13C NMR (101 MHz, CDCl3):  = 166.1, 166.1, 165.7, 165.6, 165.2, 165.0, 
165.0, 164.9, 154.2, 154.1 (10C, C=O), 145.3, 144.0, 140.0, 139.8, 138.0, 137.8, 137.2, 
137.1, 137.0, 134.3, 134.2, 133.9, 133.8, 133.7, 133.5, 133.4, 133.2, 133.0, 130.0, 129.9, 
129.8, 129.7, 129.5, 129.3, 128.9, 128.8, 128.7, 128.6, 128.5, 128.4, 128.3, 128.2, 128.2, 
128.2, 128.1, 127.8, 127.6, 127.6, 127.4, 121.8, 120.2 (66C, Ar), 106.0 (C-1’’’), 100.5 (2C, 
C-1’, C-1’’), 99.6 (C-1), 82.2 (C-3’’’), 82.1 (C-2’’’), 78.7, 78.5 (2C, C-3, C-3’), 77.4 (2C, C-4, 
C-4’), 67.8 (C-4’’’), 74.9 (C-3’’’), 74.2 (2C, CH2Ar), 73.4 (C-4’’), 72.5, 72.3 (2C, C-2, C-2’), 
70.0 (C-5’’’), 69.1 (Fmoc-CH2), 63.8 (CH2Ar), 62.7, 62.5 (3C, C-5, C-5’, C-5’’), 46.2 (Fmoc-
CH) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C98H86NaO25
+: 1685.5356; found: 





The protected tetrasaccharide 59 (1.90 g, 1.14 mmol) was dissolved in DCM 
(4.00 mL) and MeOH (8.00 mL). NaOMe (0.5 M in MeOH, 185 mg, 3.42 mmol) was added 
and the reaction mixture was stirred at r.t. for 18 h. The reaction mixture was neutralized 
by the addition of Amberlite IR-120 (H+) resin. The resin was filtered off and the solvents 
were evaporated. The crude product was purified by column chromatography (SiO2, 
EtOAc to EtOAc/MeOH = 20:1) to give semi-protected tetrasaccharide SI7 (607 mg, 
744 mmol, 65%) as a yellow oil. [𝑎]𝐷
25 = -99.2 (c 0.48, CHCl3). 
1H NMR (400 MHz , CDCl3): 
 = 7.41 – 7.27 (m, 15H, ArH), 5.28 (s, 1H, H-1’’’), 4.85 (d, J = 11.8 Hz, 1H), 4.73 – 4.62 
(m, 6H), 4.59 – 4.50 (m, 2H, H-1’), 4.27 (d, J = 6.2 Hz, 1H, H-1), 4.22 – 4.00 (m, 6H), 3.95 





NMR (101 MHz, CDCl3):  = 138.2, 137.7, 137.2, 128.4, 128.3, 128.1, 127.9, 127.8, 
127.6, 108.4, 101.4 (2C), 99.2, 84.1, 82.7, 81.1, 78.9, 76.4, 76.2, 73.6, 73.4, 73.1, 72.8, 
72.5, 70.8, 70.3, 68.6 (2C), 65.3, 61.2, 60.8, 59.2 ppm. ESI-HRMS: m/z [M+Na]+ calcd. for 
C41H52NaO17





The semi protected tetrasaccharide SI7 (550 mg, 0.674 mmol) was dissolved in 
MeOH (10.0 mL) and EtOAc (5.00 mL) and Pd/C (250 mg, 10% Pd) was added. Hydrogen 
gas was bubbled through the reaction mixture for 10 min and the reaction mixture was 
stirred under a hydrogen atmosphere for 2 d. The reaction mixture was diluted with H2O 
(5.00 mL) and NEt3 (0.1 mL) was added. The catalyst was filtered off by using a syringe 
filter (4.5 m) and the solvents were evaporated to give crude compound 43 (294 mg). 
The compound was used in the next step without further purification. 
3.4.4 Chemo-Enzymatic Synthesis of Arabinoxylan 
Oligosaccharides 
4-Methylphenyl 2,3,4-tri-O-acetyl-1-thio-β-D-xylopyranoside (SI8)232 
 
D-Xylose (15.0 g, 100 mmol) was suspended in Et2O (100 mL) and acetic anhydride 
(57.0 mL, 600 mmol), pyridine (48.0 mL, 600 mmol) and DMAP (100 mg, 0.800 mmol) 
were added. The mixture was stirred at r.t. for 20 h. The homogeneous reaction mixture 
was washed with 2 M HCl solution (3 x 150 mL) and the organic phase was dried over 
Na2SO4. After filtration, evaporation of the solvent and co-evaporation with toluene, the 
crude acetyl 2,3,4-tri-O-acetyl-1-D-xylopyranoside (32.5 g) was obtained as a colorless oil. 
The crude compound (32.5 g) was dissolved in anhydrous DCM (200 mL) and TolSH 
(13.7 g, 110 mmol) was added. After the reaction mixture was cooled to 0 °C, BF3∙Et2O 
(26.6 mL, 210 mmol) was added dropwise under Argon atmosphere. The reaction mixture 
was warmed up to r.t. and stirred overnight. The deep red mixture was quenched with aq. 
sat. NaHCO3 solution (200 mL). The layers were separated, and the organic layer was 





Na2SO4, filtered and concentrated to yield the crude product as a brown oil. The mixture 
was recrystallized from Hex/EtOAc to obtain 4-methylphenyl 2,3,4-tri-O-acetyl-1-thio-β-D-
xylopyranoside SI8 (20.7 g, 55%) as colorless crystals. 1H NMR (400 MHz, CDCl3):  = 
7.41 – 7.33 (m, 2H, ArH), 7.17 – 7.09 (m, 2H, ArH), 5.17 (t, J = 8.3 Hz, 1H, H-3), 4.99 – 
4.83 (m, 1H, H-4), 4.71 (d, J = 8.5 Hz, 1H, H-1), 4.25 (dd, J = 11.7, 5.0 Hz, 1H, H-5a), 
3.39 (dd, J = 11.7, 9.0 Hz, 1H, H-5b), 2.34 (s, 3H, CH3), 2.10 (s, 3H, CH3), 2.04 (s, 6H, 
CH3) ppm. The analytical data matches the one reported in literature.
232 
4-Methylphenyl 1-thio-β-D-xylopyranoside (68)232 
 
4-Methylphenyl 2,3,4-tri-O-acetyl-1-thio-β-D-xylopyranoside SI8 (16.0 g, 41.8 mmol) 
was dissolved in DCM (35.0 mL) and MeOH (35.0 mL). To this mixture NaOMe (2.30 g, 
41.8 mmol) was added and the reaction mixture was stirred at r.t. for 2 h. The reaction 
mixture was neutralized with Amberlite IR-120 (H+) resin. After filtration the solvent was 
evaporated. The residue was dissolved in the smallest amount of MeOH possible (about 
5 mL). After the addition of a mixture of Et2O and Hex (35 mL, 1:1 v/v) a fine solid 
precipitated. The solid was filtered off and washed with Et2O to give 4-methylphenyl 1-
thio-β-D-xylopyranoside 68 (7.01 g, 27.3 mmol, 65%) as a colorless solid. 1H NMR (400 
MHz, CD3OD):  = 7.44 – 7.34 (m, 2H, ArH), 7.18 – 7.05 (m, 2H, ArH), 4.41 (d, J = 8.4 Hz, 
1H, H-1), 3.88 (dd, J = 11.2, 5.2 Hz, 1H, H-3), 3.47 – 3.35 (m, 1H, H-4), 3.32 – 3.24 (m, 
1H, H-5a), 3.20 – 3.08 (m, 2H, H-2, H-5b), 2.28 (s, 3H, CH3) ppm. The analytical data 
matches the one reported in literature.232 
4-Methylphenyl 4-O-fluorenylmethoxycarbonyl-1-thio-β-D-xylopyranoside (69)232 
 
4-Methylphenyl 1-thio-β-D-xylopyranoside 68 (7.01 g, 27.3 mmol) was dissolved in 
anhydrous 1,4-dioxane (120 mL). Dibutyltin oxide (8.20 g, 32.8 mmol) was added. The 
suspension was refluxed for 2 h. After the solvent was evaporated a brown foam was 
obtained. The residue was taken up in anhydrous DCM (100 mL), cooled to 0 °C and 
FmocCl (7.10 g, 27.3 mmol) and pyridine (8.80 mL, 109 mmol) were added. The mixture 
was stirred at r.t. for 2 h. The reaction mixture was quenched by the addition of aq. sat. 
NaHCO3 solution (50 mL) and a colorless solid precipitated. The mixture was filtered 
through a plug of celite and the phases were separated. The organic layer was washed 
with aq. sat. NaHCO3 solution (2 x 50 mL). The aq. phase was reextracted with DCM 





mixture was concentrated and the crude product was recrystallized from EtOAc/Hex to 
give 4-methylphenyl 4-O-fluorenylmethoxycarbonyl-1-thio-β-D-xylopyranoside 69 as a 
colorless solid (9.42 g, 19.6 mmol, 72%). [𝑎]𝐷
25 = -43.9 (c 1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3):  = 7.79 – 7.67 (m, 2H, ArH), 7.63 – 7.53 (m, 2H, ArH), 7.45 – 7.36 (m, 4H, ArH), 
7.35 – 7.26 (m, 2H, ArH), 7.18 – 7.11 (m, 2H, ArH), 4.70 – 4.61 (m, 1H, H-4), 4.51 – 4.35 
(m, 3H, Fmoc-CH2, H-1), 4.23 (t, 
3J=7.2 Hz, 1H, Fmoc-CH), 4.18 (dd, J = 11.4, 5.4 Hz 1H, 
H-5a), 3.76 (t, J = 8.9 Hz, 1H, H-3), 3.40 – 3.29 (m, 2H, H-5b, H-2), 2.36 (s, 3H, CH3) 
ppm. 13C NMR (101 MHz, CDCl3):  = 154.6, 143.2, 143.0, 141.3, 138.9, 133.8, 129.9, 
129.9, 127.2, 127.9, 125.0, 125.1, 120.1 (18C, Ar), 88.4 (1C, C-1), 75.1 (1C, C-3), 74.2 
(1C, C-4), 71.7 (1C, C-2), 70.2 (1C, Fmoc-CH2), 66.4 (1C, C-5), 46.6 (1C, Fmoc-CH), 21.2 
(1C, CH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for C27H26NaO6S
+: 501.1348; found: 





4-Methylphenyl 4-O-fluorenylmethoxycarbonyl-1-thio-β-D-xylopyranoside 69 (9.00 g, 
18.8 mmol) was dissolved in anhydrous DCM (100 mL) and cooled to 0 °C. Pyridine 
(9.20 mL, 113 mmol) and benzoyl chloride (8.73 mL, 75.0 mmol) were added. The mixture 
was stirred at r.t. for 4 h. To quench the reaction 1 M HCl solution (50 mL) was added. 
After separation of the phases the organic layer was washed with aq. sat. NaHCO3 
solution (3 x 30 mL), dried over Na2SO4 and concentrated. The crude product was 
recrystallized from EtOAc/Hex to give 4-methylphenyl 2,3-di-O-benzoyl-4-O-
fluorenylmethoxycarbonyl-1-thio-β-D-xylopyranoside 65 (8.32, 12.1 mmol, 64%) as 
colorless crystals. [𝑎]𝐷
25 = -7.60 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): = 7.83 – 7.74 
(m, 4H, ArH), 7.48 – 7.42 (m, 2H, ArH), 7.28 – 7.17 (m, 4H, ArH), 7.14 – 7.03 (m, 8H, 
ArH), 6.98 – 6.92 (m, 1H, ArH), 6.91 – 6.80 (m, 3H, ArH), 5.37 (t, J = 6.7 Hz, 1H, H-3), 
5.13 (t, J = 6.4 Hz, 1H, H-2), 4.88 (d, J = 6.2 Hz, 1H, H-1), 4.75 – 4.65 (m, 1H, H-4), 4.29 
(dd, J = 12.3, 3.8 Hz, 1H, H-5a), 4.13 – 3.97 (m, 2H, Fmoc-CH2), 3.86 (t, J = 7.6 Hz, 1H, 
Fmoc-CH), 3.51 (dd, J = 12.3, 6.7 Hz, 1H, H-5b), 2.04 (s, 3H, CH3) ppm. 
13C NMR (101 
MHz, CDCl):  = 165.2, 165.2, 154.3, 143.3, 143.1, 141.3, 141.2, 138.6, 134.7, 133.7, 
133.5, 133.3, 130.7, 130.2, 130.1, 129.9, 129.3, 129.2 129.0, 128.9, 128.6, 128.5, 128.0, 
127.3, 125.3, 125.2, 120.1 (30C, Ar), 86.6 (1C, C-1), 71.5 (1C, C-4), 70.6 (1C, Fmoc-
CH2), 70.5 (1C, C-3), 69.8 (1C, C-2), 63.4 (1C, C-5), 46.6 (1C, Fmoc-CH), 21.3 (1C, CH3) 
ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C41H34NaO8S











ranoside 65 (5.12 g, 7.43 mmol) was dissolved in anhydrous DCM (150 mL) and cooled to 
0 °C under Argon atmosphere. Dibutyl hydrogen phosphate (3.68 mL, 18.6 mmol), NIS 
(2.01 g, 8.99 mmol) and TfOH (0.20 mL, 2.23 mmol) were added. After stirring for 1 h at 
0 °C the reaction was quenched with aq. sat. NaHCO3 solution (100 mL) and washed with 
aq. sat. Na2S2O3 solution (50 mL). The organic phase was dried over Na2SO4, filtered and 
after the removal of the solvent the crude product was purified by column chromatography 
(SiO2, Hex/EtOAc = 4:1) to give phosphate donor 66 as a colorless oil (4.83 g, 6.21 mmol, 
84%, α/β = 1:10). 1H NMR (400 MHz, CDCl3): δ = 8.12 – 7.99 (m, 4H, ArH), 7.75 – 7-70 
(m, 2H, ArH), 7.59 - 7.46 (m, 4H, ArH), 7.42 – 7.32 (m, 6H, ArH), 7.29 – 7.14 (m, 2H, 
ArH), 5.69 – 5.60 (m, 2H, H-1, H-3), 5.42 (dd, J = 6.4, 4.8 Hz, 1H, H-2), 5.02 (td, J = 6.2, 
3.7 Hz, 1H, H-4), 4.45 (dd, J = 12.6, 3.8 Hz, 1H, H-5a), 4.37 – 4.30 (m, 2H, Fmoc-CH2), 
4.16 (t, J = 7.6 Hz, 1H, Fmoc-CH), 4.12 – 4.03 (m, 2H, OBu), 3.95 – 3.83 (m, 3H, OBu, H-
5b), 1.70 – 1.59 (m, 2H, Bu), 1.48 – 1.34 (m, 4H, Bu), 1.23 – 1.10 (m, 2H, Bu), 0.90 (t, J = 
7.4 Hz, 3H, OBu), 0.76 (t, J = 7.4 Hz, 3H, OBu) ppm. 13C NMR (101 MHz, CDCl3): δ = 
165.0, 164.9, 154.2 (3C, C=O), 143.1, 142.9, 141.2, 133.6, 130.0, 129.9, 128.8, 128.5, 
127.9, 127.2, 125.1, 120.0 (24C, Ar), 95.8 (1C, C-1), 70.9 (1C, C-4), 70.5 (1C, Fmoc-
CH2), 69.0 (1C, C-3), 68.9 (1C, C-2), 68.1, 68.0 (2C, OBu), 61.3 (1C, C-5), 46.5 (Fmoc-
CH), 32.2, 32.0 (2C, Bu), 18.6, 18.4 (2C, Bu), 13.6, 13.7 (2C, OBu) ppm. ESI-HRMS: m/z 
[M+Na]+ calcd. for C42H45NaO12P
+: 795.2456; found: 795.2550. IR (neat): νmax = 1729, 
1246, 1026, 712 cm-1. 
4-Methylphenyl 2,3-di-O-benzoyl-1-thio-β-D-xylopyranoside (70) 
 
4-Methylphenyl 2,3-di-O-benzoyl-4-O-fluorenylmethoxycarbonyl-1-thio-β-D-xylopyra-
noside 65 (3.44 g, 5.22 mmol) was dissolved in DCM (50 mL). To the mixture was added 
NEt3 (2.90 mL, 20.1 mmol). After the reaction mixture was stirred for 10 h at r.t. the 
reaction was quenched by the addition of 1 M HCl solution (30 mL). The layers were 
separated and the aqueous layer was extracted with DCM. The combined organic layers 





column chromatography (SiO2, Hex/EtOAc = 3:1 to 2:1) to give 4-methylphenyl 2,3-di-O-
benzoyl-1-thio-β-D-xylopyranoside 70 (1.89 g, 4.09 mmol, 80%) as a colorless solid. 1H 
NMR (400 MHz, CDCl3): δ = 8.07 – 7.96 (m, 4H, ArH), 7.59 – 7.49 (m, 2H, ArH), 7.45 – 
7.36 (m, 6H, ArH), 7.17 – 7.09 (m, 2H, ArH), 5.47 – 5.24 (m, 2H, H-2, H-3), 5.01 (d, J = 
7.5 Hz, 1H, H-1), 4.41 (dd, J = 11.9, 4.4 Hz, 1H, H-5a), 4.12 – 3.90 (m, 1H, H-4), 3.58 (dd, 
J = 11.8, 8.2 Hz, 1H, H-5b), 3.17 (s, 1H, OH), 2.34 (s, 3H, CH3) ppm. The analytical data 




4-Methylphenyl 2,3-di-O-benzoyl-1-thio-β-D-xylopyranoside 70 (0.970 g, 2.09 mmol) 
and phosphate donor 66 (1.93 g, 2.51 mmol) were dissolved in anhydrous DCM (65.0 mL) 
and cooled to -78 °C under Argon atmosphere. After TMSOTf (0.378 mL, 2.09 mmol) was 
added, the mixture was slowly warmed up to 0 °C. After 4 h the reaction was quenched 
with aq. sat. NaHCO3 solution (80 mL). The layers were separated and the aqueous layer 
was extracted with DCM (2 x 50 mL). The combined organic phases were dried over 
Na2SO4 and filtered. After the solvent was evaporated the crude product was purified by 
silica gel flash column chromatography (SiO2, Hex/EtOAc = 4:1 to 2:1) to give SI19 as a 
colorless solid (1.42 g, 1.38 mmol, 66%). [𝑎]𝐷
25 = 7.45 (c 1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 8.06 – 7.91 (m, 8H, ArH), 7.75 – 7.69 (m, 2H, ArH), 7.57 – 7.33 (m, 17H, 
ArH), 7.26 – 7.13 (m, 3H, ArH), 7.11 – 7.06 (m, 2H, ArH), 5.64 (t, J = 8.0 Hz, 1H, H-3), 
5.52 (t, J = 6.6 Hz, 1H, H-3‘), 5.30 (t, J = 8.2 Hz, 1H, H-2), 5.25 – 5.15 (m, 1H, H-2‘), 4.94 
– 4.88 (m, 2H, H-1, H-1‘), 4.77 – 4.70 (m, 1H, H-4‘), 4.38 – 4.17 (m, 3H, Fmoc-CH2, H-5a), 
4.15 – 4.02 (m, 2H, Fmoc-CH, H-4), 3.91 (dd, J = 12.5, 3.7 Hz, 1H, H-5a’), 3.50 (dd, J = 
12.0 Hz, J = 8.8 Hz, 1H, H-5b), 3.42 (dd, J = 12.5 Hz, 6.2 Hz, 1H, H’-5b), 2.31 (s, 3H, 
CH3) ppm. 
13C NMR (101 MHz, CDCl3): δ = 165.4, 165.2, 165.1, 164.9, 154.1 (5C, C=O), 
143.1, 142.9, 141.2, 141.2, 138.4, 133.5, 133.3, 133.3, 130.0, 129.9, 129.8, 129.7, 129.4, 
129.3, 129.0, 128.7, 128.6, 128.5, 128.5, 128.4, 128.4, 127.9, 127.2, 125.1, 125.0, 120.0 
(42C, Ar), 99.5 (C-1‘), 86.9 (C-1), 75.2 (C-4), 73.1 (C-3), 71.2 (C-4‘), 70.4 (C-2), 70.3 
(Fmoc-CH2), 69.7 (C-2‘), 69.4 (C-3‘), 65.6 (C-5‘), 60.4 (C-5), 46.5 (Fmoc-CH), 21.2 (CH3) 
ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C60H50NaO15S
+: 1049.2819; found: 1049.2802. IR 










The protected disaccharide SI9 (1.35 g, 1.74 mmol) was dissolved in anhydrous DCM 
(18.0 mL) and NEt3 (23.4 mL, 174 mmol) was added. The reaction mixture was stirred for 
1 h and was quenched by the addition of 1 M HCl solution (25 mL). The phases were 
separated and the aqueous phase was extracted with DCM (20 mL). The combined 
organic phases were dried with Na2SO4 and the solvent was evaporated. The crude 
product was purified by column chromatography (SiO2, Hex/EtOAc = 3:2) to give 71 
(1.01 g, 1.25 mmol, 72%) as a colorless solid. [𝑎]𝐷
25 = 30.4 (c 1.0, CHCl3). 
1H NMR (400 
MHz, CDCl3):  = 8.03 – 7.91 (m, 8H, ArH), 7.58 – 7.48 (m, 4H, ArH), 7.45 – 7.30 (m, 10H, 
ArH), 7.12 – 7.00 (m, 2H, ArH), 5.64 (t, J = 8.2 Hz, H-3), 5.40 – 5.13 (m, 3H, H-2, H-2’, H-
3’), 4.90 (d, J = 8.4 Hz, H-1), 4.78 (d, J = 6.0 Hz, H-1’), 4.15 (dd, J = 12.0, 4.9 Hz, H-5a), 
4.08 – 3.98 (m, 1H, H-4), 3.78 – 3.64 (m, 2H, H-4’, H-5a’), 3.46 (dd, J = 12.0, 9.0 Hz, H-
5b), 3.18 (dd, J = 11.8, 7.7 Hz, H-5b’), 2.31 (s, 1H, CH3) ppm. 
13C NMR (101 MHz, 
CDCl3):  = 167.1, 165.6, 165.3, 165.1 (4C, C=O), 138.5, 133.7, 133.6, 133.3, 133.3, 
130.1, 130.0, 130.0, 129.9, 129.8, 129.8, 129.8, 129.6, 129.4, 129.1, 128.8, 128.7, 128.6, 
128.5, 128.5 (30C, Ar), 101.1 (C-1), 87.0 (C-1’), 76.1 (C-4), 75.5 (C-3’), 73.4 (C-3), 70.7, 
70.5 (2C, C-2, C-2’), 68.4 (C-4’), 66.2 (C-5), 64.5 (C-5’), 21.3 (CH3) ppm. ESI-HRMS: m/z 
[M+Na]+ calcd. for C45H40NaO12S
+: 827.2138; found: 827.2112. IR (neat): νmax = 1730, 




Disaccharide 71 (0.690 g, 0.860 mmol) was dissolved in anhydrous DCM (1 mL) and 
pyridine (1 mL). PivCl (0.160 mL, 1.29 mmol) was added at 0 °C and the reaction mixture 
was stirred at r.t. for 24 h. Then, the reaction was stopped by the addition of sat. aq. 
NaHCO3-Lösung (10 mL). The aqueous phase was extracted with DCM (2 x 5 mL) and 
the combined organic phases were dried with Na2SO4. The solvent was removed and the 
crude product was purified by column chromatography (SiO2, Hex/EtOAc = 6:1) to give 
72a (0.634 g, 0.713 mmol, 83%) as a colorless solid. []D
25 = 16,8 (c 0,6, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 7.99 (ddd, J = 8.5, 3.5, 1.3 Hz, 4H, Ar), 7.96 – 7.91 (m, 2H, Ar), 





2H, Ar), 7.08 (d, J = 7.9 Hz, 2H, Ar), 5.62 (t, J = 7.9 Hz, 1H, H-3‘), 5.53 (t, J = 8.4 Hz, 1H, 
H-2), 5.29 (t, J = 8.1 Hz, 1H, H-2‘), 5.23 (dd, J = 8.6, 6.5 Hz, 1H, H-3), 4.94 – 4.85 (m, 2H, 
H-4, H-1), 4.79 (d, J = 6.5 Hz, 1H, H-1‘), 4.15 (dd, J = 12.0, 4.8 Hz, 1H, H-5a‘), 4.05 – 3.95 
(m, 1H, H-4‘), 3.73 (dd, J = 11.9, 5.0 Hz, 1H, H-5a), 3.46 (dd, J = 12.1, 8.6 Hz, 1H, H-5b‘), 
3.17 (dd, J = 12.0, 8.4 Hz, 1H, H-5b), 2.31 (s, 3H, SPhCH3), 1.00 (s, 9H, OC(CH3)3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 177.0, 165.2, 164.8, (4C, C=O) 138.2, 133.3, 133.2, 
133.1, 133.0, 129.9, 129.7, 129.7, 129.6, 129.5, 129.3, 129.1, 129.0, 128.9, 128.8, 128.4, 
128.6, 128.3, 126.2 (20C, Ar), 101.15 (C-1'), 86.8 (C-1), 75.8 (C-4‘), 80.0 (C-3‘), 71.3 (C-
2), 71.1 (C-2‘), 70.4 (C-3), 68.2 (C-4), 65.7 (C-5), 61.8 (C-5‘), 28.6 (3C, OC(CH3)3), 20.8 
(SPhCH3) ppm. IR: max = 1734, 1453, 1268, 1095, 1070 cm
-1. ESI-HRMS: m/z = [m+Na]+ 
calcd. for C50H48NaO13S: 911.2713; found: 911.2845 
4-Methylphenyl 4-O-pivaloyl-2,3-di-O-benzoyl--D-xylopyranosyl-(1→4)-2,3-di-O-
benzoyl--D-xylopyranosyl fluoride (73a) 
 
Disaccharide 72a (598 mg, 0.678 mmol) was dissolved in anhydrous DCM (15 mL) 
and cooled to –50 °C. NIS (227 mg, 1.01 mmol) and HF/pyridin (85.0 L, 1.04 mmol) were 
added and the reaction mixture was stirred for 30 min at -50 °C. Then, HF/pyridin 
(6.00 mL) was added dropwise and the reaction mixture was stirred at –10 °C for 5 h. 
When the reaction was finished, the reaction mixture was diluted with DCM (10 mL) and 
the solution was carefully dropped into an aq. NH3 solution (25%, 30 mL). The phases 
were separated, and the organic phase was washed with sat. aq. NaHCO3 solution 
(30 mL). The organic phase was dried with MgSO4 and the solvent was evaporated. The 
crude product was purified by column chromatography (SiO2, Hex/EtOAc = 4:1) to give 
glycosyl fluoride 73a (0.216 g, 0.275 mmol, 41%) as a colorless solid. 1H NMR (400 MHz, 
CDCl3): δ = 8.04 – 7.94 (m, 6H, Ar), 7.93 – 7.86 (m, 2H, Ar), 7.58 – 7.47 (m, 4H, Ar), 7.44 
– 7.33 (m, 9H, Ar), 5.95 (t, J = 9.8 Hz, 1H, H-3), 5.83 (dd, J = 53.1, 2.7 Hz, 1H, H-1), 5.59 
– 5.51 (m, 1H, H-3‘), 5.29 – 5.20 (m, 1H, H-2‘), 5.20 – 5.08 (m, 1H, H-2), 4.94 (td, J = 8.0, 
4.7 Hz, 1H, H-4‘), 4.84 (d, J = 6.1 Hz, 1H, H-1‘), 4.18 (td, J = 9.7, 6.6 Hz, 1H, H-4), 3.85 
(q, J = 5.0, 4.5 Hz, 2H, H-5), 3.79 – 3.70 (m, 1H, H-5a‘), 3.19 (dd, J = 12.0, 7.9 Hz, 1H, H-
5b’), 1.03 (s, 9H, OC(CH3)3) ppm. 
13C NMR (151 MHz, CDCl3,): δ = 177.1, 165.7, 165.3, 
164.8, (5C, C=O), 133.5, 133.4, 133.3, 133.0, 129.9, 129.7, 129.6, 128.9, 128.8, 128.5, 
128.4, 128.3 (16C, Ar) 103.9 (d, J = 229.6 Hz, C-1), 100.9 (C-1‘) 75.6 (C-4), 71.5 (C-2‘), 
71.4 (C-2), 71.0 (C-3‘), 70.0 (C-3), 68.1 (C-4‘), 61.7 (C-5‘), 61.3 (C-5), 26.7 (3C, 
OC(CH3)3) ppm. 









The fully protected trisaccharide 57 (6.75 g, 5.05 mmol) was dissolved in DCM 
(50.0 mL). NEt3 (7.03 mL, 50.5 mmol) was added and the reaction mixture was stirred at 
r.t. for 2 h. The reaction mixture was quenched by the addition of 2 M HCl solution (50 mL) 
and the phases were separated. The organic phase was washed with brine (50 mL) and 
dried with Na2SO4. The solvent was evaporated and the crude product was purified by 
column chromatography (EtOAc/Hex = 1:2) to give compound SI10 (5.08 g, 4.56 mmol, 
90%) as a yellow oil. [𝑎]𝐷
25 = -7.4 (c 0.76, CHCl3).
1H NMR (400 MHz, CDCl3): δ = 8.09 – 
8.00 (m, 6H, Ar), 7.95 – 7.90 (m, 2H, ArH), 7.73 – 7.67 (m, 2H, ArH), 7.64 – 7.28 (m, 15H, 
ArH), 7.21 – 7.07 (m, 10H, ArH), 5.53 (dd, J = 4.9, 2.1 Hz, 1H, H-4’’), 5.41 (d, J = 2.1 Hz, 
1H, H-3’’), 5.39 (s, 1H, H-1’’), 5.29 (dd, J = 8.9, 7.5 Hz, 1H, H-2’), 5.21 (dd, J = 8.7, 7.2 
Hz, 1H, H-2), 4.82 (d, J = 11.4 Hz, 1H, CH2Ph), 4.79 – 4.71 (m, 3H, H-2’’, H-5a’’, CH2Ph), 
4.67 (d, J = 11.4 Hz, 1H, CH2Ph), 4.65 – 4.58 (m, 2H, H-1’, CH2Ph), 4.49 (d, J = 12.6 Hz, 
1H, H-5b’’), 4.39 (d, J = 7.2 Hz, 1H, H-1), 4.10 (dd, J = 12.0, 5.2 Hz, 1H, H-5a’), 4.01 – 
3.89 (m, 2H, H-4, H-5a), 3.89 – 3.82 (m, 1H, H-4’), 3.78 (t, J = 8.7 Hz, 1H, H-3’), 3.65 (dd, 
J = 8.7, 7.8 Hz, 1H, H-3), 3.28 (dd, J = 12.0, 9.5 Hz, 1H, H-5b’), 3.10 (dd, J = 11.5, 9.0 Hz, 
1H, H-5b) ppm. 13C NMR (101 MHz, CDCl3): δ = 166.2, 165.8, 165.3, 165.2, 165.0 (5C, 
C=O), 138.1, 137.1, 133.9, 133.6, 133.3, 133.2, 133.1, 130.2, 130.0, 129.9, 129.9, 129.8, 
129.8, 129.6, 128.9, 128.7, 128.7, 128.6, 128.5, 128.5, 128.4, 128.4, 128.2, 127.7, 127.7, 
127.6 (42 C, Ar), 107.5 (C-1’’), 101.4 (C-1’), 99.7 (C-1), 84.3 (C-3’), 81.9 (C-2’’), 81.6 (C-
3’’), 78.9 (C-3), 77.4 (C-4), 77.2 (C-4’’), 74.3 (CH2Ph), 72.4 (C-2), 72.3 (C-2’), 70.1 (C-5’’), 













A solution of trisaccharide SI10 (5.03 g, 4.51 mmol), DHP (1.02 mL, 11.3 mmol) and 
pTsOH monohydrate (17.0 mg, 90.0 mol) in anhydrous DCM (75.0 mL) was stirred at r.t. 
for 4 h. The reaction mixture was diluted with DCM (100 mL) and washed with aq. 
NaHCO3 (100 mL) and brine (100 mL). The organic layer was dried with Na2SO4 and the 
solvent was evaporated to obtain the crude trisaccharide (5.60 g). The crude compound 
(5.60 g) was dissolved in anhydrous DCM (14 mL) and MeOH (28.0 mL). NaOMe (0.5 M 
in MeOH, 16.3 mL, 8.17 mmol) was added and the reaction mixture was stirred at r.t. 
overnight. The reaction mixture was neutralized by the addition of Amberlite IR-120 (H+) 
resin. The resin was filtered off and the solvents were evaporated. The crude product was 
purified by column chromatography (SiO2, EtOAc) to give semi-protected trisaccharide 
SI11 (2.01 g, 2.96 mmol, 66% over 2 steps) as a mixture of two diastereomeres. [𝑎]𝐷
25 = -
91.6 (c 1.0, CHCl3).
 1H NMR (400 MHz, CDCl3): δ = 7.38 – 7.19 (m, 10H), 5.47 (s, 1H, H-
1‘‘), 4.81 (d, J = 11.9 Hz, 1H), 4.78 – 4.65 (m, 3H), 4.64 – 4.46 (m, 3H), 4.41 – 4.29 (m, 
2H), 4.20 – 4.05 (m, 4H), 4.04 – 3.38 (m, 15H), 3.33 – 3.22 (m, 1H), 1.79 – 1.67 (m, 2H), 
1.54 – 1.42 (m, 4H) ppm.
 13C NMR (101 MHz, CDCl3) δ 138.1, 137.9, 137.4, 129.1, 128.5, 
128.4, 128.3, 128.0, 127.9, 127.7, 125.3, 108.2, 107.6, 101.9, 101.5, 101.1, 101.0, 100.9, 
99.7, 87.1, 86.6, 79.5, 78.3, 78.2, 77.6, 77.4, 77.1, 76.8, 75.7, 74.7, 74.5, 74.2, 73.9, 73.1, 
72.9, 72.3, 70.5, 70.3, 70.2, 69.9, 65.7, 64.9, 63.3, 62.0, 61.6, 60.8, 60.3, 31.5, 30.7, 25.2, 
24.9, 21.5, 19.9 ppm. ESI-HRMS: m/z = [M+Na]+ calcd. for C34H46NaO14
+:701.2785; found: 





The semi-protected trisaccharide SI11 (700 mg, 1.03 mmol) was dissolved in MeOH 
(15 mL), EtOAc (3.5 mL) and sodium phosphate buffer (3.5 mL, 100 mM, pH 7), and Pd/C 
(700 mg, 10% Pd) was added. Hydrogen gas was bubbled through the reaction mixture 
for 10 min and was stirred under a hydrogen atmosphere for 1 d. The reaction mixture 
was diluted with H2O (5 mL) and the solution was filtered over a short celite column. After 
evaporation of the solvents the crude trisaccharide 75 (411 mg) was obtained as a mixture 







2,3-di-O-acetyl--D-xylopyranosyl fluoride (SI12) 
 
The crude trisaccharide 75 (411 mg) and DMAP (16.7 mg, 0.137 mmol) were 
dissolved in pyridine (25 mL). Acetic anhydride (412 L, 412 mmol) was slowly added and 
the reaction mixture was stirred at r.t. for 4 h. The reaction mixture was diluted with DCM 
(20 mL) and washed with 1 M HCl (20 mL) solution. The phases were separated and the 
organic phase was dried with Na2SO4. The solvent was evaporated, and the crude 
product was filtered over a short silica column (SiO2, Hex/EtOAc = 2:1 to 1:1) to give the 
crude peracetylated trisaccharide (801 mg) as a mixture of four diastereomers. The crude 
trisaccharide (260 mg) was dissolved in anhydrous DCM (3.00 mL) in a plastic vessel. 
The solution was cooled to -30 °C and HF/pyridine (2.00 mL) was added. The biphasic 
system was stirred rigorously for 2 h at -20 °C. The reaction mixture was diluted with DCM 
(5 mL) and was quenched by dropping the mixture carefully into an aq. ammonia solution 
(25%, 10 mL). The organic phase was washed with aq. sat. NaHCO3 solution (20 mL) and 
reextracted with DCM (2 x 20 mL). The solvents were evaporated and the crude product 
was purified by column chromatography (SiO2, EtOAc/Hex = 2:1) to give SI12 (293 mg, 
0.440 mmol, 60% over 3 steps, / = 8:1) as a colorless solid. [𝑎]𝐷
25 = -22.6 (c 1.11, 
CHCl3).
 1H NMR (400 MHz, CDCl3, -anomer):  = 5.62 (dd, J = 53.0, 2.8 Hz, 1H, H-1), 
5.38 (t, J = 9.5 Hz, 1H, H-3), 5.04 – 4.91 (m, 3H, H-1‘‘, H-2‘‘, H-4‘‘), 4.86 – 4.74 (m, 2H, H-
2, H-2‘), 4.40 – 4.32 (m, 3H, H-1‘, H-3‘‘, H-5a‘‘), 4.25 – 4.16 (m, 1H, H-5b‘‘), 4.01 (dd, J = 
11.9, 5.3 Hz, 1H, H-5a‘), 3.86 – 3.64 (m, 5H, H-4, H-4‘, H-5, OH), 3.42 (t, J = 8.7 Hz, 1H, 
H-3‘), 3.23 (dd, J = 11.9, 9.5 Hz, 1H, H-5b‘), 2.13 – 2.00 (m, 18H, CH3) ppm. 
13C NMR 
(101 MHz, CDCl3, -anomer):  = 170.5, 170.3, 170.2, 169.8, 169.7, 169.6, 169.2 (6C, 
C=O), 107.4 (C-1‘‘), 103.95 (d, J = 229.2 Hz, C-1), 101.5 (C-1‘), 84.8 (C-3‘), 81.4 (C-4‘‘), 
80.7 (C-3‘‘), 76.3 (C-2‘‘),75.4 (C-4‘), 71.0 (C-3‘), 70.54 (d, J = 24.9 Hz, C-2), 69.5 (C-3), 
68.7 (C-4), 65.2 (C-5‘), 63.1 (C-5‘‘), 61.18 (d, J = 4.8 Hz, C-5), 20.8, 20.8, 20.7, 20.7, 20.7, 
20.6 (6C, CH3) ppm. 
19F NMR (376 MHz, CDCl3, -anomer):  = -151.00 (dd, J = 53.1, 
24.3 Hz). ESI-HRMS: m/z = [M+Na]+ calcd. for C27H37FNaO18
+: 691.1862; found: 









-D-xylopyranosyl-(1→4)-2,3-di-O-acetyl--D-xylopyranosyl fluoride (SI13) 
 
A solution of SI12 (190 mg, 0.284 mmol), DHP (64.0 L, 0.711 mmol) and pTsOH 
monohydrate (0.910 mg, 4.79 mol) in anhydrous DCM (1.50 mL) was stirred at r.t. for 
4 h. The reaction mixture was diluted with DCM (10 mL) and washed with aq. sat. 
NaHCO3 (10 mL) and brine (10 mL). The organic layer was dried with Na2SO4 and the 
solvent was evaporated. The crude product was purified by column chromatography 
(SiO2, Hex/EtOAc = 1:1) to give fully protected fluoride SI13 (197 mg, 0.261 mmol, 91%) 
as a mixture of diastereomers. 1H NMR (400 MHz, CDCl3):  = 5.62 (dd, J = 53.1, 2.8 Hz, 
1H, H-1), 5.43 – 5.34 (m, 1H, H-3), 5.17 (0.5H, H-1’’), 5.14 (0.5H, H-1’’), 5.01 – 4.89 (m, 
2H, H-2’’, H-4’’), 4.87 – 4.74 (m, 3H, H-2, H-2’, H-4’), 4.70 – 4.63 (m, 1H, CH), 4.51 – 4.15 
(m, 4H, H-1’, H-3’’, H-5’’), 4.14 – 4.00 (m, 1H, CH2), 3.88 – 3.64 (m, 5H, CH2, H-4, H-3’), 
3.53 – 3.43 (m, 1H, CH2), 3.34 – 3.24 (m, 1H, CH2), 2.13 – 2.01 (m, 18H, CH3), 1.85 – 
1.66 (m, 2H, CH2), 1.61 – 1.43 (m, 4H, CH2) ppm. 
13C NMR (101 MHz, CDCl3):  = 170.6, 
170.3, 169.6, 169.2, 169.0, 106.5, 105.8, 103.97 (d, J = 228.9 Hz), 101.3, 100.5, 96.6, 
81.2, 80.8, 80.6, 78.4, 75.7, 75.6, 75.3, 74.7, 72.3, 71.3, 70.7, 70.5, 69.6, 69.6, 65.0, 63.3, 
63.2, 62.9, 61.9, 61.2, 30.6, 30.5, 25.2, 20.9, 20.8, 20.7, 20.6, 20.0, 19.6 ppm. 19F NMR 
(376 MHz, CDCl3): d = -150.96 (dd, J = 53.1, 24.4 Hz) ppm. ESI-HRMS: m/z = [M+Na]
+ 
calcd. for C32H45FNaO19
+: 775.2437; found: 775.2466. IR (neat): 𝜈max = 1226, 1372, 1041, 
706 cm-1. 
α-L-Arabinofuranosyl-(1→3)-4-O-tetrahydropyranosyl--D-xylopyranosyl-(1→4)--D-
xylopyranosyl fluoride (62) 
 
Glycosyl fluoride SI13 (87 mg, 0.116 mmol) was dissolved in anhydrous MeOH 
(2.50 mL) and anhydrous DCM (0.500 mL) at 0 °C. NaOMe (0.5 M in MeOH, 0.450 mL, 
0.260 mmol) was added dropwise and the solution was stirred at 0 °C for 1 h. The 
reaction mixture was neutralized by the careful addition of Amberlite IR-120 (H+) resin. 
The resin was filtered off and the solvents were evaporated to give 4-O-THP protected 





5.60 (dd, J = 53.3, 2.8 Hz, 1H, H-1), 5.40 (s, 0.5H, H-1’’), 5.32 (s, 0.5H, H-1’’), 4.74 – 4.64 
(m, 1H, CH), 4.48 – 4.40 (m, 1H, H-1’), 4.21 – 3.48 (m, 15H, H-2’, H-2’’, H-3, H-3’, H-3’’, 
H-4, H-4’, H-5, H-5’, H-5’’, CH2), 3.44 – 3.24 (m, 2H, CH2, H-2), 1.83 – 1.68 (m, 2H, CH2), 
1.57 – 1.39 (m, 4H, CH2) ppm. 
13C NMR (101 MHz, D2O):  = 108.4, 108.3, 107.7, 106.0, 
101.7, 101.6, 101.5, 97.9, 84.5, 84.3, 81.1, 80.8, 80.4, 77.5, 76.7, 76.2, 75.5, 74.8, 73.5, 
73.2, 71.4, 71.1, 70.9, 70.8, 64.3, 63.9, 63.8, 62.7, 61.1, 61.0, 61.0, 60.9, 30.2, 24.4, 24.4, 
19.5, 19.3 ppm. 19F NMR (376 MHz, D2O):  = -122.34, -152.77 (dd, J = 53.3, 26.3 Hz) 
ppm. ESI-HRMS: m/z = [M+Na]+ calcd. for C20H33FNaO13
+: 523.1803; found: 523.1830. 
4-Methylphenyl β-D-xylopyranosyl-(1→4)-1-thio-β-D-xylopyranoside (63) 
 
The protected disaccharide 76 (730 mg, 0.907 mmol) was dissolved in MeOH 
(10.0 mL) and DCM (5.00 mL) and NaOMe (0.5 M in MeOH, 907 L, 0.453 mmol) was 
added. The mixture was stirred at r.t. for 2 h. After the reaction was finished the mixture 
was neutralized with Amberlite IR-120 (H+) resin, fitered, and the solvents were 
evaporated. The crude product was purified by using a Sep-Pak C18-cartridge (waters, 
3cc, H2O/MeOH = 9:1 to 4:1 to 1:1) to give acceptor 63 (332 mg, 0.885 mmol, 94%) as a 
colorless solid. [𝑎]𝐷
25 = -76.8 (c 0.54, CHCl3). 
1H NMR (400 MHz, D2O): δ = 7.48 – 7.40 (m, 
2H, ArH), 7.27 – 7.22 (m, 2H, ArH), 4.65 (d, J = 9.7 Hz, 1H, H-1), 4.41 (d, J = 4.41, 1H, H-
2’), 4.08 (dd, J = 11.6, 5.3 Hz, 1H, H-5a), 3.93 (dd, J = 11.6, 5.4 Hz, 1H, H-5a’), 3.72 (ddd, 
J = 10.3 Hz, 9.1 Hz, 5.2 Hz, 1H, H-4), 3.64 – 3.52 (m, 2H, H-4’, H-3), 3.46 – 3.17 (m, 5H, 
H-2, H-5b, H-2’, H-3’, H-5b’), 2.32 (s, 3H, CH3) ppm. 
13C NMR (101 MHz, D2O): δ = 132.8, 
132.6, 130.0, 130.3 (6C, Ar), 101.7 (C-1’), 88.1 (C-1), 76.0 (C-4), 75.5 (C-3’), 75.1 (C-4’), 
72.7 (C-2), 71.5 (C-2’), 69.1 (C-3), 66.5 (C-5), 65.1 (C-5’) ppm. ESI-HRMS: m/z [M+Na]+ 
calcd. for C17H24NaO8S





A 300 mM aqueous solution of 4-O-THP protected fluoride 62 (166 µL, 50.0 mol), a 
300 mM aqueous solution of acceptor 63 (200 L, 60.0 mol) and a solution of 





(616 L, 100 mM). The reaction mixture was shaken at r.t. overnight. The reaction was 
stopped by heating the solution to 80 °C for 15 min. The reaction mixture was acidified by 
the addition of 1 M HCl solution (100 L, 1.00 mmol) and it was shaken at r.t. for 30 min. 
The reaction mixture was neutralized by the dropwise addition of 1 M NaOH solution. The 
reaction mixture was centrifuged and the supernatant was subjected to a Sep-Pak C18-
cartridge (waters, 6cc, H2O/MeOH: 1:0 to 1:1) to give compound 60 as a colorless solid 
(30.5 mg, 38.8 µmol, 78%). [𝑎]𝐷
25 = -97.8 (c 0.44, H2O). 
1H NMR (400 MHz, D2O):  = 7.41 
(d, J = 8.1 Hz, 2H), 7.20 (d, J = 7.9 Hz, 2H), 5.29 (d, J = 1.7 Hz, 1H), 4.62 (d, J = 9.7 Hz, 
1H), 4.47 – 4.36 (m, 3H), 4.15 – 4.10 (m, 2H), 4.09 – 4.00 (m, 3H), 3.98 – 3.88 (m, 2H), 
3.80 – 3.45 (m, 8H), 3.39 – 3.19 (m, 7H), 2.28 (s, 3H) ppm. 13C NMR (101 MHz, D2O):  = 
139.2, 132.8, 130.0, 127.3, 108.0, 101.6, 101.5, 101.5, 88.1, 83.9, 81.3, 81.1, 76.4, 76.3, 
76.2, 75.9, 75.1, 73.5, 72.8, 72.6, 72.5, 71.5, 67.7, 66.4, 64.9, 62.9, 61.1, 20.1 ppm. ESI-
HRMS: m/z [M+Na]+ calcd. for C32H48NaO20S
+: 807.2357; found: 807.2372. IR (neat): 𝜈max 




Disaccharide 71 (100 mg, 0.124 mmol) and phosphate donor 68 (98.0 mg, 
0.149 mmol) were dissolved in anhydrous DCM (2.50 mL) and cooled to -50 °C. TMSOTf 
(27.0 µL, 0.149 mmol) was added and the reaction mixture was allowed to slowly warm up 
to -10 °C. After 2 h the reaction was quenched with aq. sat. NaHCO3 solution (5 mL). The 
layers were separated and the aqueous layer was extracted with DCM (2 x 5 mL). The 
combined organic phases were dried over Na2SO4 and filtered. After the solvent was 
evaporated the crude product was purified by silica gel flash column chromatography 
(SiO2, Hex/EtOAc = 4:1) to give protected trisaccharide 77 (113 mg, 90.5 mol, 72%) as a 
colorless solid. [𝑎]𝐷
25 = -4.1 (c 0.91, CHCl3). 
1H NMR (400 MHz, CDCl3): d = 8.00 – 7.86 
(m, 14H, ArH), 7.59 – 7.47 (m, 7H, ArH), 7.42 – 7.27 (m, 17H, ArH), 7.09 – 7.05 (m, 2H, 
ArH), 5.62 – 5.55 (m, 2H, H-3, H-3’’), 5.51 (t, J = 8.1 Hz, 1H, H-3’), 5.26 (t, J = 8.3 Hz, 1H, 
H-2), 5.18 – 5.12 (m, 2H, H-2’, H-2’’), 5.00 (td, J = 6.4, 4.0 Hz, 1H, H-4’’), 4.87 (d, J = 8.4 
Hz, 1H, H-1), 4.70 (dd, J = 5.6, 3.3 Hz, 2H, H-1’, H-1’’), 4.10 (dd, J = 12.0, 4.9 Hz, 1H, H-
5a), 3.99 – 3.91 (m, 2H, H-4, H-5a’’), 3.82 (td, J = 8.2, 4.8 Hz, 1H, H-4’), 3.52 (dd, J = 
12.3, 4.8 Hz, 1H, H-5a’), 3.42 (dd, J = 12.0, 8.9 Hz, 1H, H-5b), 3.34 (dd, J = 12.3, 6.4 Hz, 
1H, H-5b’’), 3.13 (dd, J = 12.3, 8.6 Hz, 1H, H-5b’), 2.31 (s, 3H, CH3) ppm. 





MHz, CDCl3): = 165.4, 165.4, 165.3, 165.2, 165.2, 165.0, 164.9 (6C, C=O), 138.4, 
133.4, 133.4, 133.3, 133.2, 133.1, 130.0, 129.9, 129.8, 129.7, 129.5, 129.4, 129.1, 129.0, 
128.9, 128.6, 128.5, 128.4, 128.3 (48C, ArC), 101.0, 99.4 (2C, C-1’, C-1’’), 86.9 (C-1), 
75.8 (C-4), 74.8 (C-4’), 73.3 (C-3), 71.9 (C-3’), 71.4 (C-2’), 70.4 (C-2), 70.0 (C-2’’), 69.5 
(C-3’’), 68.5 (C-4’’), 66.0 (C-5), 62.1 (C-5’), 60.8 (C-5’’), 21.2 (CH3) ppm. ESI-HRMS: m/z 
[M+Na]+ calcd. for C71H60NaO19S
+: 1271.3347; found: 1271.3386. IR (neat): νmax = 1687, 




The protected trisaccharide 77 (105 mg, 84.1 mol) was dissolved in anhydrous 
MeOH (5.00 mL) and anhydrous DCM (2.50 mL). NaOMe (0.5 M in MeOH, 84.2 L, 
42.1 mol) was added. The mixture was stirred at r.t. overnight. After the reaction was 
finished the mixture was neutralized with Amberlite IR-120 (H+) resin, filtered and the 
solvents were evaporated. The crude product was purified by using a Sep-Pak C18-
cartridge (waters, 3cc, H2O/MeOH = 9:1 to 4:1 to 1:1) to give acceptor 64 (39.4 mg, 
75.7 mol, 90%) as a colorless solid. [𝑎]𝐷
25 = -90.2 (c 0.53, H2O). 
1H NMR (400 MHz, 
D2O):  = 7.34 – 7.24 (m, 2H), 7.09 – 7.02 (m, 2H), 4.51 (d, J = 9.7 Hz, 1H), 4.31 (d, J = 
7.8 Hz, 1H), 4.28 (d, J = 7.8 Hz, 1H), 4.02 – 3.90 (m, 2H), 3.84 (dd, J = 11.5, 5.4 Hz, 1H), 
3.69 – 3.35 (m, 5H), 3.30 (t, J = 9.2 Hz, 1H), 3.26 – 3.09 (m, 6H), 2.16 (s, 3H) ppm. 13C 
NMR (101 MHz, D2O):  = 139.0, 132.8, 129.9, 127.3, 101.7, 101.4, 88.0, 76.2, 75.9, 75.5, 
75.1, 73.5, 72.6, 72.5, 71.5, 69.1, 66.4, 65.1, 62.9, 20.2 ppm. ESI-HRMS: m/z [M+Na]+ 
calcd. for C22H32NaO12S






A 300 mM aqueous solution of 4-O-THP protected fluoride 62 (248 µL, 74.4 mol), a 





XynAE265G (690 µL, 9.3 mg/mL in NaxHxPO4 buffer) was added to NaxHxPO4 buffer 
(750 L, 100 mM). The reaction mixture was shaken at r.t. overnight. The mixture was 
stopped by heating the solution to 80 °C for 15 min. The reaction mixture was acidified by 
the addition of 1 M HCl solution (125 L, 1.25 mmol) and it was shaken at r.t. for 30 min 
The reaction mixture was neutralized by the dropwise addition of 1 M NaOH solution. The 
reaction mixture was centrifuged and the supernatant was subjected to a Sep-Pak C18-
cartridge (waters, 3cc, H2O/MeOH: 1:0 to 1:1) to give compound 61 as a colorless solid 
(43.5 mg, 47.5 µmol, 76%). [𝑎]𝐷
25 = -111.8 (c 0.21, H2O). 
1H NMR (400 MHz, D2O):  = 
7.32 (d, J = 7.8 Hz, 2H), 7.12 (d, J = 7.8 Hz, 2H), 5.19 (s, 1H), 4.54 (d, J = 9.7 Hz, 1H), 
4.40 – 4.29 (m, 4H), 4.06 – 3.91 (m, 6H), 3.88 – 3.79 (m, 2H), 3.70 – 3.51 (m, 7H), 3.49 – 
3.35 (m, 5H), 3.29 – 3.09 (m, 10H), 2.20 (s, 3H) ppm. 13C NMR (101 MHz, D2O):  = 
139.2, 132.8, 129.9, 127.3, 108.0, 101.6, 101.5, 101.5, 88.1, 83.9, 81.3, 81.1, 76.4, 76.3, 
76.2, 76.2, 75.9, 75.1, 73.5, 72.8, 72.6, 72.5, 71.5, 67.7, 66.4, 64.9, 62.8, 61.1, 20.1 ppm. 
ESI-HRMS: m/z [M+Na]+ calcd. for C37H56NaO24S
+: 939.2780; found: 939.2818. IR (neat): 
νmax = 3371, 1044, 988 cm
-1. 
3.4.5 Synthesis of Glycosyl Fluorides and Enyzmatic 
Polymerization 




The crude -D-xylopyranosyl-(1→4)-D-xylopyranose 52 (480 mg) was dissolved in 
acetic anhydride (4.81 mL, 51.0 mmol) and pyridine (15 mL). DMAP (20.8 mg, 
0.170 mmol) was added and the reaction mixture was stirred at r.t. for 4 h. The reaction 
mixture was diluted with DCM (10 mL) and washed with 1 M HCl solution (10 mL). The 
phases were separated and the organic phase was dried with Na2SO4. The solvent was 
evaporated and the crude product was purified by column chromatography (Hex/EtOAc = 
2:1 → 1:1) to give compound SI14 (690 mg, 1.29 mmol, 42% over 3 steps, / = 48/52) 
as a colorless solid. 1H NMR (400 MHz, CDCl3): δ = 6.19 (t, J = 2.9 Hz, 0.5H, C-1), 5.62 
(d, J = 7.4 Hz, 0.5H, C-1), 5.37 (t, J = 9.7 Hz, 0.5H, C-3), 5.14 (t, J = 8.6 Hz, 0.5H, C-





(t, J = 7.0 Hz, 1H, C-2’), 4.57 – 4.50 (m, 1H, C-2), 4.08 (dd, J = 12.5, 5.1 Hz, 1H, H-5a’), 
3.99 (ddd, J = 12.0, 5.1, 1.7 Hz, 0.5H, H-5a), 3.89 – 3.80 (m, 1H, H-4), 3.80 – 3.74 (m, 
0.5H, H-5a), 3.65 (t, J = 11.0 Hz, 0.5H, H-5b), 3.45 (dd, J = 11.8, 9.5 Hz, 0.5H H-5b), 
3.37 (ddd, J = 11.8, 7.6, 2.8 Hz, 1H, H-5b’), 2.09 – 1.98 (m, 18H, CH3) ppm. 
13C NMR 
(101 MHz, CDCl3): δ = 170.1, 170.0, 169.9, 169.9, 169.9, 169.8, 169.7, 169.3, 169.2, 
169.1 (10C, C=O), 100.0 (C-1’), 99.7 (C-1’), 92.3 (C-1), 89.3 (C-1), 75.2 (C-4/), 
74.3 (C-4/), 72.1 (C-3), 70.6 (2C, C-3/’), 70.5 (C-2/’), 70.4 (C-2/’), 69.9 (C-3), 
69.5 (C-2), 68.4 (C-4’), 68.4 (C-4’), 63.5 (C-5), 61.7 (C-5’), 61.3 (C-5), 21.0, 21.0, 20.9, 
20.9, 20.9, 20.9, 20.8, 20.7, 20.7, 20.6 (10C, CH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. 
for C22H30NaO15





Disaccharide SI14 (560 mg, 1.048 mmol) was dissolved in anhydrous DCM (3.00 mL) 
in a plastic vessel. The solution was cooled to -25 °C and HF/pyridine (3.00 mL) was 
added. The biphasic reaction mixture was rigorously stirred at -10 °C for 5 h. The reaction 
mixture was quenched by dropping the mixture carefully into an aq. ammonia solution 
(25%, 10 mL). The phases were separated and the organic phase was washed with aq. 
sat. NaHCO3 solution (20 mL). The aqueous phase was reextracted with DCM (2 x 20 mL) 
and the combined organic phases were dried with Na2SO4. After evaporation of the 
solvent the crude product was subjected to silica column chromatography (EtOAc/Hex = 
1:3) to give disaccharide fluoride SI15 (408 mg, 0.825 mmol, 79%, / =12:1) as a 
colorless solid. [𝑎]𝐷
25 = -40.3 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3, -anomer): δ = 
5.63 (dd, J = 53.0, 2.7 Hz, 1H, H-1), 5.40 (t, J = 9.8 Hz, 1H, H-3), 5.08 (t, J = 7.5 Hz, 1H, 
H-3’), 4.91 – 4.73 (m, 3H, H-2, H-2’, H-4’), 4.57 (d, J = 5.8 Hz, 1H, H-1’), 4.10 (dd, J = 
12.0, 4.5 Hz, 1H, H-5a’), 3.94 – 3.81 (m, 2H, H-4, H-5a), 3.79 – 3.67 (m, 1H, H-5b), 3.40 
(dd, J = 12.1, 7.4 Hz, 1H, H-5b’), 2.08 (s, 3H, CH3), 2.06 – 2.01 (m, 12H, CH3) ppm. 
13C 
NMR (101 MHz, CDCl3,-anomer): δ = 170.3, 170.1, 170.0, 169.7, 169.2 (5C, C=O), 
104.08 (d, J = 229.2 Hz, C-1), 99.5 (C-1’), 74.3 (C-4), 70.8 (C-2), 70.6 (C-2’), 70.3 (C-3’), 
69.6 (C-3), 68.3 (C-4’), 61.5 (C-5’), 61.0 (d, J = 4.9 Hz, C-5), 21.0, 20.9, 20.8, 20.8, 20.7 
(5C, CH3) ppm. 
19F NMR (376 MHz, CDCl3, -anomer): δ = -151.01 (dd, J = 53.1, 24.3 
Hz) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C20H27FNaO13





IR(neat): 𝜈max = 1746, 1371, 1235, 1047 cm
-1. 
-D-Xylopyranosyl-(1→4)--D-xylopyranosyl fluoride (80) 
 
Disaccharide fluoride SI15 (170 mg, 0.211 mmol) was dissolved in anhydrous MeOH 
(10.0 mL) and anhydrous DCM (1.00 mL) at 0 °C. NaOMe (0.5 M in MeOH, 1.00 mL, 
0.500 mmol) was added dropwise and the solution was stirred at 0 °C for 1 h. The 
reaction mixture was neutralized by the careful addition of Amberlite IR-120 (H+) resin. 
The resin was filtered off and the solvents were evaporated to give -D-xylopyranosyl-
(1→4)--D-xylopyranosyl fluoride 80 (60.0 mg, 0.211 mmol, 100%) as a colorless solid. 
1H NMR (400 MHz, D2O):  = 5.63 (dd, J = 53.3, 2.8 Hz, 1H, H-1), 4.45 (d, J = 7.8 Hz, 1H, 
H-1‘), 4.02 – 3.92 (m, 2H, H-5a‘, H-5a), 3.91 – 3.51 (m, 5H, H-4‘, H-5b, H-2, H-3, H-4), 
3.42 (t, J = 9,2 Hz, 1H, H-3‘), 3.35 – 3.20 (m, 2H, H-2‘, H-5b‘) ppm. 13C NMR (101 MHz, 
D2O):  = 107.1 (d, J = 223.7 Hz, C-1), 101.7 (C-1‘), 75.5 (C-3‘), 72.6 (C-2‘), 71.1, 70.8, 
70.7, 69.0, (4C, C-2, C-3, C-4, C-4‘) 65.1 (C-5), 61.0 (C-5‘) ppm. 19F NMR (376 MHz, 
D2O):  = –152.8 (dd, J = 53.3, 26.4 Hz) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for 
C10H17FNaO8




Trisaccharide 53 (567 mg, 1.37 mmol) was dissolved in acetic anhydride (3.87 mL, 
41.1 mmol) and pyridine (5 mL). DMAP (16.7 mg, 0.137 mmol) was added and the 
reaction mixture was stirred at r.t. for 4 h. The reaction mixture was diluted with DCM 
(10 mL) and washed with 1 M HCl (10 mL) solution. The phases were separated and the 
organic phase was dried with Na2SO4. The solvent was evaporated and the crude product 
was purified by column chromatography (Hex/EtOAc = 2:1 to 1:1) to give fully protected 
trisaccharide SI16 (800 mg, 1.06 mmol, 78%, / = 47/53) as a colorless solid. 1H NMR 
(400 MHz, CDCl3): δ = 6.19 (d, J = 3.7 Hz, 0.5H, H-1), 5.63 (d, J = 7.4 Hz, 0.5H, H-1), 
5.38 (dd, J = 10.2, 8.6 Hz, 0.5H, H-3), 5.15 (t, J = 8.6 Hz, 0.5H, H-3), 5.06 (s, 1H, C-1‘‘), 
4.99 – 4.84 (m, 5H, H-2, H-2‘, H-4‘, C-4‘‘), 4.48 – 4.41 (m, 1H, H-1‘), 4.41 – 4.32 (m, 1H, 
H-5a‘‘), 4.23 – 4.13 (m, 2H, H-5b‘‘), 4.06 – 3.95 (m, 1.5H, H-5a‘, H-5a), 3.86 – 3.72 (m, 





5b), 3.30 (dd, J = 12.1, 7.8 Hz, 1H, H-5b‘), 2.18 – 1.97 (m, 18H, CH3) ppm. 
13C NMR 
(101 MHz, CDCl3): δ = 170.7, 170.5, 170.1, 170.0, 170.0, 169.8, 169.8, 169.7, 169.7, 
169.4, 169.3, 169.2, 169.2 (13C, C=O), 106.6 (C-1‘‘), 106.5 (C-1'‘), 101.0 (C-1‘), 100.4 
(C-1'), 92.3 (C-1), 89.3 (C-1, 81.4 (C-4’’), 81.1 (C-3’’), 77.3 (C-3’), 76.7 (C-2’’), 75.8 
(C-4), 74.6 (C-4), 72.1 (C-3), 71.4 (C-2'), 71.1 (C-2’), 70.0 (2C, C2/), 69.7 (C-2), 
69.6 (C-4'), 69.5 (C-4'), 63.6 (C-5), 63.4 (C-5’’), 62.3 (C-5'), 62.2 (C-5'), 61.5 (C-5), 
21.6, 21.1, 21.0, 21.0, 20.9, 20.9, 20.9, 20.8, 20.8, 20.7 (10C, CH3) ppm. ESI-HRMS: m/z 
= [M+Na]+ calcd. for C31H42NaO21
+:773.2116; found: 773.2144. IR (neat): 𝜈max = 1041, 
1070, 1220, 1746 cm-1. 
2,3,5-Tri-O-acetyl--L-arabinofuranosyl-(1→3)-2,4-di-O-acetyl--D-xylopyranosyl-
(1→4)-2,3-di-O-acetyl--D-xylopyranosyl fluoride (SI17) 
 
The protected trisaccharide SI16 (550 mg, 0.733 mmol) was dissolved in anhydrous 
DCM (3.00 mL) in a plastic vessel. The solution was cooled to -25 °C and HF/pyridine 
(3.00 mL) was added. The biphasic system was stirred rigorously for 5 h at -10 °C. The 
reaction mixture was diluted with DCM (5 mL) and was quenched by dropping the mixture 
carefully into aq. ammonia solution (25%, 10 mL). The organic phase was washed with 
aq. sat. NaHCO3 solution (20 mL) and reextracted with DCM (2 x 20 mL). The combined 
organic phases were dried with Na2SO4 and the solvents were evaporated. The crude 
product was purified by column chromatography (SiO2, EtOAc/Hex = 1:2) to give 
trisaccharide fluoride SI17 (463 mg, 0.652 mmol, 89%) as a colorless solid. [𝑎]𝐷
25 = -57.0 
(c 0.92, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 5.63 (dd, J = 53.1 Hz, 2.8 Hz, 1H, H-1), 
5.40 (dd, J = 10.2, 8.5 Hz, 1H, H-3), 5.07 (s, 1H, H-1’’), 4.94 − 4.76 (m, 5H, H-2, H-2’, H-
4’, H-3’’, H-4’’), 4.47 (d, J = 6.11 Hz, 1H, H-1’), 4.37 (dd, J = 10.8, 2.5 Hz, 1H, H-5a’’), 4.24 
− 4.14 (m, 2H, H-3’’, H-5b’’), 4.04 (dd, J = 12.1, 4.8 Hz, 1H, H-5a’), 3.88 − 3.73 (m, 4H, H-
4, H-5a, H-5b, H-3’), 3.32 (dd, J = 12.1, 7.5 Hz, 1H, H-5b’), 2.12 − 2.02 (m, 21H, CH3) 
ppm.13C NMR (101 MHz, CDCl3): δ = 170.5, 170.4, 170.2, 169.9, 169.5, 169.1 (7C, C=O), 
106.4 (C-1’’), 103.94 (d, J = 229.0 Hz, C-1), 100.3 (C-1’), 81.2 (C-4’’), 81.0 (C-3’’), 76.8 
(C-3’), 76.6 (C-2’’), 74.6 (C-3), 71.0 (C-2’), 70.5 (d, J = 24.9 Hz, C-2), 69.4 (2, C-3, C-4’), 
63.2 (C-5’’), 61.9 (C-5’), 61.0 (d, J = 4.7 Hz, C-5), 20.9, 20.8, 20.7, 20.6 (7C, CH3) ppm. 
19F NMR (376 MHz, CDCl3): d = -151.06 (dd, J = 53.2, 24.0 Hz) ppm. 
19F-NMR (400 MHz, 
CDCl3): d = -150.92 (dd, J = 53.1, 24.3 Hz) ppm. ESI-HRMS: m/z = [M+Na]
+ calcd. for 
C29H39FNaO19









Trisaccharide fluoride SI17 (150 mg, 0.211 mmol) was dissolved in anhydrous MeOH 
(9.00 mL) and anhydrous DCM (1.00 mL) at 0 °C. NaOMe (0.5 M in MeOH, 1.00 mL, 
0.500 mmol) was added dropwise and the solution was stirred at 0 °C for 1 h. The 
reaction mixture was neutralized by the careful addition of Amberlite IR-120 (H+) resin. 
The resin was filtered off and the solvents were evaporated to give fully deprotected 
trisaccharide fluoride 81 (88.0 mg, 0.211 mmol, 100%) as a colorless solid. 1H-NMR (400 
MHz, D2O):  = 5.60 (dd, J = 53.3, 2.8 Hz, 1H), 5.30 (d, J = 1.5 Hz, 1H), 4.46 (d, J = 7.8 
Hz, 1H), 4.23 – 4.06 (m, 2H), 4.04 – 3.88 (m, 3H), 3.85 – 3.61 (m, 6H), 3.61 – 3.48 (m, 
2H), 3.43 – 3.22 (m, 3H) ppm. 13C NMR (101 MHz, D2O):  = 108.0, 107.2 (d, J = 223.7 
Hz), 101.7, 83.9, 81.4, 81.1, 76.4, 75.5, 72.7, 71.01 (d, J = 24.9 Hz), 70.8, 67.7, 64.9, 61.2 
ppm. ESI-HRMS: m/z = [M+Na]+ calcd. for C15H25FNaO12





Tetrasaccharide 43 (200 mg) and DMAP (4.47 mg, 36.6 mol) were dissolved in 
pyridine (5 mL). Acetic anhydride (692 L, 7.32 mmol) was added and the reaction 
mixture was stirred at r.t. for 2 h. The reaction mixture was diluted with DCM (10 mL) and 
washed with 1 M HCl (10 mL) solution. The phases were separated and the organic 
phase was dried with Na2SO4. The solvent was evaporated and the crude product was 
purified by column chromatography (SiO2, Hex/EtOAc = 2:1→1:1) to give protected 
trisaccharide SI18 (318 mg, 329 mol, 90%, / = 1:1.5) as a colorless solid. 1H NMR 
(400 MHz, CDCl3):  = 6.13 (d, J = 3.7 Hz, 0.5H, H-1), 5.58 (d, J = 7.2 Hz, 0.5H, H-1), 
5.30 (dd, J = 10.2, 8.7 Hz, 0.5H, H-3), 5.07 (t, J = 8.4 Hz, 0.5H, H-3), 5.03 – 4.96 (m, 
2H, H-3’, H-1’’’), 4.91 – 4.76 (m, 5H, H-2, H-2’’, H-2’’’, H-4’’, H-4’’’), 4.68 (dd, J = 8.7, 6.9 





2H, H-3’’’, H-5b’’’), 3.99 – 3.90 (m, 1.5H, H-5a, H-5a’’), 3.86 (dd, J = 11.9, 5.0 Hz, 1H, H-
5a’), 3.81 – 3.66 (m, 3.5H, H-4, H-5a, H-4’, H-3’’), 3.58 (t, J = 10.6 Hz, 0.5H, H-5b), 
3.40 (dd, J = 12.1, 9.1 Hz, 0.5H, H-5b), 3.33 – 3.19 (m, 2H, H-5b’, H-5b’’), 2.13 – 1.90 
(m, 30H, CH3) ppm. 
13C NMR (101 MHz, CDCl3):  = 170.5, 170.4, 169.9, 169.8, 169.8, 
169.8, 169.6, 169.6, 169.5, 169.4, 169.4, 169.2, 169.1, 169.0 (10C, C=O), 106.3 (C-1’’’), 
100.8, 100.4, 100.2, 100.2 (2C, C-1/’, C-1/’’), 92.1 (C-1), 89.1 (C-1), 81.2 (C-4’’’), 
80.9 (C-3’’’), 76.6 (2C, C-2’’’, C-3’’), 75.8 (C-4), 74.7 (C-4), 74.6 (C-4’), 72.0 (C3), 
71.9. 71.8 (C-3’), 71.0 (C-2’’), 70.9 (C-2’), 69.9 (C-3), 69.6 (C-2), 69.4 (2C, C-2, C-4’’), 
63.3 (C-5), 63.2 (C-5'''), 62.7, 62.7 (C-5’), 61.9, 61.9 (C-5''), 61.3 (C-5), 20.9, 20.8, 20.8, 
20.7, 20.6, 20.5 (20C, CH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for C40H54NaO27
+: 






Tetrasaccharide SI18 (150 mg, 0.155 mmol) was dissolved in anhydrous DMF (6 mL) 
at 0 °C. Hydrazine acetate (14.2 mg, 0.155 mmol) was added and the reaction mixture 
was stirred at 0 °C for 5 h. The reaction mixture was quenched by the addition of 1 M HCl 
solution (10 mL). The phases were separated and the organic phase was washed with aq. 
sat. NaHCO3 solution (10 mL). The organic phase was dried with Na2SO4 and the solvent 
was evaporated to give crude anomeric alcohol (145 mg). The compound (145 mg) was 
dissolved in anhydrous DCM (5 mL). The solution was cooled to 0 °C and Argon gas was 
bubbled through the solution for 5 min. DAST (1.55 M in DCM, 100 L, 0.155 mmol) was 
added and the reaction mixture was stirred at 0 °C. After 1 h the reaction mixture was 
diluted with DCM (5 mL) and the reaction mixture was washed with H2O (20 mL). The 
organic phase was dried with Na2SO4 and the solvent was evaporated to give crude -
fluoride (135 mg). The compound (135 mg) was dissolved in anhydrous DCM (1.00 mL) in 
a plastic vessel. The solution was cooled to -30 °C and HF/pyridine (0.200 mL) was 
added. The biphasic system was stirred rigorously for 2 h at -10 °C. The reaction mixture 
was diluted with DCM (5 mL) and the reaction mixture was quenched by dropping the 
mixture carefully into an aq. ammonia solution (25%, 3 mL). The organic phase was 
washed with aq. sat. NaHCO3 solution (10 mL) and reextracted with DCM (2 x 10 mL). 





The crude product was purified by column chromatography (SiO2, EtOAc/Hex = 2:3 to 1:1) 
to give protected tetrasaccharide fluoride SI19 (110 mg, 0.119 mmol, 77% over 3 steps) 
as a colorless solid. [𝑎]𝐷
25 = -19.5 (c 0.7, CHCl3). 
1H NMR (400 MHz, CDCl3):  =5.62 (dd, 
J = 53.1, 2.8 Hz, 1H, H-1), 5.37 (t, J = 9.6 Hz, 1H, H-3), 5.06 (s, 1H, H-1’’’), 5.04 (t, J = 8.2 
Hz, 1H, H-3’), 4.92 – 4.90 (m, 1H, H-2’’’), 4.89 – 4.84 (m, 3H, H-2’’, H-4’’, H-4’’’), 4.80 
(ddd, J = 24.3, 10.2, 2.8 Hz, 1H, H-2), 4.70 (dd, J = 8.4, 6.7 Hz, 1H, H-2’), 4.47 (d, J = 6.7 
Hz, 1H, H-1’), 4.45 (d, J = 6.3 Hz, 1H, H-1’’), 4.36 (dd, J = 11.5, 3.2 Hz, 1H, H-5a’’’), 4.20 
– 4.18 (m, 1H, H-3’’’), 4.16 (dd, J = 11.5, 5.9 Hz, 1H, H-5b’’’), 4.01 (dd, J = 12.1, 4.8 Hz, 
1H, H-5a’’), 3.91 (dd, J = 12.0, 4.9 Hz, 1H, H-5a’), 3.86 – 3.81 (m, 2H, H-4, H-5a), 3.79 – 
3.70 (m, 3H, H-5b, H-4’, H-3’’), 3.33 (dd, J = 12.0, 8.8 Hz, 1H, H-5b’), 3.29 (dd, J = 12.1, 
7.6 Hz, 1H, H-5b’’), 2.10 – 2.06 (m, 18H, CH3), 2.03 (s, 3H, CH3), 2.01 (s, 3H, CH3), 2.00 
(s, 3H, CH3) ppm. 
13C NMR (101 MHz, CDCl3):  = 170.5, 170.4, 170.2, 169.8, 169.5, 
169.4, 169.1 (10C, C=O), 106.3 (C-1’’’), 103.94 (d, J = 229.3 Hz, C-1), 100.4 (C-1’), 100.2 
(C-1’’), 81.3 (C-4’’’), 81.0 (C-3’’’), 76.7 (2C, C-3’’, C-2’’’), 74.9 (C-4), 74.5 (C-4’), 71.8 (C-
3’), 71.1 (C-2’’), 70.9 (C-2’’), 70.57 (d, J = 24.8 Hz, C-2), 69.6 (C-3), 69.5 (C-4’’), 63.3 (C-
5’’’), 62.6 (C-5’), 62.0 (C-5’’), 61.1, 61.05 (d, J = 4.6 Hz, C-5’’’), 20.9, 20.8, 20.7, 20.7, 
20.7, 20.6, 20.6 (9C, CH3) ppm. 
19F NMR (564 MHz, CDCl3): = -151.10 (dd, J = 53.1, 
24.3 Hz). ESI-HRMS: m/z [M+Na]+ calcd. for C38H51FNaO25
+: 949.2601; found: 949.2641. 
IR (neat): νmax = 1748, 1373, 1223, 1050 cm
-1. 
α-L-Arabinofuranosyl-(1→3)--D-xylopyranosyl-(1→4)--D-xylopyranosyl-(14)--D-
xylopyranosyl fluoride (48) 
 
The protected tetrasaccharide fluoride SI19 (70 mg, 0.0756 mmol) was dissolved in 
anhydrous MeOH (1.50 mL) and anhydrous DCM (0.400 mL) at 0 °C. NaOMe (0.5 M in 
MeOH, 90.0 L, 0.0756 mmol) was added dropwise and the solution was stirred at 0 °C 
for 1 h. The reaction mixture was neutralized by the careful addition of Amberlite IR-120 
(H+) resin. The resin was filtered off and the solvents were evaporated to give fully 
deprotected tetrasaccharide fluoride 48 (42.0 mg, 0.0756 mmol, 100%) as a colorless 
solid. 1H NMR (400 MHz, D2O):  =5.50 (dd, J = 53.3, 2.9 Hz, 1H), 5.19 (s, 1H), 4.38 – 
4.31 (m, 2H), 4.07 – 3.35 (m, 17H), 3.30 – 3.11 (m, 5H) ppm.13C NMR (101 MHz, D2O):  
= 108.0, 107.11 (d, J = 223.8 Hz), 101.6, 83.9, 81.3, 81.1, 76.4, 76.3, 75.4, 73.5, 72.7, 
72.5, 71.1, 70.8, 70.7, 67.7, 64.9, 62.9, 61.1, 60.95 (d, J = 4.1 Hz) ppm. ESI-HRMS: m/z 
[M+Na]+ calcd. for C20H33FNaO16









The unprotected tetrasaccharide 78 (30.0 mg, 54.9 µmol) was dissolved in pyridine 
(5 mL) and acetic anhydride (5.19 mL, 54.9 mmol) and DMAP (0.670 mg, 5.49 µmol) were 
added. The reaction mixture was diluted with DCM (5 mL) and washed with 1 M HCl 
(5 mL) solution. The phases were separated and the organic phase was dried with 
Na2SO4. The solvent was evaporated to give protected tetrasaccharide SI20 (50.1 mg, 
51.7 mol, 94%). 1H NMR (400 MHz, CDCl3):  = 6.18 (d, J = 3.7 Hz, 0.5H, H-1), 5.63 (d, 
J = 7.1 Hz, 0.5H, H-1), 5.35 (t, J = 9.6 Hz, 0.5H, H-3), 5.16 – 5.02 (m, 3.5H, H-3,H-3’, 
H-3’’), 4.96 – 4.89 (m, 3H, H-2/, H-2’’’, H-4’’’), 4.88 – 4.77 (m, 1H, H-4’’), 4.75 (dd, J = 
8.7, 6.8 Hz, 1H, H-2’), 4.52 – 4.46 (m, 1H, H-1’/), 4.42 (d, J = 6.4 Hz, 1H, H-1’’), 4.40 – 
4.30 (m, 2H, H-3’’’, H-5a’’’), 4.17 (dd, J = 11.5, 5.6 Hz, 1H, H-5b’’’), 4.07 – 3.96 (m, 2.5H, 
H-5a, H-5a’, H-5a’’), 3.86 – 3.73 (m, 2.5H, H-5a, H-4, H-4’), 3.68 – 3.59 (m, 0.5H, H-
5b), 3.54 (dd, J = 8.8, 6.4 Hz, 1H, H-2’’), 3.49 – 3.36 (m, 1.5H, H-5b, H-5b’), 3.31 (dd, J 
= 11.9, 8.3 Hz, 1H, H-5b’’), 2.18 – 1.92 (m, 30H) ppm. 13C NMR (101 MHz, CDCl3):  = 
170.7, 170.7, 170.2, 170.2, 170.1, 170.0, 170.0, 169.9, 169.7, 169.7, 169.6, 169.6, 169.4, 
169.3, 169.2, 169.1, 106.5 (C-1’’’), 101.3 (C-1’’), 100.7 (C-1’b), 100.2 (C-1’), 92.1 (C-1), 
89.2 (C-1), 81.2 (C-4’’’), 80.8 (C-3’’’), 76.9 (C-2’’’), 75.8 (C-2’’), 75.6 (C-4), 74.4 (C-4), 
74.2 (C-4’), 71.9, 71.8, 71.7 (3C, C-3, C-3’, C-3’’), 71.0 (C-2’), 70.8 (C-2’), 69.9 (C-3a), 
69.6 (C-2), 69.4 (C-2), 69.2 (C-4’’), 63.3 (2C, C-5, C-5’’’), 62.6 (C-5’), 62.1 (C-5), 
61.3 (C-5’’), 21.0, 20.9, 20.8, 20.7, 20.6 (10C, CH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. 
for C40H54NaO27











The protected tetrasaccharide SI20 (50.1 mg) was dissolved in anhydrous DCM 
(2.00 mL) in a plastic vessel. The solution was cooled to -30 °C and HF/pyridine (1.50 mL) 
was added. The biphasic system was stirred rigorously for 2 h at -20 °C. The reaction 
mixture was diluted with DCM (10 mL) and was quenched by dropping the mixture 
carefully into an aq. ammonia solution (25%, 10 mL). The organic phase was washed with 
aq. sat. NaHCO3 solution (10 mL) and reextracted with DCM (2 x 10 mL). The combined 
organic phases were dried over Na2SO4 and the solvents were evaporated. The crude 
product was purified by column chromatography (SiO2, EtOAc/Hex = 2:1) to give 
protected tetrasaccharide fluoride SI21 (20.5 mg, 22.1 mol, 43%) as a colorless solid. 
[𝑎]𝐷
25 = -19.5 (c 0.7, CHCl3). 
1H NMR (400 MHz, CDCl3):  = 5.62 (dd, J = 53.0, 2.8 Hz, 
1H, H-1), 5.37 (t, J = 9.4 Hz, 1H, H-3), 5.13 – 5.07 (m, 2H, H-1’’’, H-3’’), 5.05 (t, J = 8.2 
Hz, 1H, H-3’), 4.97 – 4.88 (m, 2H, H-2’’’, H-4’’’), 4.88 – 4.76 (m, 2H, H-2, H-4’’), 4.72 (dd, J 
= 8.4, 6.5 Hz, 1H, H-2’), 4.51 (d, J = 6.5 Hz, 1H, H-1’), 4.43 (d, J = 6.4 Hz, 1H, H-1’’), 4.38 
(dd, J = 11.8, 3.9 Hz, 1H, H-5a’’’), 4.35 – 4.30 (m, 1H, H-3’’’), 4.17 (dd, J = 11.8, 5.7 Hz, 
1H, H-5b’’’), 4.03 (dd, J = 12.0, 4.9 Hz, 1H, H-5a’), 3.99 (dd, J = 11.9, 5.0 Hz, 1H, H-5a’’), 
3.89 – 3.76 (m, 3H, H-4, H-4’, H-5a), 3.75 – 3.67 (m, 1H, H-5b), 3.54 (dd, J = 8.8, 6.5 Hz, 
1H, H-2’’), 3.42 (dd, J = 12.1, 8.7 Hz, 1H, H-5b’), 3.31 (dd, J = 12.1, 8.3 Hz, 1H, H-5b’’), 
2.13 – 1.87 (m, 27H) ppm. 13C NMR (101 MHz, CDCl3):  = 170.6, 170.1, 170.0, 169.9, 
169.5, 169.4, 169.2 (9C, C=O), 106.5 (C-1’’’), 103.9 (d, J = 229.1 Hz, C-1), 101.3 (C-1’’), 
100.2 (C-1’), 81.2 (C-4’’’), 80.8 (C-3’’’), 76.8 (C-2’’’), 75.9 (C-2’’), 74.6 (C-4), 74.1 (C-4’), 
71.9 (C-3’’), 71.6 (C-3), 70.8 (C-2’), 70.5 (d, J = 24.7 Hz, C-2), 69.5 (C-3), 69.2 (C-4’’), 
63.2 (C-5’’’), 62.5 (C-5’), 62.1 (C-5’’), 61.0 (d, J = 4.7 Hz, C-5), 20.8, 20.7, 20.6, 20.5 (9C, 
CH3) ppm. 
19F-NMR (400 MHz, CDCl3):  = -152.79 (dd, J = 53.3, 26.4 Hz). ESI-HRMS: 
m/z [M+Na]+ calcd. for C38H51FNaO25
+:949.2601; found: 949.2597. IR (neat): νmax = 1748, 
1373, 1228, 1050 cm-1. 
α-L-Arabinofuranosyl-(1→2)--D-xylopyranosyl-(1→4)--D-xylopyranosyl-(14)--D-
xylopyranosyl fluoride (82) 
 
The protected tetrasaccharide fluoride SI21 (20.5 mg, 22.1 mol) was dissolved in 
anhydrous MeOH (2.00 mL) at 0 °C. NaOMe (0.5 M in MeOH, 40.0 L, 22.1 mol) was 
added dropwise and the solution was stirred at 0 °C for 1 h. The reaction mixture was 
neutralized by the careful addition of Amberlite IR-120 (H+) resin. The resin was filtered off 





(12.1 mg, 22.1 mol, 100%) as a colorless solid. 1H-NMR (400 MHz, D2O):  = 5.91 – 5.44 
(m, 1H), 5.26 (s, 1H), 4.54 (d, J = 7.5 Hz, 1H), 4.45 (d, J = 7.7 Hz, 1H), 4.27 – 4.07 (m, 
3H), 4.02 – 3.49 (m, 13H), 3.43 – 3.23 (m, 4H) ppm. 13C NMR (101 MHz, D2O):  = 108.4, 
107.1 (d, J = 223.6 Hz), 101.6, 100.1, 84.5, 80.9, 78.0, 76.6, 76.0, 75.6, 75.4, 73.6, 72.6, 
70.99 (d, J = 24.9 Hz), 70.7, 69.0, 64.9, 63.0, 61.2, 60.96 (d, J = 3.2 Hz) ppm. 19F-NMR 
(400 MHz, D2O):  = -152.79 (dd, J = 53.3, 26.4 Hz) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. 
for C20H33NaO16F





Pentasaccharide 79 (50.0 mg, 73.7 µmol) was dissolved in pyridine (8 mL) and acetic 
anhydride (6.96 mL, 73.7 mmol) and DMAP (0.899 mg, 7.37 µmol) were added. The 
reaction mixture was stirred at r.t. for 2 h. The reaction mixture was diluted with DCM 
(10 mL) and washed with 1 M HCl (10 mL) solution. The phases were separated and the 
organic phase was dried with Na2SO4. The solvent was evaporated and the crude product 
was purified by column chromatography (SiO2, EtOAc/Hex = 1:1) to give fully protected 
pentasaccharide SI22 (84.0 mg, 71.1 mol, 96%,  = 2:3). 1H NMR (400 MHz, CDCl3): 
= 6.15 (d, J = 3.7 Hz, 0.5H), 5.60 (dd, J = 7.1, 1.7 Hz, 0.5H), 5.34 – 5.28 (m, 0.5H), 5.23 
(d, J = 10.6 Hz, 2H), 5.08 (td, J = 8.2, 1.7 Hz, 0.5H), 5.01 (t, J = 8.3 Hz, 1H), 4.98 – 4.93 
(m, 2H), 4.92 – 4.85 (m, 2H), 4.84 – 4.80 (m, 1H), 4.78 (q, J = 7.1 Hz, 1H), 4.72 – 4.67 (m, 
1H), 4.51 – 4.45 (m, 1H), 4.41 – 4.37 (m, 1H), 4.37 – 4.27 (m, 3H), 4.18 – 4.07 (m, 3H), 
4.01 – 3.94 (m, 1.5H), 3.90 (dd, J = 10.9, 4.4 Hz, 1H), 3.84 – 3.71 (m, 3.5H), 3.63 – 3.55 
(m, 1.5H), 3.46 – 3.33 (m, 1.5H), 3.19 (dd, J = 12.3, 7.4 Hz, 1H), 2.18 – 1.84 (m, 36H) 
ppm. 13C NMR (101 MHz, CDCl3):  = 170.7, 170.7, 170.4, 170.1, 169.9, 169.8, 169.8, 
169.7, 169.5, 169.5, 169.5, 169.4, 169.3, 169.2, 169.2, 169.1, 168.9, 106.3, 106.1, 101.2, 
101.2, 100.4, 100.0, 92.0, 89.1, 81.0, 80.8, 80.6, 80.5, 77.8, 77.8, 77.5, 77.2, 75.2, 74.1, 
73.6, 73.6, 71.7, 71.6, 70.9, 70.8, 70.8, 69.9, 69.6, 69.4, 64.2, 63.4, 63.3, 63.3, 63.1, 62.7, 
62.4, 62.4, 61.3, 20.9, 20.8, 20.7, 20.6, 20.5, 20.4 ppm. ESI-HRMS: m/z [M+Na]+ calcd. 
for C49H66NaO33








(1→4)-2,3-di-O-acetyl--D-xylopyranosyl fluoride (SI23) 
 
The fully protected pentasaccharide SI22 (73.0 mg, 61.7 mol) was dissolved in 
anhydrous DMF (1.50 mL) at 0 °C. Hydrazine acetate (5.70 mg, 61.7 mol) was added 
and the reaction mixture was stirred at 0 °C for 5 h. The reaction mixture was quenched 
by the addition of 1 M HCl solution (10 mL). The phases were separated and the organic 
phase was washed with aq. sat. NaHCO3 solution (10 mL). The organic phase was dried 
with Na2SO4 and the solvent was evaporated to give crude anomeric alcohol (70.3 mg). 
The crude compound (70.3 mg) was dissolved in anhydrous DCM (0.500 mL). The solu-
tion was cooled to 0 °C and Argon was bubbled through the solution for 5 min. DAST 
(8.10 L, 61.7 mol) was added and the reaction mixture was stirred at 0 °C. After 1 h the 
reaction mixture was diluted with DCM (5 mL) and the reaction mixture was washed with 
H2O (5 mL). The organic phase was dried with Na2SO4 and the solvent was evaporated to 
give crude -fluoride (71.0 mg). The crude compound (71.0 mg) was dissolved in 
anhydrous DCM (2.00 mL) in a plastic vessel. The solution was cooled to -30 °C and 
HF/pyridine (0.200 mL) was added. The biphasic system was stirred rigorously for 2 h at -
15 °C. The reaction mixture was diluted with DCM (5 mL) and was quenched by dropping 
the mixture carefully into an aq. ammonia solution (25%, 3 mL). The organic phase was 
washed with aq. sat. NaHCO3 solution (5 mL) and reextracted with DCM (2 x 5 mL). The 
combined organic phases were dried over Na2SO4 and the solvents were evaporated. The 
crude product was purified by column chromatography (SiO2, EtOAc/Hex = 1:1) to give 
protected pentasaccharide fluoride SI23 (31.2 mg, 27.3 mol, 44% over 3 steps) as a 
colorless solid. [𝑎]𝐷
25 = -17.4 (c 0.73, CHCl3). 
1H-NMR (400 MHz, CDCl3):  = 5.61 (dd, J = 
53.1, 2.8 Hz, 1H), 5.37 (t, J = 9.4 Hz, 1H), 5.29 (s, 1H), 5.27 (s, 1H), 5.08 – 4.97 (m, 3H), 
4.92 (d, J = 4.8 Hz, 1H), 4.88 – 4.75 (m, 3H), 4.71 (dd, J = 8.3, 6.5 Hz, 1H), 4.52 (d, J = 
6.5 Hz, 1H), 4.47 – 4.29 (m, 4H), 4.21 – 4.14 (m, 3H), 4.00 (dd, J = 12.0, 4.7 Hz, 1H), 3.93 
(dd, J = 12.2, 5.2 Hz, 1H), 3.85 (t, J = 8.5 Hz, 2H), 3.80 – 3.66 (m, 1H), 3.62 (dd, J = 9.4, 
6.6 Hz, 1H), 3.43 (dd, J = 12.0, 8.5 Hz, 1H), 3.22 (dd, J = 12.2, 7.4 Hz, 1H), 2.26 – 1.88 
(m, 33H, CH3) ppm. 
13C NMR (101 MHz, CDCl3):  = 170.9, 170.6, 170.3, 170.1, 170.0, 
169.7, 169.6, 169.4, 106.5, 106.3, 104.1 (d, J = 229.0 Hz), 101.5, 100.1, 81.2, 81.0, 80.9, 





63.5, 62.9, 62.5, 61.2 (d, J = 4.6 Hz), 21.1, 21.0, 20.9, 20.8, 20.7 ppm.19F-NMR (400 MHz, 
CDCl3):  = -150.99 (dd, J = 53.1, 24.1 Hz) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for 
C47H63FNaO31
+: 1165.3235; found: 1165.3219. IR (neat): νmax = 1740, 1370, 1216, 1023 
cm-1. 
α-L-Arabinofuranosyl-(1→3)-2-O-[α-L-arabinofuranosyl]--D-xylopyranosyl-(1→4)--
D-xylopyranosyl-(1→4)--D-xylopyranosyl fluoride (83) 
 
The protected pentasaccharide fluoride SI23 (20.0 mg, 17.5 mol) was dissolved in 
anhydrous MeOH (4.00 mL) at 0 °C. NaOMe (0.5 M in MeOH, 35.0 L, 17.5 mol) was 
added dropwise and the solution was stirred at 0 °C for 1 h. The reaction mixture was 
neutralized by the careful addition of Amberlite IR-120 (H+) resin. The resin was filtered off 
and the solvent was evaporated to give fully deprotected pentasaccharide fluoride 83 
(11.4 mg, 16.8 mol, 96%) as a colorless solid. 1H-NMR (400 MHz, D2O):  = 5.63 (dd, J = 
53.3, 2.8 Hz, 1H), 5.12 (s, 1H), 5.12 (s, 1H), 4.58 (d, J = 7.4 Hz, 1H), 4.46 (d, J = 7.7 Hz, 
1H), 4.36 – 4.07 (m, 5H), 4.05 – 3.88 (m, 4H), 3.89 – 3.62 (m, 13H), 3.37 – 3.19 (m, 3H) 
ppm. 13C NMR (101 MHz, D2O):  = 108.6, 108.4, 107.1 (d, J = 224.5 Hz), 101.6, 99.9, 
84.3, 83.9, 82.0, 81.1, 81.0, 78.0, 76.6, 76.4, 75.8, 75.4, 73.6, 72.6, 71.0 (d, J = 24.8 Hz), 
70.7, 67.9, 64.7, 62.9, 61.1 (d, J = 7.3 Hz) ppm. 19F-NMR (400 MHz, D2O):  = -152.79 





(14)-2,3-di-O-acetyl--D-xylopyranosyl fluoride (SI24) 
 
Pentasaccharide 60 (30.5 mg, 38.8 µmol) was dissolved in pyridine (5.00 mL) and 
acetic anhydride (3.76 mL, 38.9 mmol) and DMAP (0.474 mg, 3.88 µmol) were added. 
The reaction mixture was stirred at r.t. for 3 h. The reaction mixture was diluted with DCM 
(10 mL) and washed with 1 M HCl (10 mL) solution. The phases were separated and the 





protected thioglycoside (59.0 mg). The crude compound (40.1 mg) was dissolved in 
anhydrous DCM (1.50 mL) in a plastic vessel. The solution was cooled to -50 °C and NIS 
(8.78 mg, 39.0 mol) and HF/pyridine (50.0 L) were added. The biphasic system was 
stirred rigorously for 30 min, then more HF/pyridine (1.00 mL) was added and the reaction 
mixture was allowed to warm up to -15 °C. After 2 h the reaction mixture was diluted with 
DCM (10 mL) and was quenched by dropping the mixture carefully into an aq. ammonia 
solution (25%, 5 mL). The organic phase was washed with aq. sat. NaHCO3 solution 
(10 mL) and reextracted with DCM (2 x 10 mL). The combined organic phases were dried 
over Na2SO4 and the solvents were evaporated. The crude product was purified by 
column chromatography (SiO2, EtOAc/Hex = 1:1 → 3:2) to give protected 
pentasaccharide fluoride SI24 (16.0 mg, 14.0 mol, 53% over 2 steps) as a colorless 
solid. [𝑎]𝐷
25 = -56.8 (c 0.93, H2O). 
1H NMR (400 MHz, CDCl3): δ = 5.62 (dd, J = 53.0, 2.8 
Hz, 1H, H-1), 5.38 (t, J = 9.6 Hz, 1H, H-3), 5.10 – 4.99 (m, 3H, H-1’’’’, H-3’, H-3’’), 4.93 – 
4.76 (m, 5H, H-2, H-2’’’, H-4’’’, H-2’’’’, H-3’’’’), 4.74 – 4.64 (m, 2H, H-2’, H-2’’), 4.49 – 4.42 
(m, 3H, H-1’, H-1’’, H-1’’’), 4.36 (dd, J = 11.3, 3.0 Hz, 1H, H-5a’’’’), 4.24 – 4.14 (m, 2H, H-
4’’’’, H-5b’’’’), 4.01 (dd, J = 12.1, 4.9 Hz, 1H, H-5a’’’), 3.94 – 3.87 (m, 2H, H-5a’, H-5a’’), 
3.87 – 3.79 (m, 2H, H-4, H-5a), 3.79 – 3.68 (m, 4H, H-5b, H-4’, H-4’’, H-3’’’), 3.42 – 3.21 
(m, 3H, H-5b’, H-5b’’, H-5b’’’), 2.18 – 1.96 (m, 33H, CH3) ppm. 
13C NMR (101 MHz, 
CDCl3): δ = 170.6, 170.5, 170.3, 169.9, 169.9, 169.6, 169.5, 169.4, 169.2 (11C, C=O), 
106.5 (C-1’’’’), 104.06 (d, J = 229.5 Hz, C-1), 100.3 (3C, C-1’, C-1’’, C-1’’’), 81.4 (C-4’’’’), 
81.1 (C-3’’’’), 76.8 (2C, C-3’’’, C-2’’’’), 74.9 (C-4), 74.7 (2C, C-4’, C-4’’), 72.0, 71.8 (2C, C-
3’, C-3’’), 71.2 (C-2’’’), 71.0, 70.8 (2C, C-2’, C-2’’), 70.7 (d, J = 24.7 Hz, C-2), 69.6 (2C, C-
3, C-4’’’), 63.4 (C-5’’’’), 62.7, 62.5 (2C, C-5’, C-5’’), 62.1 (C-5’’’), 61.1 (C-5), 21.1, 21.0, 
20.9, 20.8, 20.7 (11C, CH3) ppm. 
19F NMR (564 MHz, CDCl3): δ = -151.07 (dd, J = 53.0, 
24.3 Hz) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C47H63FNaO31
+: 1165.3235; found: 
1165.3230. IR (neat): νmax = 1748, 1372, 1221, 1050 cm
-1. 
α-L-Arabinofuranosyl-(1→3)--D-xylopyranosyl-(1→4)--D-xylopyranosyl-(1→4)--D-
xylopyranosyl-(14)--D-xylopyranosyl fluoride (84) 
 
Pentasaccharide fluoride SI24 (21.0 mg, 18.3 mol) was dissolved in anhydrous 
MeOH (2.00 mL) and anhydrous DCM (0.200 mL) at 0 °C. NaOMe (0.5 M in MeOH, 
36.6 L, 18.3 mol) was added dropwise and the solution was stirred at 0 °C for 1 h. The 





The resin was filtered off and the solvents were evaporated to give fully deprotected 
pentasaccharide fluoride 84 (12.4 mg, 18.2 mol, 99%) as a colorless solid. 1H NMR (400 
MHz, D2O):  = 5.57 (dd, J = 53.3, 2.8 Hz, 1H), 5.26 (d, J = 1.6 Hz, 1H), 4.45 – 4.36 (m, 
3H), 4.13 – 4.09 (m, 2H), 4.05 – 4.01 (m, 2H), 3.94 – 3.86 (m, 3H), 3.81 – 3.76 (m, 1H), 
3.76 – 3.68 (m, 4H), 3.66 – 3.56 (m, 3H), 3.56 – 3.44 (m, 3H), 3.35 – 3.19 (m, 7H) ppm. 
13C NMR (101 MHz, D2O):  = 108.1, 107.24 (d, J = 223.7 Hz), 101.7, 101.7, 101.6, 84.0, 
81.5, 81.2, 76.5, 76.4, 76.3, 75.5, 73.7, 73.6, 72.8, 72.7, 72.7, 71.08 (d, J = 25.0 Hz), 
70.8, 67.8, 65.0, 63.0, 63.0, 61.2, 61.1 (d, J = 4.2 Hz) ppm. ESI-HRMS: m/z [M+Na]+ 
calcd. for C25H41FNaO20






The unprotected hexasaccharide 79 (51.8 mg, 56.6 µmol) was dissolved in pyridine 
(10 mL) and acetic anhydride (5.34 mL, 56.6 mmol) and DMAP (0.689 mg, 5.66 µmol) 
were added. The reaction mixture was stirred at r.t. for 3 h. The reaction mixture was 
diluted with DCM (10 mL) and washed with 1 M HCl (10 mL) solution. The phases were 
separated and the organic phase was dried with Na2SO4. The solvent was evaporated to 
give crude protected thioglycoside (85.2 mg). The crude compound (39.9 mg) was 
dissolved in anhydrous DCM (1.50 mL) in a plastic vessel. The solution was cooled to -
50 °C and NIS (7.59 mg, 33.7 mol) and HF/pyridine (0.05 mL) were added. The biphasic 
system was stirred rigorously for 30 min, then more HF/pyridine (1.00 mL) was added and 
the reaction mixture was allowed to warm up to -15 °C. After 3 h the reaction mixture was 
diluted with DCM (10 mL) and was quenched by dropping the mixture carefully into an aq. 
ammonia solution (25%, 10 mL). The organic phase was washed with aq. sat. NaHCO3 
solution (10 mL) and reextracted with DCM (2 x 10 mL). The combined organic phases 
were dried over Na2SO4 and the solvents were evaporated. The crude product was 
purified by column chromatography (SiO2, EtOAc/Hex = 1:1 to 3:2) to give protected 
hexasaccharide fluoride SI25 (18.9 mg, 13.9 mol, 52% over 2 steps) as a colorless solid. 
[𝑎]𝐷
25 = -68.2 (c 0.67, CHCl3). 
1H NMR (400 MHz, CDCl3):  = 5.63 (dd, J = 53.1, 2.8 Hz, 
1H, H-1), 5.38 (dd, J = 10.2, 8.6 Hz, 1H, H-3), 5.12 – 4.99 (m, 4H, H-1‘‘‘‘‘, H-3‘, H-3‘‘, H-





H-2‘‘‘), 4.51 – 4.42 (m, 4H, H-1‘, H-1‘‘, H-1‘‘‘, H-1‘‘‘‘), 4.39 – 4.33 (m, 1H, H-5a‘‘‘‘‘), 4.22 – 
4.13 (m, 2H, H-4‘‘‘‘‘, H-5b‘‘‘‘‘), 4.01 (dd, J = 12.1, 4.8 Hz, 1H, H-5a‘‘‘‘), 3.94 – 3.87 (m, 2H, 
H-5a‘, H-5a‘‘, H-5a‘‘‘), 3.86 – 3.67 (m, 6H, H-4, H-5, H-4‘, H-4‘‘, H-4‘‘‘, H-3‘‘‘‘), 3.35 – 3.25 
(m, 4H, H-5b‘, H-5b‘‘, H-5b‘‘‘), 2.14 – 1.94 (m, 39H, CH3) ppm. 
13C NMR (101 MHz, 
CDCl3):  = 170.6, 170.4, 170.3, 169.9, 169.8, 169.8, 169.6, 169.4, 169.4, 169.3, 169.2 
(13C, C=O), 106.3 (C-1‘‘‘‘‘), 103.93 (d, J = 229.1 Hz, C-1), 100.3, 100.3, 100.2, 100.0 (4C, 
C-1‘, C-1‘‘, C-1‘‘‘, C-1‘‘‘‘), 81.3 (C-4‘‘‘‘‘), 81.0 (C-3‘‘‘‘‘),76.6 (2C, C-3‘‘‘‘, C-2‘‘‘‘‘), 74.9, 74.6, 
74.4 (4C, C-4, C-4‘, C-4‘‘, C-4‘‘‘), 71.9, 71.7 (3C, C-3‘, C-3‘‘, C-3‘‘‘), 70.9, 70.7 (4C, C-2‘, 
C-2‘‘, C-2‘‘‘, C-2‘‘‘‘), 70.54 (d, J = 24.9 Hz, C-2), 69.5 (2C, C-3, C-4‘‘‘‘), 63.3 (C-5‘‘‘‘‘), 62.6, 
62.4, 62.4 (3C, C-5‘, C-5‘‘, C-5‘‘‘), 61.9 (C-5‘‘‘‘), 61.02 (d, J = 4.8 Hz, C-5), 21.0, 20.9, 
20.8, 20.7, 20.6 (13C, CH3) ppm. 
19F NMR (376 MHz, CDCl3):  = -151.05 (dd, J = 53.0, 
24.1 Hz) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C56H75FNaO37
+: 1381.3869; found: 
1381.3931. IR (neat): νmax = 1745, 1372, 1219, 1048 cm
-1. 
α-L-Arabinofuranosyl-(1→3)--D-xylopyranosyl-(1→4)--D-xylopyranosyl-(1→4)--D-
xylopyranosyl-(1→4)--D-xylopyranosyl-(14)--D-xylopyranosyl fluoride (85) 
 
The protected hexasaccharide fluoride SI25 (18.9 mg, 13.9 mol) was dissolved in 
anhydrous MeOH (1.00 mL) and anhydrous DCM (0.200 mL) at 0 °C. NaOMe (0.5 M in 
MeOH, 30.0 L, 13.9 mol) was added dropwise and the solution was stirred at 0 °C for 
1 h. The reaction mixture was neutralized by the careful addition of Amberlite IR-120 (H+) 
resin. The resin was filtered off and the solvents were evaporated to give fully deprotected 
hexasaccharide fluoride 85 (11.3 mg, 13.9 mol, 100%) as a colorless solid. 1H NMR (400 
MHz, D2O):  = 5.51 (dd, J = 53.3, 2.8 Hz, 1H), 5.19 (s, 1H), 4.40 – 4.26 (m, 4H), 4.10 – 
3.90 (m, 5H), 3.88 – 3.80 (m, 3H), 3.77 – 3.36 (m, 13H), 3.28 – 3.09 (m, 9H) ppm. 13C 
NMR (101 MHz, D2O):  = 108.0, 107.17 (d, J = 223.4 Hz), 101.6, 101.6, 101.6, 83.9, 
81.4, 81.1, 76.4, 76.3, 76.3, 75.4, 73.6, 73.6, 72.7, 72.6, 72.6, 71.1, 70.9, 70.8, 67.7, 64.9, 
62.9, 61.2, 61.0 ppm. 19F NMR (564 MHz, D2O):  = -152.67 (dd, J = 53.3, 26.5 Hz) ppm. 
ESI-HRMS: m/z [M+Na]+ calcd. for C30H49FNaO24








3.4.5.2 Glycosynthase-Catalyzed Enzymatic Polymerizations 
General procedure: An aqueous solution of the fluoride donor (600 mM) and a 
phosphate buffered solution of XynAE265G (7.70 mg/mL, VFluoride/VXT6E265G = 1:3.6) were 
added to NaxHxPO4 buffer (100 mM, VFluoride/Vbuffer = 1:5). The reaction was shaken at r.t. 
overnight. If a white precipitate was formed, it was centrifuged and washed three times 
with MilliQ water to give a water-insoluble fraction of polysaccharides. The aqueous phase 
was removed with a pipette, heated to 80 °C for 15 min to inactivate the glycosynthase 
and the precipitate was centrifuged off. The remaining solution was passed through a 
Sep-Pak C18-cartridge (Waters, H2O/MeOH: 1:0 to 1:1) to give a water-soluble fraction of 
polysaccharides. If no precipitate was formed the solution was heated to 80 °C for 15 min 
to inactivate the glycosynthase and the precipitate was centrifuged off. The remaining 
solution was passed through a Sep-Pak C18-cartridge (Waters, H2O/MeOH: 1:0 to 1:1) to 
a give water-soluble fraction of polysaccharides. 
(1→4)--D-Xylan (XX)n (86) 
 
Fluoride donor: 34.6 mg 
Water-soluble fraction: 0.98 mg (3%) 










Water-insoluble fraction: 13.9 mg (43%) 
13C NMR (DMSO-d6, 161 MHz): X-Ray diffractorgramm: 
 
-L-Arabinofuranosyl-(1→3)--D-xylosyl-(1→4)--D-xylan (A3X)n (87) 
 
 
Fluoride donor: 103 mg; Yield: 55.0 mg (51%) 














Fluoride donor: 45.4 mg 
 
Water-soluble fraction: 5.87 mg, (13%) 




Water-insoluble fraction: 24.6 mg (56%) 











Fluoride donor: 4.18 mg 
 
Water-soluble fraction: 0.42 mg (10%). 




Water-insoluble fraction: 2.31 mg (57%) 









syl-(1→4)--D-xylan (A2,3XX)n (89) 
 
Fluoride donor: 6.00 mg; Yield: 1.83 mg (31%) 





(1→4)--D-xylan (A3XXX)n (90) 
 
Fluoride donor: 4.49 mg; Yield: 1.24 mg (28%)  









(1→4)--D-xylosyl-(1→4)--D-xylan (A3XXXX)n (91) 
 
Fluoride donor: 3.65 mg; Yield: 0.98 mg (27%) 
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